Sila Realty Trust (SILA) 10-K 27 Mar 20 2019 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2019	Mar. 24, 2020	Jun. 30, 2019
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Entity Registrant Name	Carter Validus Mission Critical REIT II, Inc.
Entity Central Index Key	0001567925
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Shell Company	false
Class A shares [Member]
Entity Public Float			$ 759,644
Entity Common Stock, Shares Outstanding		166,408
Class I shares [Member]
Entity Public Float			115,530
Entity Common Stock, Shares Outstanding		12,544
Class T shares [Member]
Entity Public Float			354,325
Entity Common Stock, Shares Outstanding		38,939
Class T2 shares [Member]
Entity Public Float			$ 31,899
Entity Common Stock, Shares Outstanding		3,496

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Real estate:
Land	$ 343,444	$ 246,790
Buildings and improvements, less accumulated depreciation of $128,304 and $84,594, respectively	2,422,102	1,426,942
Construction in progress	2,916	0
Total real estate, net	2,768,462	1,673,732
Cash and cash equivalents	69,342	68,360
Acquired intangible assets, less accumulated amortization of $64,164 and $42,081, respectively	285,459	154,204
Right-of-use assets - operating leases	29,537
Other assets, net	86,734	67,533
Total assets	3,239,534	1,963,829
Liabilities:
Notes payable, net of deferred financing costs of $2,500 and $3,441, respectively	454,845	464,345
Credit facility, net of deferred financing costs of $7,385 and $2,489, respectively	900,615	352,511
Accounts payable due to affiliates	9,759	12,427
Accounts payable and other liabilities	45,354	29,555
Acquired intangible liabilities, less accumulated amortization of $12,332 and $7,592, respectively	59,538	57,606
Operating lease liabilities	31,004
Total liabilities	1,501,115	916,444
Stockholders’ equity:
Preferred stock, $0.01 par value per share, 100,000,000 shares authorized; none issued and outstanding
Common stock, $0.01 par value per share, 510,000,000 and 500,000,000 shares authorized, respectively; 231,416,123 and 143,412,353 shares issued, respectively; 221,912,714 and 136,466,242 shares outstanding, respectively	2,219	1,364
Additional paid-in capital	1,981,848	1,192,340
Accumulated distributions in excess of earnings	(240,946)	(152,421)
Accumulated other comprehensive (loss) income	(4,704)	6,100
Total stockholders’ equity	1,738,417	1,047,383
Noncontrolling interests	2	2
Total equity	1,738,419	1,047,385
Total liabilities and stockholders’ equity	$ 3,239,534	$ 1,963,829

CONSOLIDATED BALANCE SHEETS (PA

CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Buildings and improvements, accumulated depreciation	$ 128,304	$ 84,594
Acquired intangible assets, accumulated amortization	64,164	42,081
Notes payable, deferred financing costs	2,500	3,441
Credit facility, deferred financing costs	7,385	2,489
Acquired intangible liabilities, accumulated amortization	$ 12,332	$ 7,592
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	510,000,000	500,000,000
Common stock, shares issued (in shares)	231,416,123	143,412,353
Common stock, shares outstanding (in shares)	221,912,714	136,466,242

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Revenue:
Rental revenue	$ 210,901	$ 177,333	$ 125,087
Expenses:
Rental expenses	40,984	37,327	26,096
General and administrative expenses	8,421	5,396	4,069
Asset management fees	16,475	13,114	9,963
Depreciation and amortization	74,104	58,258	41,133
Impairment loss on real estate	21,000	0	0
Total expenses	160,984	114,095	81,261
Gain on real estate disposition	79	0	0
Income from operations	49,996	63,238	43,826
Interest and other expense, net	47,214	34,365	22,547
Net income attributable to common stockholders	2,782	28,873	21,279
Other comprehensive (loss) income:
Unrealized (loss) income on interest rate swaps, net	(10,907)	2,390	2,870
Other comprehensive (loss) income	(10,907)	2,390	2,870
Comprehensive (loss) income attributable to common stockholders	$ (8,125)	$ 31,263	$ 24,149
Weighted average number of common shares outstanding:
Basic (in shares)	157,247,345	131,040,645	101,714,148
Diluted (in shares)	157,271,668	131,064,388	101,731,944
Net income per common share attributable to common stockholders:
Basic (in dollars per share)	$ 0.02	$ 0.22	$ 0.21
Diluted (in dollars per share)	$ 0.02	$ 0.22	$ 0.21

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Distributions in Excess of Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total Stockholders’ Equity [Member]	Noncontrolling Interests [Member]
Balance, (in shares) at Dec. 31, 2016		82,744,288
Balance, at Dec. 31, 2016	$ 668,428	$ 827	$ 723,859	$ (57,100)	$ 840	$ 668,426	$ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		39,920,746
Issuance of common stock	386,091	$ 399	385,692			386,091	0
Issuance of common stock under the distribution reinvestment plan (in shares)		3,536,813
Issuance of common stock under the distribution reinvestment plan	32,264	$ 35	32,229			32,264	0
Issuance of common stock in connection with the REIT Merger	0
Vesting of restricted stock (in shares)		6,750
Vesting of restricted stock	76	$ 0	76			76	0
Commissions on sale of common stock and related dealer manager fees	(22,713)		(22,713)			(22,713)	0
Distribution and servicing fees	(9,617)		(9,617)			(9,617)	0
Other offering costs	(7,480)		(7,480)			(7,480)	0
Repurchase of common stock (in shares)		(1,880,820)
Repurchase of common stock	(17,159)	$ (18)	(17,141)			(17,159)	0
Issuance of noncontrolling interests	0
Distributions to common stockholders	(63,488)			(63,488)		(63,488)	0
Other comprehensive income (loss)	2,870				2,870	2,870	0
Net income (loss)	21,279			21,279		21,279	0
Balance, (in shares) at Dec. 31, 2017		124,327,777
Balance, at Dec. 31, 2017	990,551	$ 1,243	1,084,905	(99,309)	3,710	990,549	2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		12,376,366
Issuance of common stock	118,605	$ 124	118,481			118,605	0
Issuance of common stock under the distribution reinvestment plan (in shares)		4,453,653
Issuance of common stock under the distribution reinvestment plan	40,938	$ 44	40,894			40,938	0
Issuance of common stock in connection with the REIT Merger	0
Vesting of restricted stock (in shares)		9,000
Vesting of restricted stock	90	$ 0	90			90	0
Commissions on sale of common stock and related dealer manager fees	(4,836)		(4,836)			(4,836)	0
Distribution and servicing fees	(368)		(368)			(368)	0
Other offering costs	(3,643)		(3,643)			(3,643)	0
Repurchase of common stock (in shares)		(4,700,554)
Repurchase of common stock	(43,230)	$ (47)	(43,183)			(43,230)	0
Issuance of noncontrolling interests	0
Distributions to common stockholders	(81,985)			(81,985)		(81,985)	0
Other comprehensive income (loss)	2,390				2,390	2,390	0
Net income (loss)	$ 28,873			28,873		28,873	0
Balance, (in shares) at Dec. 31, 2018	136,466,242	136,466,242
Balance, at Dec. 31, 2018	$ 1,047,385	$ 1,364	1,192,340	(152,421)	6,100	1,047,383	2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under the distribution reinvestment plan (in shares)		4,317,245
Issuance of common stock under the distribution reinvestment plan	39,934	$ 43	39,891			39,934	0
Issuance of common stock in connection with the REIT Merger (in shares)		83,676,775
Issuance of common stock in connection with the REIT Merger	774,010	$ 837	773,173			774,010	0
Vesting of restricted stock (in shares)		9,750
Vesting of restricted stock	89	$ 0	89			89	0
Distribution and servicing fees	563		563			563	0
Other offering costs	(578)		(578)			(578)	0
Repurchase of common stock (in shares)		(2,557,298)
Repurchase of common stock	(23,655)	$ (25)	(23,630)			(23,655)	0
Issuance of noncontrolling interests	1					0	1
Distributions to noncontrolling interests	(1)					0	(1)
Distributions to common stockholders	(91,204)			(91,204)		(91,204)	0
Other comprehensive income (loss)	(10,907)				(10,907)	(10,907)	0
Net income (loss)	$ 2,782			2,782		2,782	0
Balance, (in shares) at Dec. 31, 2019	221,912,714	221,912,714
Balance, at Dec. 31, 2019	$ 1,738,419	$ 2,219	$ 1,981,848	$ (240,946)	$ (4,704)	$ 1,738,417	$ 2

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net income attributable to common stockholders	$ 2,782	$ 28,873	$ 21,279
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	74,104	58,258	41,133
Amortization of deferred financing costs	2,825	2,810	2,612
Amortization of above-market leases	1,013	552	309
Amortization of below-market leases	(5,261)	(4,832)	(2,126)
Reduction in the carrying amount of right-of-use assets - operating leases, net	577	0	0
Gain on real estate disposition	(79)	0	0
Impairment loss on real estate	21,000	0	0
Straight-line rent	(14,207)	(13,364)	(10,596)
Stock-based compensation	89	90	76
Ineffectiveness of interest rate swaps	0	98	(58)
Changes in operating assets and liabilities:
Accounts payable and other liabilities	2,214	5,151	5,385
Accounts payable due to affiliates	1,151	413	645
Other assets	(6,099)	(3,838)	(6,832)
Net cash provided by operating activities	80,109	74,211	51,827
Cash flows from investing activities:
Investment in real estate	(528,259)	(217,332)	(604,372)
Proceeds from real estate disposition	2,882	0	0
Capital expenditures	(12,841)	(15,583)	(32,511)
Real estate deposits, net	(100)	100	190
Net cash used in investing activities	(538,318)	(232,815)	(636,693)
Cash flows from financing activities:
Proceeds from issuance of common stock	0	118,605	386,091
Proceeds from notes payable	0	0	309,452
Payments on notes payable	(10,441)	(349)	(43)
Proceeds from credit facility	605,000	155,000	240,000
Payments on credit facility	(52,000)	(20,000)	(240,000)
Payments of deferred financing costs	(6,351)	(4,958)	(3,564)
Repurchase of common stock	(23,655)	(43,230)	(17,159)
Offering costs on issuance of common stock	(4,146)	(12,388)	(32,079)
Distributions to common stockholders	(49,494)	(40,296)	(28,994)
Distributions to noncontrolling interests	(1)	0	0
Net cash provided by financing activities	458,912	152,384	613,704
Net change in cash, cash equivalents and restricted cash	703	(6,220)	28,838
Cash, cash equivalents and restricted cash - Beginning of year	79,527	85,747	56,909
Cash, cash equivalents and restricted cash - End of year	80,230	79,527	85,747
Supplemental cash flow disclosure:
Interest paid, net of interest capitalized of $142, $1,179 and $2,137, respectively	43,132	32,503	20,867
Supplemental disclosure of non-cash transactions:
Common stock issued through distribution reinvestment plan	39,934	40,938	32,264
Equity consideration transferred in the REIT Merger	774,010	0	0
Net assets assumed in the REIT Merger	778	0	0
Issuance of noncontrolling interests	1	0	0
Distribution and servicing fees accrued during the period	0	0	7,626
Liabilities assumed at acquisition	0	0	6,551
Credit facility revolving loan to term loan conversion	30,000	0	0
Accrued capital expenditures	126	0	2,643
Accrued deal costs	$ 139	$ 0	$ 0

CONSOLIDATED STATEMENTS OF CA_2

CONSOLIDATED STATEMENTS OF CASH FLOWS (PARENTHETICAL) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Statement of Cash Flows [Abstract]
Interest capitalized	$ 142	$ 1,179	$ 2,137

Organization and Business Opera

Organization and Business Operations	12 Months Ended
	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Business Operations	Organization and Business Operations Carter Validus Mission Critical REIT II, Inc., or the Company, is a Maryland corporation that was formed on January 11, 2013. The Company elected, and currently qualifies, to be taxed as a real estate investment trust, or a REIT, under the Internal Revenue Code of 1986, as amended, or the Code, for federal income tax purposes. Substantially all of the Company’s business is conducted through Carter Validus Operating Partnership II, LP, a Delaware limited partnership, or the Operating Partnership, formed on January 10, 2013. The Company is the sole general partner of the Operating Partnership, and Carter Validus Advisors II, LLC, or the Advisor, is the special limited partner of the Operating Partnership. The Company was formed to invest primarily in quality income-producing commercial real estate, with a focus on data centers and healthcare properties, preferably with long-term leases to creditworthy tenants, as well as to make other real estate-related investments in such property types, which may include equity or debt interests, including securities, in other real estate entities. As of December 31, 2019 , the Company owned 152 real estate properties. The Company raised the equity capital for its real estate investments through two public offerings, or the Offerings, from May 2014 through November 2018, and the Company has offered shares pursuant to its distribution reinvestment plan, or the DRIP, pursuant to two Registration Statements on Form S-3 (each, a “DRIP Offering” and together the "DRIP Offerings") since November 2017. On April 11, 2019, the Company, along with Carter Validus Mission Critical REIT, Inc., or REIT I, the Operating Partnership, Carter/Validus Operating Partnership, LP, the operating partnership of REIT I, or CVOP, and Lightning Merger Sub, LLC, a wholly-owned subsidiary of the Company, or Merger Sub, entered into an Agreement and Plan of Merger, or the Merger Agreement. Pursuant to the terms and conditions of the Merger Agreement, on October 4, 2019 , REIT I merged with and into Merger Sub, or the REIT Merger, with Merger Sub surviving the REIT Merger, or the Surviving Entity, such that following the REIT Merger, the Surviving Entity continues as a wholly-owned subsidiary of the Company. In accordance with the applicable provisions of the Maryland General Corporation Law, the separate existence of REIT I ceased. The combined company after the REIT Merger, or the Combined Company, retained the name “Carter Validus Mission Critical REIT II, Inc.” See Note 3—"Acquisitions and Dispositions" for further discussion. Substantially all of the Company's business is managed by the Advisor. The Advisor is managed by, and is a subsidiary of, the Company's sponsor, Carter Validus REIT Management Company II, LLC, or the Sponsor. Carter Validus Real Estate Management Services II, LLC, or the Property Manager, a wholly-owned subsidiary of the Sponsor, serves as the Company's property manager. The Advisor and the Property Manager received, and will continue to receive, fees during the acquisition and operational stages and the Advisor may be eligible to receive fees during the Company's liquidation stage. SC Distributors, LLC, an affiliate of the Advisor, or the Dealer Manager, served as the dealer manager of the Offerings. The Dealer Manager received fees for services related to the Offerings. The Company continues to pay the Dealer Manager a distribution and servicing fee with respect to Class T and Class T2 shares that were sold in the Offerings. Except as the context otherwise requires, the “Company” refers to Carter Validus Mission Critical REIT II, Inc., the Operating Partnership and all wholly-owned subsidiaries.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements. Such consolidated financial statements and the accompanying notes thereto are the representation of management. These accounting policies conform to United States generally accepted accounting principles, or GAAP, in all material respects, and have been consistently applied in preparing the consolidated financial statements. Principles of Consolidation and Basis of Presentation The accompanying consolidated financial statements include the accounts of the Company, the Operating Partnership, and all wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of the consolidated financial statements and accompanying notes in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates are made and evaluated on an ongoing basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates. Restricted Cash Restricted cash consists of restricted cash held in escrow and restricted bank deposits. Restricted cash held in escrow includes cash held by lenders in escrow accounts for tenant and capital improvements, repairs and maintenance and other lender reserves for certain properties, in accordance with the respective lender’s loan agreement. Restricted bank deposits consist of tenant receipts for certain properties which are required to be deposited into lender-controlled accounts in accordance with the respective lender's loan agreement. Restricted cash held in escrow and restricted bank deposits are reported in other assets, net in the accompanying consolidated balance sheets . See Note 7—"Other Assets, Net." The following table presents a reconciliation of the beginning of year and end of year cash, cash equivalents and restricted cash reported within the consolidated balance sheets to the totals shown in the consolidated statements of cash flows (amounts in thousands): Year Ended Beginning of year: 2019 2018 2017 Cash and cash equivalents 68,360 74,803 50,446 Restricted cash 11,167 10,944 6,463 Cash, cash equivalents and restricted cash $ 79,527 $ 85,747 $ 56,909 End of year: Cash and cash equivalents 69,342 68,360 74,803 Restricted cash 10,888 11,167 10,944 Cash, cash equivalents and restricted cash $ 80,230 $ 79,527 $ 85,747 Deferred Financing Costs Deferred financing costs are loan fees, legal fees and other third-party costs associated with obtaining financing. These costs are amortized over the terms of the respective financing agreements using the effective interest method. Unamortized deferred financing costs are generally expensed when the associated debt is refinanced or repaid before maturity unless specific rules are met that would allow for the carryover of such costs to the refinanced debt. Costs incurred in seeking financing transactions that do not close are expensed in the period in which it is determined that the financing will not close. Deferred financing costs are recorded as a reduction of the related debt on the accompanying consolidated balance sheets . Deferred financing costs related to a revolving line of credit are recorded in other assets, net , on the accompanying consolidated balance sheets . Leasing Commission Fees Leasing commission fees are fees incurred for the initial lease-up, leasing-up of newly constructed properties or re-leasing to existing tenants. Leasing commission fees are capitalized in other assets, net , in the accompanying consolidated balance sheets and amortized over the terms of the related leases. Investment in Real Estate Real estate costs related to the acquisition, development, construction and improvement of properties are capitalized. Repair and maintenance costs are expensed as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset in determining the appropriate useful life. Real estate assets, other than land, are depreciated or amortized on a straight-line basis over each asset’s useful life. The Company anticipates the estimated useful lives of its assets by class as follows: Buildings and improvements 15 – 40 years Tenant improvements Shorter of lease term or expected useful life Furniture, fixtures, and equipment 3 – 10 years Allocation of Purchase Price of Real Estate Upon the acquisition of real properties, the Company evaluates whether the acquisition is a business combination or an asset acquisition. For both business combinations and asset acquisitions we allocate the purchase price of properties to acquired tangible assets, consisting of land, buildings and improvements, and acquired intangible assets and liabilities, consisting of the value of above-market and below-market leases and the value of in-place leases. For asset acquisitions, the Company capitalizes transaction costs and allocates the purchase price using a relative fair value method allocating all accumulated costs. For business combinations, the Company expenses transaction costs incurred and allocates the purchase price based on the estimated fair value of each separately identifiable asset and liability. Acquisition fees and costs associated with transactions determined to be asset acquisitions are capitalized in total real estate, net in the accompanying consolidated balance sheets. For the years ended December 31, 2019, 2018 and 2017, all of the Company's acquisitions were determined to be asset acquisitions. The fair values of the tangible assets of an acquired property (which includes land, buildings and improvements) are determined by valuing the property as if it were vacant, and the “as-if-vacant” value is then allocated to land and buildings and improvements based on management’s determination of the relative fair value of these assets. Management determines the as-if-vacant fair value of a property using methods similar to those used by independent appraisers. Factors considered by management in performing these analyses include an estimate of carrying costs during the expected lease-up periods considering current market conditions and costs to execute similar leases, including leasing commissions and other related costs. In estimating carrying costs, management includes real estate taxes, insurance, and other operating expenses during the expected lease-up periods based on current market conditions. The fair values of above-market and below-market in-place leases are recorded based on the present value (using an interest rate which reflects the risks associated with the leases acquired) of the difference between (i) the contractual amounts to be paid pursuant to the in-place leases and (ii) an estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease including any fixed rate bargain renewal periods, with respect to a below-market lease. The above-market and below-market lease values are capitalized as intangible lease assets or liabilities. Above-market lease values are amortized as an adjustment of rental revenue over the remaining terms of the respective leases. Below-market leases are amortized as an adjustment of rental revenue over the remaining terms of the respective leases, including any fixed rate bargain renewal periods. If a lease were to be terminated prior to its stated expiration, all unamortized amounts of above-market and below-market in-place lease values related to that lease would be recorded as an adjustment to rental revenue. The fair values of in-place leases include an estimate of direct costs associated with obtaining a new tenant and opportunity costs associated with lost rentals that are avoided by acquiring an in-place lease. Direct costs associated with obtaining a new tenant include commissions, tenant improvements, and other direct costs and are estimated based on management’s consideration of current market costs to execute a similar lease. The value of opportunity costs is calculated using the contractual amounts to be paid pursuant to the in-place leases over a market absorption period for a similar lease. These lease intangibles are amortized to depreciation and amortization expense over the remaining terms of the respective leases. If a lease were to be terminated prior to its stated expiration, all unamortized amounts of in-place lease assets relating to that lease would be expensed. Impairment of Long-Lived Assets The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate and related intangible assets may not be recoverable. When indicators of potential impairment suggest that the carrying value of real estate and related intangible assets may not be recoverable, the Company assesses the recoverability of the assets by estimating whether the Company will recover the carrying value of the assets through its undiscounted future cash flows and their eventual disposition. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of the assets, the Company will record an impairment loss to the extent that the carrying value exceeds the estimated fair value of the assets. When developing estimates of expected future cash flows, the Company makes certain assumptions regarding future market rental income amounts subsequent to the expiration of current lease arrangements, property operating expenses, terminal capitalization and discount rates, the expected number of months it takes to re-lease the property, required tenant improvements and the number of years the property will be held for investment. The use of alternative assumptions in the future cash flow analysis could result in a different determination of the property’s future cash flows and a different conclusion regarding the existence of an impairment, the extent of such loss, if any, as well as the carrying value of the real estate and related assets. In addition, the Company estimates the fair value of the assets by applying a market approach using comparable sales for certain properties. The use of alternative assumptions in the market approach analysis could result in a different determination of the property’s estimated fair value and a different conclusion regarding the existence of an impairment, the extent of such loss, if any, as well as the carrying value of the real estate and related assets. Impairment of Real Estate During the third quarter ended September 30, 2019, real estate assets related to one healthcare property were determined to be impaired due to a tenant of the property, which was experiencing financial difficulty, vacating its space, and a second tenant indicating its desire to terminate its lease early, which the Company determined would be consistent with its strategic plans for the property. On November 8, 2019, the Company terminated the lease with the second tenant. The aggregate carrying amount of the assets of $40,266,000 exceeded their fair value. The carrying value of the property was reduced to its estimated fair value of $27,266,000 , resulting in an impairment charge of $13,000,000 . In addition, during the fourth quarter ended December 31, 2019, real estate assets related to another healthcare property with an aggregate carrying amount of $30,412,000 were reduced to their estimated fair value of $22,412,000 , resulting in an impairment charge of $8,000,000 based on a letter of intent from a prospective buyer to purchase the property. Impairment charges are recorded as impairment loss on real estate in the consolidated statements of comprehensive (loss) income . During the years ended December 31, 2018 and 2017, no impairment losses were recorded on real estate. See Note 13—"Fair Value" for further discussion. Impairment of Acquired Intangible Assets and Acquired Intangible Liabilities During the year ended December 31, 2019 , the Company wrote off a below-market lease intangible liability in the amount of approximately $212,000 , by accelerating the amortization of the acquired intangible liability related to one tenant in the healthcare property discussed above. During the year ended December 31, 2019 , the Company recognized impairments of in-place lease intangible assets in the amount of approximately $3,195,000 , by accelerating the amortization of the acquired intangible assets related to two tenants in the healthcare property discussed above. During the years ended December 31, 2018 and 2017, no impairment losses were recorded on acquired intangible assets or intangible liabilities. Fair Value Accounting Standards Codification, or ASC, 820, Fair Value Measurements and Disclosures , or ASC 820, defines fair value, establishes a framework for measuring fair value in accordance with GAAP and expands disclosures about fair value measurements. ASC 820 emphasizes that fair value is intended to be a market-based measurement, as opposed to a transaction-specific measurement. Fair value is defined by ASC 820 as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Depending on the nature of the asset or liability, various techniques and assumptions can be used to estimate the fair value. Assets and liabilities are measured using inputs from three levels of the fair value hierarchy, as follows: Level 1—Inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. An active market is defined as a market in which transactions for the assets or liabilities occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2—Inputs other than quoted prices for similar assets and liabilities in active markets that are observable for the asset or liability (i.e., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data correlation or other means (market corroborated inputs). Level 3—Unobservable inputs, only used to the extent that observable inputs are not available, reflect the Company’s assumptions about the pricing of an asset or liability. The following describes the methods the Company used to estimate the fair value of the Company’s financial assets and liabilities: Cash and cash equivalents, restricted cash, tenant receivables, prepaid and other assets, accounts payable and accrued liabilities —The Company considered the carrying values of these financial instruments, assets and liabilities, to approximate fair value because of the short period of time between origination of the instruments and their expected realization. Notes payable—Fixed Rate —The fair value is estimated by discounting the expected cash flows on notes payable at current rates at which management believes similar loans would be made considering the terms and conditions of the loan and prevailing market interest rates. Credit facility—Fixed Rate —The fair value is estimated by discounting the expected cash flows on the fixed rate credit facility at current rates at which management believes similar borrowings would be made considering the terms and conditions of the borrowings and prevailing market interest rates. Credit facility—Variable Rate —The fair value of the Company's variable rate credit facility is estimated based on the interest rates currently offered to the Company by financial institutions. The carrying value of the variable rate credit facility approximates fair value as the interest is calculated at the London Interbank Offered Rate, plus an applicable margin. The interest rate resets to market on a monthly basis. Derivative instruments —The Company’s derivative instruments consist of interest rate swaps. These swaps are carried at fair value to comply with the provisions of ASC 820. The fair value of these instruments is determined using interest rate market pricing models. The Company incorporated credit valuation adjustments to appropriately reflect the Company’s nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. Considerable judgment is necessary to develop estimated fair values of financial assets and liabilities. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize, or be liable for on disposition of the financial assets and liabilities. See additional discussion in Note 13—"Fair Value." Revenue Recognition, Tenant Receivables and Allowance for Uncollectible Accounts Effective January 1, 2018, the Company recognizes non-rental related revenue in accordance with ASC 606, Revenue from Contracts with Customers , or ASC 606. The Company has identified its primary revenue streams as rental income from leasing arrangements and tenant reimbursements, which are outside the scope of ASC 606. The core principle of ASC 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Non-rental revenue, subject to ASC 606, is immaterial to the Company's consolidated financial statements. Effective January 1, 2019, the majority of the Company's revenue is derived from rental revenue which is accounted for in accordance with ASC 842, Leases, or ASC 842. In accordance with ASC 842, minimum rental revenue is recognized on a straight-line basis over the term of the related lease (including rent holidays). For lease arrangements when it is not probable that the Company will collect all or substantially all of the remaining lease payments under the term of the lease, rental revenue is limited to the lesser of the rental revenue that would be recognized on a straight-line basis or the lease payments that have been collected from the lessee. Differences between rental revenue recognized and amounts contractually due under the lease agreements are credited or charged to straight-line rent receivable or straight-line rent liability, as applicable. Tenant reimbursements, which are comprised of additional amounts recoverable from tenants for common area maintenance expenses and certain other recoverable expenses, are recognized when the services are provided and the performance obligations are satisfied. Prior to the adoption of ASC 842, tenant receivables and straight-line rent receivables were carried net of the provision for credit losses. The provision for credit losses was established for estimated losses resulting from the inability of certain tenants to meet the contractual obligations under their lease agreements. The Company’s determination of the adequacy of these provisions was based primarily upon evaluations of historical loss experience, the tenant’s financial condition, security deposits, letters of credit, lease guarantees, current economic conditions and other relevant factors. Effective January 1, 2019, upon adoption of ASC 842, the Company is no longer recording a provision for credit losses but is, instead, assessing whether or not it is probable that the Company will collect all or substantially all of the remaining lease payments under the term of the lease. When it is not probable that the Company will collect all or substantially all of the remaining lease payments under the term of the lease, rental revenue is limited to the lesser of the rental revenue that would be recognized on a straight-line basis or the lease payments that have been collected from the lessee. During the year ended December 31, 2019 , the Company recorded $672,000 in bad debt expenses as a reduction of rental revenue in the accompanying consolidated statements of comprehensive (loss) income . Notes Receivable Notes receivable are reported at their outstanding principal balance, net of any unearned income, unamortized deferred fees and costs and allowances for loan losses. The Company evaluates the collectability of both interest and principal on each note receivable to determine whether it is collectible, primarily through the evaluation of credit quality indicators, such as the tenant's financial condition, collateral, evaluations of historical loss experience, current economic conditions and other relevant factors, including contractual terms of repayments. Evaluating a note receivable for potential impairment requires management to exercise judgment. The use of alternative assumptions in evaluating a note receivable could result in a different determination of the note's estimated fair value and a different conclusion regarding the existence of an impairment, the extent of such loss, if any, as well as the carrying value of the note receivable. As part of the REIT Merger, the Company acquired one note receivable in the amount of $2,700,000 . The principal balance of the Company's note receivable is secured by its collateral. Earnings Per Share The Company calculates basic earnings per share by dividing net income attributable to common stockholders for the period by the weighted average shares of its common stock outstanding for that period. Diluted earnings per share are computed based on the weighted average number of shares outstanding and all potentially dilutive securities. Shares of non-vested restricted common stock give rise to potentially dilutive shares of common stock. During the years ended December 31, 2019 , 2018 and 2017, diluted earnings per share reflected the effect of approximately 24,000 , 24,000 and 18,000 of non-vested shares of restricted common stock that were outstanding as of such period, respectively. Reportable Segments ASC 280, Segment Reporting , establishes standards for reporting financial and descriptive information about an enterprise’s reportable segments. As of December 31, 2019 and 2018, the Company operated through two reportable business segments­— real estate investments in data centers and healthcare. With the continued expansion of the Company’s portfolio, segregation of the Company’s operations into two reporting segments is useful in assessing the performance of the Company’s business in the same way that management reviews performance and makes operating decisions. See Note 12—"Segment Reporting" for further discussion on the reportable segments of the Company. Derivative Instruments and Hedging Activities As required by ASC 815, Derivatives and Hedging , or ASC 815, the Company records all derivative instruments at fair value as assets and liabilities on its consolidated balance sheets . The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge of a net investment in a foreign operation. For derivative instruments not designated as hedging instruments, the income or loss is recognized in the consolidated statements of comprehensive (loss) income during such period. In accordance with the fair value measurement guidance Accounting Standards Update, or ASU, 2011-04, Fair Value Measurement , the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio. The Company is exposed to variability in expected future cash flows that are attributable to interest rate changes in the normal course of business. The Company’s primary strategy in entering into derivative contracts is to add stability to future cash flows by managing its exposure to interest rate movements. The Company utilizes derivative instruments, including interest rate swaps, to effectively convert some of its variable rate debt to fixed rate debt. The Company does not enter into derivative instruments for speculative purposes. In accordance with ASC 815, the Company designates interest rate swap contracts as cash flow hedges of floating-rate borrowings. For derivative instruments that are designated and qualify as cash flow hedges, the gains or losses on the derivative instruments are reported as a component of other comprehensive (loss) income in the consolidated statements of comprehensive (loss) income and are reclassified into earnings in the same line item associated with the forecasted transaction in the same period during which the hedged transactions affect earnings. See additional discussion in Note 14—"Derivative Instruments and Hedging Activities." Concentration of Credit Risk and Significant Leases As of December 31, 2019 , the Company had cash on deposit, including restricted cash, in certain financial institutions that had deposits in excess of current federally insured levels. The Company limits its cash investments to financial institutions with high credit standings; therefore, the Company believes it is not exposed to any significant credit risk on its cash deposits. To date, the Company has not experienced a loss or lack of access to cash in its accounts. As of December 31, 2019 , the Company owned real estate investments in two micropolitan statistical areas and 67 metropolitan statistical areas, or MSA, one MSA of which accounted for 10.0% or more of rental revenue. Real estate investments located in the Atlanta-Sandy Springs-Roswell, Georgia MSA accounted for 15.0% of rental revenue for the year ended December 31, 2019 . As of December 31, 2019 , the Company had no exposure to tenant concentration that accounted for 10.0% or more of rental revenue for the year ended December 31, 2019 . Share Repurchase Program The Company’s share repurchase program allows for repurchases of shares of the Company’s common stock when certain criteria are met. The share repurchase program provides that all repurchases during any calendar year, including those redeemable upon death or a Qualifying Disability of a stockholder, are limited to those that can be funded with equivalent proceeds raised from the DRIP during the prior calendar year and other operating funds, if any, as the board of directors, in its sole discretion, may reserve for this purpose. Repurchases of shares of the Company’s common stock are at the sole discretion of the Company’s board of directors, provided, however, that the Company will limit the number of shares repurchased during any calendar year to 5.0% of the number of shares of common stock outstanding as of December 31 st of the previous calendar year. In addition, the Company’s board of directors, in its sole discretion, may suspend (in whole or in part) the share repurchase program at any time, and may amend, reduce, terminate or otherwise change the share repurchase program upon 30 days' prior notice to the Company’s stockholders for any reason it deems appropriate. In connection with entering into the Merger Agreement, on April 10, 2019, the Company's board of directors approved the Sixth Amended and Restated Share Repurchase Program, or the Sixth Amended & Restated SRP, which became effective on May 11, 2019, and was applied beginning with repurchases made on the 2019 third quarter repurchase date. Under the Sixth Amended & Restated SRP, the Company only repurchased shares of common stock (Class A shares, Class I shares, Class T Shares and Class T2 shares) in connection with the death, qualifying disability, or involuntary exigent circumstance (as determined by the Company's board of directors in its sole discretion) of a stockholder, subject to certain terms and conditions specified in the Sixth Amended & Restated SRP. In connection with the REIT Merger, on October 2, 2019, the Company's board of directors approved an amended share repurchase program, or the Amended SRP. The Amended SRP applied to all eligible stockholders, beginning with repurchases made on the first quarter repurchase date of 2020, which was January 30, 2020 . For purposes of determining whether any former REIT I stockholder qualifies for participation under the Amended SRP, former REIT I stockholders received full credit for the time they held REIT I common stock prior to the closing of the REIT Merger. Subject to the terms and limitations of the Amended SRP, including, but not limited to, quarterly share limitations, an annual 5.0% share limitation, and DRIP funding limitations, the Amended SRP may be available to any stockholder as a potential means of interim liquidity. The Company will honor valid repurchase requests approximately 30 days following the end of the applicable quarter. See PART II, "Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities " for further discussion. During the year ended December 31, 2019 , the Company repurchased 2,557,298 Class A shares, Class I shares, Class T shares and Class T2 shares of common stock ( 1,910,894 Class A shares, 189,947 Class I shares, 451,058 Class T shares and 5,399 Class T2 shares), or 1.87% of shares outstanding as of December 31, 2018, for an aggregate purchase price of approximately $23,655,000 (an average of $9.25 per share). During the year ended December 31, 2018 , the Company repurchased 4,700,554 Class A shares, Class I shares and Class T shares of common stock ( 4,117,566 Class A shares, 71,180 Class I shares and 511,808 Class T shares), or 3.80% of shares outstanding as of December 31, 2017, for an aggregate purchase price of approximately $43,230,000 (an average of $9.20 per share). Distribution Policy and Distributions Payable In order to maintain its status as a REIT, the Company is required to make distributions each taxable year equal to at least 90% of its REIT taxable income, computed without regard to the dividends paid deduction and excluding capital gains. To the extent funds are available, the Company intends to continue to pay regular distributions to stockholders. Distributions are paid to stockholders of record as of the applicable record dates. Distributions are payable to stockholders from legally available funds therefor. The Company declared distributions per share of common stock in the amounts of $0.58 , $0.63 and $0.62 for the years ended December 31, 2019 , 2018 and 2017, respectively. As of December 31, 2019 , the Company had distributions payable of approximately $9,093,000 . Of these distributions payable, approximately $6,446,000 was paid in cash and approximately $2,647,000 was reinvested in shares of common stock pursuant to the DRIP on January 2, 2020. Distributions to stockholders are determined by the board of directors of the Company and are dependent upon a number of factors, including funds available for the payment of distributions, financial condition, the timing of property acquisitions, capital expenditure requirements, and annual distribution requirements in order to maintain the Company’s status as a REIT under the Code. See Note 21—"Subsequent Events" for further discussion. Income Taxes The Company currently qualifies and is taxed as a REIT under Sections 856 through 860 of the Code. Accordingly, it will generally not be subject to corporate U.S. federal or state income tax to the extent that it makes qualifying distributions to stockholders, and provided it satisfies, on a continuing basis, through actual investment and operating results, the REIT requirements, including certain asset, income, distribution and stock ownership tests. If the Company fails to qualify as a REIT, and does not qualify for certain statutory relief provisions, it would be subject to U.S. federal, state and local income taxes and may be precluded from qualifying as a REIT for the subsequent four taxable years following the year in which it lost its REIT qualification, unless the Internal Revenue Service grants the Company relief under certain statutory provisions. Accordingly, failure to qualify as a REIT could have a material adverse impact

Acquisitions and Dispositions

Acquisitions and Dispositions	12 Months Ended
	Dec. 31, 2019
Real Estate [Abstract]
Acquisitions and Dispositions	Acquisitions and Dispositions 2019 Acquisitions During the year ended December 31, 2019 , the Company purchased 67 real estate properties, or the 2019 Acquisitions, including 60 properties acquired in the REIT Merger, all of which were determined to be asset acquisitions. Upon the completion of each 2019 acquisition, the Company allocated the purchase price of the real estate properties to acquired tangible assets, consisting of land, buildings and improvements, tenant improvements, acquired intangible assets and acquired intangible liabilities, based on the relative fair value method of allocating all accumulated costs. The following table summarizes the consideration transferred for the 2019 Acquisitions during the year ended December 31, 2019 : Property Description Date Acquired Ownership Percentage Purchase Price Bryant Healthcare Facility II, f.k.a. Bryant Healthcare Facility 8/16/2019 100% $ 4,408 TAM Healthcare Facilities (1) 9/19/2019 100% 65,443 REIT Merger (2) 10/04/2019 100% 1,229,365 Tucson Healthcare Facility II (3) 12/26/2019 100% 651 Tucson Healthcare Facility III (4) 12/27/2019 100% 1,763 Total $ 1,301,630 (1) The TAM Healthcare Facilities consists of four properties. U pon acquisition of the TAM Healthcare Facilities, the Company entered into four ground lease agreements. See further discussion in Note 6—"Leases." (2) The REIT Merger consists of 60 healthcare properties. See further discussion below. (3) The Tucson Healthcare Facility II was acquired as a development healthcare property. The purchase price was recorded as a ground leasehold asset in the amount of $651,000 . U pon acquisition of the Tucson Healthcare Facility II, the Company entered into a ground lease agreement. See further discussion in Note 6—"Leases" . At the closing date, the Company funded $1,764,000 for the construction of the development property. (4) The Tucson Healthcare Facility III was acquired as a development healthcare property and the purchase price was recorded as land in the amount of $1,763,000 . At the closing date, the Company funded $1,152,000 for the construction of the development property. The following table summarizes the Company's purchase price allocation of the 2019 Acquisitions during the year ended December 31, 2019 (amounts in thousands): Total Land $ 98,723 Buildings and improvements 1,047,755 In-place leases 141,407 Tenant improvements 5,349 Ground leasehold assets (1) 3,731 Above-market leases 17,906 Total assets acquired $ 1,314,871 Ground lease liabilities (1) (6,048 ) Below-market leases (7,193 ) Total liabilities acquired (13,241 ) Net assets acquired $ 1,301,630 (1) Represents a component of the ROU assets- operating leases. Acquisition fees and costs associated with transactions determined to be asset acquisitions are capitalized. The Company capitalized acquisition fees and costs of approximately $30,546,000 related to the 2019 Acquisitions during the years ended December 31, 2019 , which are included in the Company's allocation of the real estate acquisitions presented above. The total amount of all acquisition fees and costs is limited to 6.0% of the contract purchase price of a property, unless the Company’s board of directors determines a higher transaction fee to be commercially competitive, fair and reasonable to the Company. The contract purchase price is the amount actually paid or allocated in respect of the purchase, development, construction or improvement of a property exclusive of acquisition fees and costs. During the year ended December 31, 2019 , acquisition fees and costs did not exceed 6.0% of the contract purchase price of the 2019 Acquisitions during such period. Completion of REIT Merger On October 4, 2019 , pursuant to the terms and conditions of the Merger Agreement, REIT I merged with and into Merger Sub, with Merger Sub surviving the REIT Merger, such that following the REIT Merger, the Surviving Entity continued as a wholly-owned subsidiary of the Company. In accordance with the applicable provisions of the Maryland General Corporation Law, the separate existence of REIT I ceased. The Combined Company retained the name “Carter Validus Mission Critical REIT II, Inc.” At the effective time of the REIT Merger, each issued and outstanding share of REIT I’s common stock (or a fraction thereof), $0.01 par value per share, or the REIT I Common Stock, was converted into the right to receive: (i) $1.00 in cash; and (ii) 0.4681 shares of the Company's Class A Common Stock, par value $0.01 per share, or the REIT II Class A Common Stock. The following summarizes the consideration transferred for the REIT I stockholders for the REIT Merger on October 4, 2019, exclusive of acquisition fees and costs and the payoff of REIT I debt (amounts in thousands): Total Consideration Value of Company's Class A common stock issued to REIT I stockholders (1) $ 774,010 Cash consideration paid 178,758 Total consideration transferred $ 952,768 (1) The Company issued 83,676,775 shares of its Class A common stock to REIT I stockholders. 2019 Disposition On November 26, 2019, the Company sold one of three buildings and a portion of land related to one healthcare property for an aggregate sale price of $3,106,000 and generated net proceeds of $2,882,000 . The Company recognized an aggregate gain on sale of $79,000 , in gain on real estate disposition on the consolidated statements of comprehensive (loss) income for the year ended December 31, 2019.

Acquired Intangible Assets, Net

Acquired Intangible Assets, Net	12 Months Ended
	Dec. 31, 2019
Finite-Lived Intangible Assets, Net [Abstract]
Acquired Intangible Assets, Net	Acquired Intangible Assets, Net Acquired intangible assets, net, consisted of the following as of December 31, 2019 and 2018 (amounts in thousands, except weighted average life amounts): December 31, 2019 December 31, 2018 In-place leases, net of accumulated amortization of $62,252 and $41,143, respectively (with a weighted average remaining life of 10.4 years and 10.1 years, respectively) $ 266,856 $ 151,135 Above-market leases, net of accumulated amortization of $1,912 and $899, respectively (with a weighted average remaining life of 10.5 years and 5.1 years, respectively) 18,603 1,710 Ground leasehold assets, net of accumulated amortization of $0 and $39, respectively (with a weighted average remaining life of 0.0 years and 83.5 years, respectively) — (1) 1,359 $ 285,459 $ 154,204 (1) On January 1, 2019, as part of the adoption of ASC 842, as discussed in Note 2—"Summary of Significant Accounting Policies - Recently Adopted Accounting Pronouncements," the Company reclassified the ground leasehold assets balance from acquired intangible assets, net, to right-of-use assets - operating leases within the consolidated balance sheet. The aggregate weighted average remaining life of the acquired intangible assets was 10.4 years and 10.6 years as of December 31, 2019 and December 31, 2018 , respectively. Amortization of the acquired intangible assets was $26,699,000 , $19,919,000 and $14,167,000 for the years ended December 31, 2019 , 2018 and 2017, respectively. Of the $26,699,000 recorded for the year ended December 31, 2019 , $3,195,000 was attributable to accelerated amortization due to the impairment of two in-place lease intangible assets. Amortization of the in-place leases is included in depreciation and amortization and the above-market leases are recorded as an adjustment to rental revenue in the accompanying consolidated statements of comprehensive (loss) income . Estimated amortization expense on the acquired intangible assets as of December 31, 2019 , for each of the next five years ending December 31 and thereafter, are as follows (amounts in thousands): Year Amount 2020 $ 33,211 2021 32,409 2022 30,071 2023 28,094 2024 26,019 Thereafter 135,655 $ 285,459

Acquired Intangible Liabilities

Acquired Intangible Liabilities, Net	12 Months Ended
	Dec. 31, 2019
Intangible Lease Liabilities, Net [Abstract]
Acquired Intangible Liabilities, Net	Acquired Intangible Liabilities, Net Acquired intangible liabilities, net, consisted of the following as of December 31, 2019 and 2018 (amounts in thousands, except weighted average life amounts): December 31, 2019 December 31, 2018 Below-market leases, net of accumulated amortization of $12,332 and $7,592, respectively (with a weighted average remaining life of 16.1 years and 17.6 years, respectively) $ 59,538 $ 57,606 Amortization of the below-market leases was $5,261,000 , $4,832,000 and $2,126,000 for the years ended December 31, 2019 , 2018 and 2017, respectively. Of the $5,261,000 recorded for the year ended December 31, 2019 , $212,000 was attributable to accelerated amortization of a below-market lease intangible liability. Amortization of below-market leases is recorded as an adjustment to rental revenue in the accompanying consolidated statements of comprehensive (loss) income . Estimated amortization of the acquired intangible liabilities as of December 31, 2019 , for each of the next five years ending December 31 and thereafter, are as follows (amounts in thousands): Year Amount 2020 $ 5,486 2021 5,458 2022 4,394 2023 3,779 2024 3,677 Thereafter 36,744 $ 59,538

Leases

Leases	12 Months Ended
	Dec. 31, 2019
Leases [Abstract]
Leases	Leases Lessor Rental Revenue The Company’s real estate properties are leased to tenants under operating leases with varying terms. Typically, the leases have provisions to extend the terms of the lease agreements. The Company retains substantially all of the risks and benefits of ownership of the real estate properties leased to tenants. Future minimum rent to be received from the Company's investments in real estate assets under the terms of non-cancelable operating leases in effect as of December 31, 2019 , including optional renewal periods, for each of the next five years ending December 31 and thereafter, are as follows (amounts in thousands): Year Amount 2020 $ 224,837 2021 231,052 2022 235,334 2023 234,949 2024 230,179 Thereafter 1,619,494 $ 2,775,845 Lessee Rental Expense The Company has 17 ground leases, for which four do not have corresponding operating lease liabilities because the Company did not have future payment obligations at the acquisition of these leases. During the year ended December 31, 2019 , the Company entered into or assumed 11 ground lease agreements, including six ground lease agreements acquired as a part of the REIT Merger, for an aggregate present value of future rent payments of $22,265,000 . The ground lease obligations generally require fixed annual rental payments and may also include escalation clauses. The weighted average remaining lease term for the Company's operating leases was 50.7 years and 27.2 years as of December 31, 2019 and December 31, 2018 , respectively. The Company's ground leases do not provide an implicit interest rate. In order to calculate the present value of the remaining ground lease payments, the Company used incremental borrowing rates, or IBR, adjusted for a number of factors. The determination of an appropriate IBR involves multiple inputs and judgments. The Company determined its IBR considering the general economic environment, the Company's credit rating and various financing and asset specific adjustments to ensure the IBR is appropriate for the intended use of the underlying ground lease. As a result, the weighted average adjusted incremental borrowing rates ranged between 5.0% and 6.6% . The future minimum rent payments, discounted by the Company's adjusted incremental borrowing rates, under non-cancelable ground leases, as of December 31, 2019 , for each of the next five years ending December 31 and thereafter, are as follows (amounts in thousands): Year Amount 2020 $ 1,633 2021 1,634 2022 1,634 2023 1,638 2024 1,687 Thereafter 136,719 Total undiscounted rental payments 144,945 Less imputed interest (113,941 ) Total operating lease liabilities $ 31,004 Due to the adoption of the of ASC 842, the Company reclassified ground leasehold assets as of January 1, 2019, from acquired intangible assets and liabilities, to right-of-use assets - operating leases within the consolidated balance sheet. As discussed in Note 2—"Summary of Significant Accounting Policies," the Company adopted ASC 842, effective January 1, 2019, and consequently, financial information was not updated, and the disclosures required under the new lease standard are not provided for dates and periods before January 1, 2019. The following represents approximate future minimum rent payments under non-cancelable ground leases by year as of December 31, 2018, and for each of the next five years ending December 31 and thereafter, are as follows (amounts in thousands): Year Amount 2019 $ 123 2020 123 2021 123 2022 123 2023 123 Thereafter 2,246 Total undiscounted rental payments $ 2,861 This table excludes future minimum rent payments from one tenant that pays the ground lease obligations directly to the lessor, consistent with the Company's accounting policy prior to its adoption of ASC 842 on January 1, 2019.

Other Assets, Net

Other Assets, Net	12 Months Ended
	Dec. 31, 2019
Other Assets [Abstract]
Other Assets, Net	Other Assets, Net Other assets, net, consisted of the following as of December 31, 2019 and 2018 (amounts in thousands): December 31, 2019 December 31, 2018 Deferred financing costs, related to the revolver portion of the credit facility, net of accumulated amortization of $5,696 and $4,686, respectively $ 2,623 $ 3,053 Leasing commissions, net of accumulated amortization of $240 and $82, respectively 10,288 5,006 Restricted cash 10,888 11,167 Tenant receivables 7,750 6,080 Note receivable 2,700 — Straight-line rent receivable 46,892 32,685 Prepaid and other assets 4,709 3,338 Derivative assets 884 6,204 $ 86,734 $ 67,533 Amortization of deferred financing costs related to the revolver portion of the credit facility for the years ended December 31, 2019, 2018 and 2017 was $1,010,000 , $1,260,000 and $1,637,000 , respectively, which was recorded as interest and other expense, net , in the accompanying consolidated statements of comprehensive (loss) income . Amortization of leasing commissions for the years ended December 31, 2019, 2018 and 2017 was $158,000 , $76,000 and $6,000 , respectively, which was recorded as depreciation and amortization in the accompanying consolidated statements of comprehensive (loss) income .

Accounts Payable and Other Liab

Accounts Payable and Other Liabilities	12 Months Ended
	Dec. 31, 2019
Payables and Accruals [Abstract]
Accounts Payable and Other Liabilities	Accounts Payable and Other Liabilities Accounts payable and other liabilities consisted of the following as of December 31, 2019 and December 31, 2018 (amounts in thousands): December 31, 2019 December 31, 2018 Accounts payable and accrued expenses $ 11,448 $ 9,188 Accrued interest expense 5,185 3,219 Accrued property taxes 3,537 2,309 Distributions payable to stockholders 9,093 7,317 Tenant deposits 1,500 875 Deferred rental income 9,003 6,647 Derivative liabilities 5,588 — $ 45,354 $ 29,555

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2019
Notes Payable [Abstract]
Notes Payable	Notes Payable As of December 31, 2019 , the Company had $457,345,000 principal outstanding in notes payable collateralized by real estate properties with a weighted average interest rate of 4.4% . The following table summarizes the notes payable balances as of December 31, 2019 and 2018 (amounts in thousands): Interest Rates December 31, 2019 December 31, 2018 Range Weighted Maturity Date Fixed rate notes payable $ 219,567 $ 220,351 4.0% - 4.8% 4.3% 12/11/2021 - 7/1/2027 Variable rate notes payable fixed through interest rate swaps 237,778 247,435 3.7% - 5.1% 4.5% 10/28/2021 - 11/16/2022 Total notes payable, principal amount outstanding 457,345 467,786 Unamortized deferred financing costs related to notes payable (2,500 ) (3,441 ) Total notes payable, net of deferred financing costs $ 454,845 $ 464,345 The Company did not enter into any notes payable during the year ended December 31, 2019 . On December 10, 2019, the Company made a partial pre-payment of $8,500,000 on its debt in connection with one of the Company's notes payable, with an outstanding principal balance of $30,266,000 at the time of repayment, in order to comply with certain requirements of the loan agreement. The principal payments due on the notes payable as of December 31, 2019 , for each of the next five years ending December 31 and thereafter, are as follows (amounts in thousands): Year Amount 2020 $ 3,925 2021 146,025 2022 166,209 2023 2,710 2024 27,360 Thereafter 111,116 $ 457,345

Credit Facility

Credit Facility	12 Months Ended
	Dec. 31, 2019
Line of Credit Facility [Abstract]
Credit Facility	Credit Facility The Company's outstanding credit facility as of December 31, 2019 and 2018 consisted of the following (amounts in thousands): December 31, 2019 December 31, 2018 Variable rate revolving line of credit $ 108,000 $ 105,000 Variable rate term loan fixed through interest rate swaps 250,000 100,000 Variable rate term loans 550,000 150,000 Total credit facility, principal amount outstanding 908,000 355,000 Unamortized deferred financing costs related to the term loan credit facility (7,385 ) (2,489 ) Total credit facility, net of deferred financing costs $ 900,615 $ 352,511 Significant activities regarding the credit facility during the year ended December 31, 2019 and subsequent include: • The Company drew $605,000,000 on its credit facility for 2019 acquisitions and the REIT Merger, to fund share repurchases and repaid $52,000,000 on its credit facility. • The Company entered into two interest rate swap agreements, with an effective date of April 1, 2019 , which effectively fixed LIBOR related to $150,000,000 of the term loans of its credit facility, and three interest rate swap agreements with an effective date of January 1, 2020 , which will effectively fix LIBOR related to $150,000,000 of the term loans of its credit facility. • On January 29, 2019, the Company amended its credit facility agreement by adding beneficial ownership provisions, modifying certain definitions related to change of control and consolidated total secured debt, and clarified certain covenants related to restrictions on indebtedness and restrictions on liens. • On April 11, 2019, the Operating Partnership, the Company and certain of the Operating Partnership’s subsidiaries entered into the Consent and Second Amendment to the Third Amended and Restated Credit Agreement, which (i) increased the amount of Secured Debt that is Recourse Indebtedness from 15% to 17.5% for four full consecutive fiscal quarters immediately following the date on which the REIT Merger was consummated and one partial fiscal quarter (to include the quarter in which the REIT Merger was consummated), (ii) allowed, after April 27, 2019, the Operating Partnership, the Company, Merger Sub and CVOP to incur, assume or guarantee indebtedness as permitted under the Company's credit facility and with respect to which there is a lien on any equity interests of such entity, and (iii) from and after the consummation of the REIT Merger, allowed Merger Sub and CVOP to be additional guarantors to the Company's credit facility. • On April 11, 2019, in connection with the execution of the Merger Agreement, the Operating Partnership entered into a commitment letter to obtain a senior secured bridge facility, or the Bridge Facility, in an amount of $475,000,000 . Upon the closing of the Term Loan (defined below), on August 7, 2019, the Company terminated its Bridge Facility. • On April 29, 2019, KeyBank National Association, or KeyBank, and the Operating Partnership entered into the Release of Collateral Assignment of Interests, whereby KeyBank released its lien and security interest in the mortgaged properties. Therefore, effective April 29, 2019, the Company's credit facility is unsecured. • On August 7, 2019, in anticipation of the REIT Merger, the Company and certain of the Company’s subsidiaries entered into the Fourth Amended and Restated Credit Agreement, or the A&R Credit Agreement, with KeyBank, as Administrative Agent for the lenders, to amend the borrower from the Operating Partnership to the Company. The A&R Credit Agreement increased the maximum commitments available under the Company's credit facility from $700,000,000 to an aggregate of up to $780,000,000 , consisting of a $500,000,000 revolving line of credit, with a maturity date of April 27, 2022 , subject to the Company's right to one , 12 -month extension period, and a $280,000,000 term loan, with a maturity date of April 27, 2023 . • On August 7, 2019, as a result of entering into the A&R Credit Agreement, the Company converted $30,000,000 of its variable rate revolving line of credit under its credit facility to a variable rate term loan under its credit facility. • Simultaneously with the A&R Credit Agreement’s execution, on August 7, 2019, the Company and certain of the Company’s subsidiaries entered into the Senior Unsecured Term Loan Agreement, or the Term Loan, with KeyBank, as Administrative Agent for the lenders, for the maximum commitment available of up to $520,000,000 with a maturity date of December 31, 2024 . The Term Loan is pari passu with the A&R Credit Agreement. The Term Loan was funded upon the consummation of the REIT Merger on October 4, 2019 . The Company used proceeds from the Term Loan to payoff REIT I's outstanding debt in the amount of $248,580,000 , to fund the $178,758,000 in cash consideration paid to REIT I stockholders, to pay acquisition fees and costs in the amount of $27,350,000 and to pay down the Company's revolver portion of the credit facility in the amount of $52,000,000 at the time of closing of the REIT Merger. • In connection with the REIT Merger, on October 3, 2019, the Operating Partnership, the Company, certain of the Company's subsidiaries, and KeyBank entered into the First Amendment to the A&R Credit Agreement and the First Amendment to the Term Loan (together, the "First Amendments to the Unsecured Credit Facility"). The First Amendments to the Unsecured Credit Facility allow for the Contributions (as defined in Note 11—"Related-Party Transactions and Arrangements" ) by amending and adding certain language in the A&R Credit Agreement and Senior Unsecured Term Loan Agreement in order to conform to the contemplated organizational structure following the REIT Merger. • Subsequent to December 31, 2019, the Company drew $95,000,000 on its credit facility, $20,000,000 of which was related to a property acquisition (discussed in Note 21—"Subsequent Events" ) and to fund share repurchases, and $75,000,000 was drawn to provide additional liquidity due to the uncertainty in overall economic conditions created by the coronavirus outbreak. The principal payments due on the credit facility as of December 31, 2019 , for each of the next five years ending December 31, are as follows (amounts in thousands): Year Amount 2020 $ — 2021 — 2022 108,000 2023 280,000 2024 520,000 $ 908,000 The proceeds of loans made under the credit facility may be used to finance the acquisitions of real estate investments, for tenant improvements and leasing commissions with respect to real estate, for repayment of indebtedness, for capital expenditures with respect to real estate, and for general corporate and working capital purposes. The credit facility can be increased to $1,600,000,000 , subject to certain conditions. The annual interest rate payable under the credit facility is, at the Company's option, either: (a) LIBOR, plus an applicable margin ranging from 1.75% to 2.25% , which is determined based on the Company's overall leverage, or (b) a base rate which means, for any day, a fluctuating rate per annum equal to the prime rate for such day plus an applicable margin ranging from 0.75% to 1.25% , which is determined based on the Company's overall leverage. As of December 31, 2019 , the weighted average interest rate on the variable rate portion of the credit facility was 3.9% and the weighted average interest rate on the variable rate fixed through interest rate swap portion of the credit facility was 4.2% . In addition to interest, the Company is required to pay a fee on the unused portion of the lenders’ commitments under the A&R Credit Agreement at a per annum rate equal to 0.25% if the daily amount outstanding under the A&R Credit Agreement is less than 50% of the lenders’ commitments, or 0.15% if the daily amount outstanding under the A&R Credit Agreement is greater than or equal to 50% of the lenders’ commitments. The unused fee is payable quarterly in arrears. The actual amount of credit available under the credit facility is a function of certain loan-to-cost, loan-to-value and debt service coverage ratios contained in the credit facility agreements. The amount of credit available under the credit facility will be a maximum principal amount of the value of the assets that are included in the pool availability. The credit facility agreements contain various affirmative and negative covenants that are customary for credit facilities and transactions of this type, including limitations on the incurrence of debt by the Company, the Operating Partnership and its subsidiaries that own properties that serve as collateral for the credit facility, limitations on the nature of the Company's business, the Operating Partnership and its subsidiaries, and limitations on distributions by the Company, the Operating Partnership and its subsidiaries. The credit facility agreements impose the following financial covenants, which are specifically defined in the credit facility agreements, on the Company: (a) maximum ratio of indebtedness to gross asset value; (b) minimum ratio of adjusted consolidated earnings before interest, taxes, depreciation and amortization to consolidated fixed charges; (c) minimum tangible net worth; (d) minimum liquidity thresholds; (e) minimum weighted average remaining lease term of properties in the collateral pool; and (f) minimum number of properties in the collateral pool. In addition, the credit facility agreements include events of default that are customary for credit facilities and transactions of this type.

Related-Party Transactions and

Related-Party Transactions and Arrangements	12 Months Ended
	Dec. 31, 2019
Related Party Transactions [Abstract]
Related-Party Transactions and Arrangements	Related-Party Transactions and Arrangements The Company has no direct employees. Substantially all of the Company's business is managed by the Advisor. The employees of the Advisor and other affiliates provide services to the Company related to acquisitions, property management, asset management, accounting, investor relations, and all other administrative services. Amendments to CVREIT II Advisory Agreement On April 11, 2019, concurrently with the execution of the Merger Agreement, the Company, CVOP, the Operating Partnership and the Advisor entered into the Third Amended and Restated CVREIT II Advisory Agreement, or the Third A&R CVREIT II Advisory Agreement, which became effective as of the effective time of the REIT Merger. First Amendment to Third A&R CVREIT II Advisory Agreement On October 3, 2019, the Company, CVOP, the Operating Partnership and the Advisor entered into the First Amendment to the Third A&R CVREIT II Advisory Agreement, or the First Amendment, which became effective on October 4, 2019, simultaneously with the effectiveness of the Third A&R CVREIT II Advisory Agreement at the effective time of the REIT Merger. The purpose of the First Amendment was to clarify that any subordinated fees payable to the Advisor under the Third A&R CVREIT II Advisory Agreement will be offset by any distributions the Advisor or any of its affiliates receives as a special limited partner of the Operating Partnership or CVOP. Fourth A&R CVREIT II Advisory Agreement Following the completion of the Contributions (as defined herein), on October 4, 2019, the Company, the Operating Partnership and the Advisor entered into the Fourth Amended and Restated Advisory Agreement, or the Fourth A&R CVREIT II Advisory Agreement, in order to, among other things, clarify that CVOP will not be a party to the Fourth A&R CVREIT II Advisory Agreement and that any subordinated fees the Advisor would have received under the Third A&R CVREIT II Advisory Agreement would be made to the Advisor in its capacity as a special limited partner of the Operating Partnership pursuant to the A&R CVOP II Partnership Agreement (as defined herein). Amendments to CVOP II Operating Partnership Agreement Fifth Amendment to CVOP II Operating Partnership Agreement Concurrent with the execution of the Merger Agreement, the Company entered into an amendment, or the Fifth Amendment, to the Amended and Restated Limited Partnership Agreement of the Operating Partnership, by and between the Company and the Advisor, as amended, or the CVOP II Partnership Agreement. The purpose of the Fifth Amendment was to revise the economic interests of the Advisor by providing that the Advisor would not receive any subordinated distributions as a special limited partner of the Operating Partnership. The Fifth Amendment was to become effective as of the effective time of the REIT Merger. Sixth Amendment to CVOP II Operating Partnership Agreement On October 3, 2019, the Company and the Advisor entered into the Sixth Amendment to CVOP II Partnership Agreement, or the Sixth Amendment. The purpose of the Sixth Amendment is to rescind the Fifth Amendment in its entirety such that the revisions to the CVOP II Partnership Agreement set forth in the Fifth Amendment did not go into effect. A&R CVOP II Partnership Agreement Following the completion of the Contributions (as defined herein), on October 4, 2019, the Company and the Advisor entered into the Second Amended and Restated Agreement of Limited Partnership of the Operating Partnership, or the A&R CVOP II Partnership Agreement. The A&R CVOP II Partnership Agreement amends and restates the CVOP II Partnership Agreement in order to, among other things, amend the provisions related to distributions payable to the Advisor upon a Listing (as defined in the A&R CVOP II Partnership Agreement), termination of the Fourth A&R Advisory Agreement (unless such termination is by the Company because of a material breach of the Fourth A&R Advisory Agreement or occurs upon a change of control), and upon an Investment Liquidity Event (as defined in the A&R CVOP II Partnership Agreement). The A&R CVOP II Partnership Agreement also increases the threshold of the Priority Return (as defined in the A&R CVOP II Partnership Agreement) from 6.0% to 8.0% , as previously agreed to and disclosed in connection with the REIT Merger. Omnibus Assignment and Amendment to Property Management and Leasing Agreements On October 4, 2019, immediately prior to the effective time of the REIT Merger, pursuant to the Omnibus Assignment and Amendment to the Property Management and Leasing Agreements, or the Assignment Amendment, the Property Manager, as assignee, or the Assignee, acquired, and Carter Validus Real Estate Management Services, LLC, as assignor, or the Assignor, assigned, transferred, conveyed, and delivered to the Assignee, all of the Assignor's rights, titles, and interests in the Property Management and Leasing Agreements by and among the Assignor and CVOP's wholly-owned subsidiaries. Therefore, the Assignee, the property manager for the Company, will act as the property manager and leasing agent for the properties the Company acquired in the REIT Merger. Operating Partnership Contribution On October 4, 2019, following completion of the REIT Merger, the Advisor purchased all of Carter/Validus Advisors, LLC's, or CVREIT Advisor, units of ownership interest in CVOP, or OP Units, and all of CVREIT Advisor's rights and entitlements as a partner of CVOP, or the CVREIT II Advisor OP Unit Purchase, for an aggregate purchase price of $1,066 , pursuant to that certain Partnership Interest Purchase Agreement, or the Purchase Agreement, by and between the Advisor, as buyer, and CVREIT Advisor, as Seller, dated October 4, 2019. On October 4, 2019, CVOP, the Company, the Operating Partnership, the Advisor, Merger Sub, and CVOP Partner, LLC, or CVOP Partner, a wholly owned subsidiary of the Operating Partnership, entered into a contribution agreement, or the Contribution Agreement, whereby effective on October 4, 2019, following the CVREIT II Advisor OP Unit Purchase, (i) Merger Sub and the Advisor, each a Contributor, and together, the Contributors, each contributed to the Operating Partnership all of their interests in CVOP and the Operating Partnership acquired from the Contributors all of the Contributors’ right, title and interest in CVOP in exchange for limited partnership interests in the Operating Partnership, and (ii) the Operating Partnership contributed to CVOP Partner all of its limited OP Units, or collectively, the Contributions. Amended and Restated CVOP Partnership Agreement Following the completion of the Contributions, on October 4, 2019, the Operating Partnership, as the general partner of CVOP, and CVOP Partner, as the limited partner of CVOP, entered into the First Amended and Restated Agreement of Limited Partnership of CVOP, or the A&R CVOP Partnership Agreement. The primary purpose of the A&R CVOP Partnership Agreement is to provide for the allocation of CVOP’s profits and losses and distributions of cash and other assets of CVOP to the Operating Partnership as general partner and CVOP Partner as limited partner of CVOP. Distribution and Servicing Fees Through the termination of the Offering on November 27, 2018, the Company paid the Dealer Manager selling commissions and dealer manager fees in connection with the sale of shares of certain classes of common stock. The Company continues to pay the Dealer Manager a distribution and servicing fee with respect to its Class T and Class T2 shares of common stock that were sold in the Initial Offering (primary Offering only) and the Offering. Distribution and servicing fees are recorded in the accompanying consolidated statements of stockholders' equity as a reduction to equity as incurred. Acquisition Fees and Expenses The Company pays to the Advisor 2.0% of the contract purchase price of each property or asset acquired. In addition, the Company reimburses the Advisor for acquisition expenses incurred in connection with the selection and acquisition of properties or real estate-related investments (including expenses relating to potential investments that the Company does not close), such as legal fees and expenses, costs of real estate due diligence, appraisals, non-refundable option payments on properties not acquired, travel and communications expenses, accounting fees and expenses and title insurance premiums, whether or not the property was acquired. Since the Company's formation through December 31, 2019 , the Company reimbursed the Advisor expenses of approximately 0.01% of the aggregate purchase price all of properties acquired. Acquisition fees and expenses associated with the acquisition of properties determined to be business combinations are expensed as incurred, including investment transactions that are no longer under consideration. Acquisition fees and expenses associated with transactions determined to be asset acquisitions are capitalized in total real estate, net, in the accompanying consolidated balance sheets . Asset Management Fees The Company pays to the Advisor an asset management fee calculated on a monthly basis in an amount equal to 1/12th of 0.75% of aggregate asset value, which is payable monthly, in arrears. Operating Expense Reimbursement The Company reimburses the Advisor for all operating expenses it paid or incurred in connection with the services provided to the Company, subject to certain limitations. Expenses in excess of the operating expenses in the four immediately preceding quarters that exceed the greater of (a) 2% of average invested assets or (b) 25% of net income, subject to certain adjustments, will not be reimbursed unless the independent directors determine such excess expenses are justified. The Company will not reimburse the Advisor for personnel costs in connection with services for which the Advisor receives an acquisition fee or a disposition fee. Operating expenses incurred on the Company’s behalf are recorded in general and administrative expenses in the accompanying consolidated statements of comprehensive (loss) income . Property Management Fees In connection with the rental, leasing, operation and management of the Company’s properties, the Company pays the Property Manager, and its affiliates, aggregate fees equal to 3.0% of gross revenues from the properties managed, or property management fees. The Company reimburses the Property Manager and its affiliates for property-level expenses that any of them pay or incur on the Company’s behalf, including certain salaries, bonuses and benefits of persons employed by the Property Manager and its affiliates, except for the salaries, bonuses and benefits of persons who also serve as one of its executive officers. The Property Manager and its affiliates may subcontract the performance of their duties to third parties and pay all or a portion of the property management fee to the third parties with whom they contract for these services. If the Company contracts directly with third parties for such services, it will pay them customary market fees and may pay the Property Manager an oversight fee equal to 1.0% of the gross revenues of the properties managed. In no event will the Company pay the Property Manager or any affiliate both a property management fee and an oversight fee with respect to any particular property. Property management fees are recorded in rental expenses in the accompanying consolidated statements of comprehensive (loss) income . Leasing Commission Fees The Company pays the Property Manager a separate fee for the initial lease-up, leasing-up of newly constructed properties or re-leasing to existing tenants. Leasing commission fees are capitalized in other assets, net, in the accompanying consolidated balance sheets and amortized over the terms of the related leases. Construction Management Fees For acting as general contractor and/or construction manager to supervise or coordinate projects or to provide major repairs or rehabilitation on the Company's properties, the Company may pay the Property Manager up to 5.0% of the cost of the projects, repairs and/or rehabilitation, as applicable, or construction management fees. Construction management fees are capitalized in real estate, net, in the accompanying consolidated balance sheets . Disposition Fees The Company pays its Advisor, or its affiliates, if it provides a substantial amount of services (as determined by a majority of the Company’s independent directors) in connection with the sale of properties, a disposition fee, equal to the lesser of 1.0% of the contract sales price or one-half of the total brokerage commission paid if a third party broker is also involved, without exceeding the lesser of 6.0% of the contract sales price or a reasonable, customary and competitive real estate commission. As of December 31, 2019 , the Company had no t incurred any disposition fees to the Advisor or its affiliates. Subordinated Participation in Net Sale Proceeds Prior to the completion of the REIT Merger on October 4, 2019, upon the sale of the Company, the Advisor would have received 15% of the remaining net sale proceeds after return of capital contributions plus payment to investors of a 6.0% annual cumulative, non-compounded return on the capital contributed by investors, or the subordinated participation in net sale proceeds. As of October 4, 2019, the Company had no t incurred any subordinated participation in net sale proceeds to the Advisor or its affiliates. The Fourth A&R CVREIT II Advisory Agreement, which became effective immediately following the Contributions, does not provide for the payment of a subordinated participation in net sales proceeds to the Advisor or its affiliates. The A&R CVOP II Partnership Agreement became effective following completion of the Contributions, and provides that the Advisor, as a special limited partner of CVOP II, would be entitled to a distribution upon an Investment Liquidity Event (as defined in the A&R CVOP II Partnership Agreement). The A&R CVOP II Partnership Agreement also increases the threshold of the Priority Return (as defined in the A&R CVOP II Partnership Agreement) from 6.0% to 8.0% , as previously agreed to and disclosed in connection with the REIT Merger. Subordinated Incentive Listing Fee Prior to the completion of the REIT Merger on October 4, 2019, upon the listing of the Company’s shares on a national securities exchange, the Advisor would have received 15% of the amount by which the sum of the Company’s adjusted market value plus distributions exceeded the sum of the aggregate capital contributed by investors plus an amount equal to a 6.0% annual cumulative, non-compounded return to investors, or the subordinated incentive listing fee. As of October 4, 2019, the Company had no t incurred any subordinated incentive listing fees to the Advisor or its affiliates. The Fourth A&R CVREIT II Advisory Agreement does not provide for the payment of a subordinated incentive listing fee to the Advisor or its affiliates. The A&R CVOP II Partnership Agreement provides that the Advisor, as a special limited partner of CVOP II, would be entitled to a distribution upon an Investment Liquidity Event (as defined in the A&R CVOP II Partnership Agreement). The A&R CVOP II Partnership Agreement also increases the threshold of the Priority Return (as defined in the A&R CVOP II Partnership Agreement) from 6.0% to 8.0% , as previously agreed to and disclosed in connection with the REIT Merger. Subordinated Distribution Upon Termination Fee Prior to the completion of the REIT Merger on October 4, 2019, upon termination or non-renewal of the advisory agreement, with or without cause, the Advisor would have been entitled to receive subordinated termination fees from the Operating Partnership equal to 15% of the amount by which the sum of the Company’s adjusted market value plus distributions exceeded the sum of the aggregate capital contributed by investors plus an amount equal to an annual 6.0% cumulative, non-compounded return to investors. As of October 4, 2019, the Company had no t incurred any subordinated termination fees to the Advisor or its affiliates. The Fourth A&R CVREIT II Advisory Agreement does not provide for the payment of a subordinated termination fee to the Advisor or its affiliates. The A&R CVOP II Partnership Agreement provides that the Advisor, as a special limited partner of CVOP II, would be entitled to a distribution upon the termination of the Fourth A&R Advisory Agreement (unless such termination is by the Company because of a material breach of the Fourth A&R Advisory Agreement or occurs upon a change of control). The A&R CVOP II Partnership Agreement also increases the threshold of the Priority Return (as defined in the A&R CVOP II Partnership Agreement) from 6.0% to 8.0% , as previously agreed to and disclosed in connection with the REIT Merger. The following table details amounts incurred in connection with the Company's related parties transactions as described above for the years ended December 31, 2019 , 2018 and 2017 (amounts in thousands): Incurred Year Ended Fee Entity 2019 2018 2017 Distribution and servicing fees SC Distributors, LLC $ (563 ) (1) $ 368 $ 9,617 Acquisition fees and costs Carter Validus Advisors II, LLC and its affiliates 26,072 4,272 11,979 Asset management fees Carter Validus Advisors II, LLC and its affiliates 16,475 13,114 9,963 Property management fees Carter Validus Real Estate Management Services II, LLC 5,403 4,391 3,246 Operating expense reimbursement Carter Validus Advisors II, LLC and its affiliates 4,492 2,692 2,101 Leasing commission fees Carter Validus Real Estate Management Services II, LLC 1,241 497 907 Construction management fees Carter Validus Real Estate Management Services II, LLC 276 243 719 Total $ 53,396 $ 25,577 $ 38,532 (1) Reduction of distribution and servicing fees is a result of repurchases of Class T and Class T2 shares of common stock. The following table details amounts payable to affiliates in connection with the Company's related parties transactions as described above as of December 31, 2019 and 2018 (amounts in thousands): Payable December 31, 2019 December 31, 2018 Fee Entity Other offering costs reimbursement Carter Validus Advisors II, LLC and its affiliates $ — $ 89 Distribution and servicing fees SC Distributors, LLC 6,210 10,218 Acquisition fees and costs Carter Validus Advisors II, LLC and its affiliates — 32 Asset management fees Carter Validus Advisors II, LLC and its affiliates 2,100 1,182 Property management fees Carter Validus Real Estate Management Services II, LLC 433 420 Operating expense reimbursement Carter Validus Advisors II, LLC and its affiliates 518 421 Leasing commission fees Carter Validus Real Estate Management Services II, LLC 299 25 Construction management fees Carter Validus Real Estate Management Services II, LLC 199 40 Total $ 9,759 $ 12,427

Segment Reporting

Segment Reporting	12 Months Ended
	Dec. 31, 2019
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting Management reviews the performance of individual properties and aggregates individual properties based on operating criteria into two reportable segments—commercial real estate investments in data centers and healthcare, and makes operating decisions based on these two reportable segments. The Company’s commercial real estate investments in data centers and healthcare are based on certain underwriting assumptions and operating criteria, which are different for data centers and healthcare. The Company evaluates performance based on net operating income of the individual properties in each segment. Net operating income, a non-GAAP financial measure, is defined as rental revenue, less rental expenses, which excludes depreciation and amortization, general and administrative expenses, asset management fees, impairment loss on real estate, gain on real estate disposition and interest and other expense, net. The Company believes that segment net operating income serves as a useful supplement to net income because it allows investors and management to measure unlevered property-level operating results and to compare operating results to the operating results of other real estate companies between periods on a consistent basis. Segment net operating income should not be considered as an alternative to net income determined in accordance with GAAP as an indicator of financial performance, and accordingly, the Company believes that in order to facilitate a clear understanding of the consolidated historical operating results, segment net operating income should be examined in conjunction with net income as presented in the accompanying consolidated financial statements and data included elsewhere in this Annual Report on Form 10-K . Non-segment assets primarily consist of corporate assets, including cash and cash equivalents, real estate and escrow deposits, deferred financing costs attributable to the revolving line of credit portion of the Company's credit facility, leasing commissions and other assets not attributable to individual properties. Summary information for the reportable segments during the years ended December 31, 2019 , 2018 and 2017 is as follows (amounts in thousands): Data Center Healthcare Year Ended December 31, 2019 Revenue: Rental revenue $ 109,689 $ 101,212 $ 210,901 Expenses: Rental expenses (30,270 ) (10,714 ) (40,984 ) Segment net operating income $ 79,419 $ 90,498 169,917 Expenses: General and administrative expenses (8,421 ) Asset management fees (16,475 ) Depreciation and amortization (74,104 ) Impairment loss on real estate - healthcare (21,000 ) Gain on real estate disposition 79 Income from operations 49,996 Interest and other expense, net (47,214 ) Net income attributable to common stockholders $ 2,782 Data Center Healthcare Year Ended December 31, 2018 Revenue: Rental revenue $ 103,226 $ 74,107 $ 177,333 Expenses: Rental expenses (27,289 ) (10,038 ) (37,327 ) Segment net operating income $ 75,937 $ 64,069 140,006 Expenses: General and administrative expenses (5,396 ) Asset management fees (13,114 ) Depreciation and amortization (58,258 ) Income from operations 63,238 Interest and other expense, net (34,365 ) Net income attributable to common stockholders $ 28,873 Data Center Healthcare Year Ended Revenue: Rental revenue $ 62,377 $ 62,710 $ 125,087 Expenses: Rental expenses (17,571 ) (8,525 ) (26,096 ) Segment net operating income $ 44,806 $ 54,185 98,991 Expenses: General and administrative expenses (4,069 ) Asset management fees (9,963 ) Depreciation and amortization (41,133 ) Income from operations 43,826 Interest and other expense, net (22,547 ) Net income attributable to common stockholders $ 21,279 There were no intersegment sales or transfers during the years ended December 31, 2019 , 2018 and 2017 . Assets by each reportable segment as of December 31, 2019 and 2018 are as follows (amounts in thousands): December 31, 2019 December 31, 2018 Assets by segment: Data centers $ 989,953 $ 1,001,357 Healthcare 2,184,450 900,114 All other 65,131 62,358 Total assets $ 3,239,534 $ 1,963,829 Capital additions, acquisitions and dispositions on a cash basis by reportable segments for the years ended December 31, 2019 , 2018 and 2017 are as follows (amounts in thousands): Year Ended 2019 2018 2017 Capital additions by segment: Data Centers $ 7,004 $ 2,763 $ 197 Healthcare 5,837 12,820 32,314 Total 12,841 15,583 32,511 Acquisitions by segment: Data Centers — 112,181 472,241 Healthcare 528,259 105,151 132,131 Total 528,259 217,332 604,372 Dispositions by segment: Data Centers — — — Healthcare (2,882 ) — — Total (2,882 ) — — Total capital additions, acquisitions and dispositions $ 538,218 $ 232,915 $ 636,883

Fair Value

Fair Value	12 Months Ended
	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Fair Value	Fair Value Notes payable—Fixed Rate —The estimated fair value of notes payable — fixed rate measured using observable inputs from similar liabilities (Level 2) was approximately $222,816,000 and $214,282,000 as of December 31, 2019 and 2018 , respectively, as compared to the outstanding principal of $219,567,000 and $220,351,000 as of December 31, 2019 and 2018 , respectively. The estimated fair value of notes payable — variable rate fixed through interest rate swap agreements (Level 2) was approximately $238,555,000 and $241,739,000 as of December 31, 2019 and 2018 , respectively, as compared to the outstanding principal of $237,778,000 and $247,435,000 as of December 31, 2019 and 2018 , respectively. Credit facility — Variable Rate —The outstanding principal of the credit facility—variable was $658,000,000 and $255,000,000 , which approximated its fair value as of December 31, 2019 and 2018 , respectively. The fair value of the Company's variable rate credit facility is estimated based on the interest rates currently offered to the Company by financial institutions. Credit facility — Fixed Rate —The estimated fair value of the credit facility—variable rate fixed through interest rate swap agreements (Level 2) was approximately $251,907,000 and $96,146,000 as of December 31, 2019 and 2018 , respectively, as compared to the outstanding principal of $250,000,000 and $100,000,000 as of December 31, 2019 and 2018 , respectively. Note receivable —The outstanding principal balance of the note receivable in the amount of $2,700,000 and $0 approximated its fair value as of December 31, 2019 and 2018 , respectively. The fair value was measured using significant other observable inputs (Level 2), which requires certain judgments to be made by management. Derivative instruments —Considerable judgment is necessary to develop estimated fair values of financial instruments. Accordingly, the estimates presented herein are not necessarily indicative of the amount the Company could realize, or be liable for, on disposition of the financial instruments. The Company determined that the majority of the inputs used to value its interest rate swaps fall within Level 2 of the fair value hierarchy. The credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by the Company and the respective counterparty. However, as of December 31, 2019 , the Company assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions, and determined that the credit valuation adjustments are not significant to the overall valuation of its interest rate swaps. As a result, the Company determined that its interest rate swaps valuation in its entirety is classified in Level 2 of the fair value hierarchy. See Note 14—"Derivative Instruments and Hedging Activities" for further discussion of the Company's derivative instruments. The following tables show the fair value of the Company’s financial assets and liabilities that are required to be measured at fair value on a recurring basis as of December 31, 2019 and 2018 (amounts in thousands): December 31, 2019 Fair Value Hierarchy Quoted Prices in Active Significant Other Significant Total Fair Assets: Derivative assets $ — $ 884 $ — $ 884 Total assets at fair value $ — $ 884 $ — $ 884 Liabilities: Derivative liabilities $ — $ 5,588 $ — $ 5,588 Total liabilities at fair value $ — $ 5,588 $ — $ 5,588 December 31, 2018 Fair Value Hierarchy Quoted Prices in Active Significant Other Significant Total Fair Assets: Derivative assets $ — $ 6,204 $ — $ 6,204 Total assets at fair value $ — $ 6,204 $ — $ 6,204 Real estate assets —As discussed in Note 2—"Summary of Significant Accounting Policies," during the third quarter ended September 30, 2019, real estate assets related to one healthcare property with an aggregate carrying amount of $40,266,000 were determined to be impaired and the carrying value of the property was reduced to its estimated fair value of $27,266,000 . In addition, during the fourth quarter ended December 31, 2019, real estate assets related to another healthcare property with an aggregate carrying amount of $30,412,000 were determined to be impaired and the carrying value of the property was reduced to its estimated fair value of $22,412,000 . The fair values of the Company's impaired real estate assets were estimated using significant other observable inputs based on market activity. The Company used a market valuation approach, using comparable sales to estimate the fair value. Based upon these inputs, the Company determined that its valuation of the properties using a market approach model is classified within Level 2 of the fair value hierarchy. During the years ended December 31, 2018 and 2017, no impairment losses were recorded on real estate assets. The following table shows the fair value of the Company's real estate assets measured at fair value on a non-recurring basis as of December 31, 2019 (amounts in thousands): December 31, 2019 Fair Value Hierarchy Quoted Prices in Active Significant Other Significant Re-Measured Balance Total Losses (1) Real estate assets $ — $ 22,412 $ — $ 22,412 $ 8,000 (1) Total losses are included in impairment loss on real estate in the consolidated statements of comprehensive (loss) income .

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	12 Months Ended
	Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	Derivative Instruments and Hedging Activities Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable rate amounts from a counterparty in exchange for the Company making fixed rate payments over the life of the agreements without exchange of the underlying notional amount. Changes in the fair value of derivatives designated, and that qualify, as cash flow hedges are recorded in accumulated other comprehensive income (loss) in the accompanying consolidated statements of stockholders' equity and are subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. During the year ended December 31, 2019, the Company accelerated the reclassification of amounts in other comprehensive (loss) income to earnings, as a result of a hedged forecasted transaction becoming probable not to occur, due to a partial pre-payment of a note payable related to a healthcare property. The accelerated amount was a loss of $92,000 and was recorded in interest expense, net, in the accompanying consolidated statements of comprehensive (loss) income . Amounts reported in accumulated other comprehensive income (loss) related to derivatives will be reclassified to interest and other expense, net , as interest payments are made on the Company’s variable rate debt. During the next twelve months, the Company estimates that an additional $1,352,000 will be reclassified from accumulated other comprehensive income (loss) as an increase to interest and other expense, net. See Note 13—"Fair Value" for further discussion of the fair value of the Company’s derivative instruments. The following table summarizes the notional amount and fair value of the Company’s derivative instruments (amounts in thousands): Derivatives Balance Effective Maturity December 31, 2019 December 31, 2018 Outstanding Fair Value of Outstanding Fair Value of Asset (Liability) Asset (Liability) Interest rate swaps Other assets, net/ 07/01/2016 to (1) 12/22/2020 to $ 637,778 $ 884 $ (5,588 ) $ 347,435 $ 6,204 $ — (1) During the year ended December 31, 2019 , the Company entered into two interest rate swap agreements, with an effective date of April 1, 2019, which effectively fixed LIBOR related to $150,000,000 of the term loans of the credit facility and three interest rate swap agreements, with an effective date of January 1, 2020, which will effectively fix LIBOR related to $150,000,000 of the term loans of the credit facility. The notional amount under the agreements is an indication of the extent of the Company’s involvement in each instrument at the time, but does not represent exposure to credit, interest rate or market risks. Accounting for changes in the fair value of a derivative instrument depends on the intended use and designation of the derivative instrument. The Company designated the interest rate swaps as cash flow hedges to hedge the variability of the anticipated cash flows on its variable rate credit facility and notes payable. The change in fair value of the derivative instruments that are designated as hedges are recorded in other comprehensive (loss) income , or OCI, in the accompanying consolidated statements of comprehensive (loss) income . The table below summarizes the amount of (loss) income recognized on the interest rate derivatives designated as cash flow hedges for the years ended December 31, 2019 , 2018 and 2017 (amounts in thousands): Derivatives in Cash Flow Hedging Relationships Amount of (Loss) Income Recognized Location of (Loss) Income Amount of Income (Loss) Total Amount of Interest and Other Expense, Net Presented in Consolidated Statements of Comprehensive (Loss) Income Year Ended December 31, 2019 Interest rate swaps $ (9,305 ) Interest and other expense, net $ 1,602 $ 47,214 Total $ (9,305 ) $ 1,602 Year Ended December 31, 2018 Interest rate swaps $ 3,208 Interest and other expense, net $ 818 $ 34,365 Total $ 3,208 $ 818 Year Ended December 31, 2017 Interest rate swaps $ 1,484 Interest and other expense, net $ (1,386 ) $ 22,547 Total $ 1,484 $ (1,386 ) Credit Risk-Related Contingent Features T he Company has agreements with each of its derivative counterparties that contain a provision where if the Company either defaults or is capable of being declared in default on any of its indebtedness, then the Company could also be declared in default on its derivative obligations. The Company records credit risk valuation adjustments on its interest rate swaps based on the respective credit quality of the Company and the counterparty. The Company believes it mitigates its credit risk by entering into agreements with creditworthy counterparties. As of December 31, 2019 , the fair value of derivatives in a net liability position was $5,926,000 , inclusive of accrued interest but excluding any adjustment for nonperformance risk related to the agreement. As of December 31, 2019 , there were no termination events or events of default related to the interest rate swaps. Tabular Disclosure Offsetting Derivatives The Company has elected not to offset derivative positions in its consolidated financial statements. The following tables present the effect on the Company’s financial position had the Company made the election to offset its derivative positions as of December 31, 2019 and 2018 (amounts in thousands): Offsetting of Derivative Assets Gross Amounts Not Offset in the Balance Sheet Gross Gross Amounts Net Amounts of Financial Instruments Cash Collateral Net December 31, 2019 $ 884 $ — $ 884 $ (5 ) $ — $ 879 December 31, 2018 $ 6,204 $ — $ 6,204 $ — $ — $ 6,204 Offsetting of Derivative Liabilities Gross Amounts Not Offset in the Balance Sheet Gross Gross Amounts Net Amounts of Financial Instruments Cash Collateral Net December 31, 2019 $ 5,588 $ — $ 5,588 $ (5 ) $ — $ 5,583 December 31, 2018 $ — $ — $ — $ — $ — $ — The Company reports derivative assets and derivative liabilities in the accompanying consolidated balance sheets as other assets, net , and accounts payable and other liabilities , respectively.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) The following table presents a rollforward of amounts recognized in accumulated other comprehensive income (loss) by component for the years ended December 31, 2019 , 2018 and 2017 (amounts in thousands): Unrealized Income (Loss) on Derivative Balance as of December 31, 2016 $ 840 Other comprehensive income before reclassification 1,484 Amount of loss reclassified from accumulated other comprehensive income to net income (effective portion) 1,386 Other comprehensive income 2,870 Balance as of December 31, 2017 3,710 Other comprehensive income before reclassification 3,208 Amount of income reclassified from accumulated other comprehensive income to net income (effective portion) (818 ) Other comprehensive income 2,390 Balance as of December 31, 2018 6,100 Cumulative effect of accounting change 103 Balance as of January 1, 2019 6,203 Other comprehensive loss before reclassification (9,305 ) Amount of income reclassified from accumulated other comprehensive income to net income (including missed forecast) (1,602 ) Other comprehensive loss (10,907 ) Balance as of December 31, 2019 $ (4,704 ) The following table presents reclassifications out of accumulated other comprehensive income (loss) for the years ended December 31, 2019 , 2018 and 2017(amounts in thousands): Details about Accumulated Other Amounts Reclassified from Affected Line Items in the Consolidated Statements of Comprehensive (Loss) Income Year Ended 2019 2018 2017 Interest rate swap contracts $ (1,602 ) $ (818 ) $ 1,386 Interest and other expense, net

Stock-based Compensation

Stock-based Compensation	12 Months Ended
	Dec. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-based Compensation	Stock-based Compensation On May 6, 2014, the Company adopted the Carter Validus Mission Critical REIT II, Inc. 2014 Restricted Share Plan, or the Incentive Plan, pursuant to which the Company has the power and authority to grant restricted or deferred stock awards to persons eligible under the Incentive Plan. The Company authorized and reserved 300,000 shares of its Class A shares for issuance under the Incentive Plan, subject to certain adjustments. Subject to certain limited exceptions, restricted stock may not be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of and is subject to forfeiture within the vesting period. Restricted stock awards generally vest ratably over four years. The Company uses the straight-line method to recognize expenses for service awards with graded vesting. Restricted stock awards are entitled to receive dividends during the vesting period. In addition to the ratable amortization of fair value over the vesting period, dividends paid on unvested shares of restricted stock which are not expected to vest are charged to compensation expense in the period paid. On September 25, 2019, the Company granted an aggregate of 12,000 shares of restricted Class A common stock to its independent directors in connection with their re-election to the board of directors of the Company. The fair value of each share of restricted common stock was estimated at the date of grant at $9.25 per share. The restricted stock awards vest over a period of four years. The awards are amortized using the straight-line method over four years. On March 6, 2020, the Company's board of directors approved the Amended and Restated 2014 Restricted Share Plan, or the A&R Incentive Plan. See Note 21—"Subsequent Events" for more information. As of December 31, 2019 and 2018, there was $215,000 and $192,000 , respectively, of total unrecognized compensation expense related to nonvested shares of the Company’s restricted Class A common stock. This expense is expected to be recognized over a remaining weighted average period of 2.25 years . This expected expense does not include the impact of any future stock-based compensation awards. As of December 31, 2019 and 2018, the fair value of the nonvested shares of restricted Class A common stock was $240,038 and $235,875 , respectively. A summary of the status of the nonvested shares of restricted Class A common stock as of December 31, 2018 and the changes for the year ended December 31, 2019 is presented below: Restricted Stock Shares Nonvested at December 31, 2018 25,500 Vested (9,750 ) Granted 12,000 Nonvested at December 31, 2019 27,750 Stock-based compensation expense for the years ended December 31, 2019, 2018 and 2017 was approximately $89,000 , $90,000 and $76,000 , respectively, which is reported in general and administrative costs in the accompanying consolidated statements of comprehensive (loss) income .

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes As a REIT, the Company generally will not be subject to U.S. federal income tax on taxable income that it distributes to the stockholders. For U.S. federal income tax purposes, distributions to stockholders are characterized as either ordinary dividends, capital gain distributions, or nontaxable distributions. Nontaxable distributions will reduce U.S. stockholders’ respective bases in their shares. The following table shows the character of distributions the Company paid on a percentage basis during the years ended December 31, 2019, 2018 and 2017: Year Ended December 31, Character of Class A Distributions: 2019 2018 2017 Ordinary dividends 17.93 % 41.38 % 36.49 % Capital gain distributions 0.38 % — % — % Nontaxable distributions 81.69 % 58.62 % 63.51 % Total 100.00 % 100.00 % 100.00 % Year Ended December 31, Character of Class I Distributions: 2019 2018 2017 Ordinary dividends 17.93 % 41.38 % 36.49 % Capital gain distributions 0.38 % — % — % Nontaxable distributions 81.69 % 58.62 % 63.51 % Total 100.00 % 100.00 % 100.00 % Year Ended December 31, Character of Class T Distributions: 2019 2018 2017 Ordinary dividends 4.79 % 33.01 % 25.93 % Capital gain distributions 0.43 % — % — % Nontaxable distributions 94.78 % 66.99 % 74.07 % Total 100.00 % 100.00 % 100.00 % Year Ended December 31, Character of Class T2 Distributions: 2019 2018 2017 Ordinary dividends 4.79 % 33.01 % — % Capital gain distributions 0.43 % — % — % Nontaxable distributions 94.78 % 66.99 % — % Total 100.00 % 100.00 % — % The Company is subject to certain state and local income taxes on income, property or net worth in some jurisdictions, and in certain circumstances may also be subject to federal excise tax on undistributed income. Texas, Tennessee, California, Louisiana and Massachusetts are the major state and local tax jurisdictions for the Company. The Company applies the rules under ASC 740-10, Accounting for Uncertainty in Income Taxes , for uncertain tax positions using a “more likely than not” recognition threshold for tax positions. Pursuant to these rules, the financial statement effects of a tax position are initially recognized when it is more likely than not, based on the technical merits of the tax position, that such a position will be sustained upon examination by the relevant tax authorities. If the tax benefit meets the “more likely than not” threshold, the measurement of the tax benefit will be based on the Company's estimate of the ultimate tax benefit to be sustained if audited by the taxing authority. The Company concluded there was no impact related to uncertain tax positions from the results of the operations of the Company for the years ended December 31, 2019, 2018 and 2017. The earliest tax year subject to examination is 2016. The Company’s policy is to recognize accrued interest related to unrecognized tax benefits as a component of interest expense and penalties related to unrecognized tax benefits as a component of general and administrative expenses. From inception through December 31, 2019, the Company has no t recognized any interest expense or penalties related to unrecognized tax benefits.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies In the ordinary course of business, the Company may become subject to litigation or claims. As of December 31, 2019 , there were, and currently there are, no material pending legal proceedings to which the Company is a party. While the resolution of a lawsuit or proceeding may have an impact to the Company's financial results for the period in which it is resolved, the Company believes that the final resolution of the lawsuits or proceedings in which it is currently involved, either individually or in the aggregate, will not have a material adverse effect on its financial position, results of operations or liquidity.

Economic Dependency

Economic Dependency	12 Months Ended
	Dec. 31, 2019
Economic Dependency [Abstract]
Economic Dependency	Economic Dependency The Company is dependent on the Advisor and its affiliates for certain services that are essential to the Company, including the identification, evaluation, negotiation, purchase and disposition of real estate investments and other investments; the management of the daily operations of the Company’s real estate portfolio; and other general and administrative responsibilities. In the event that the Advisor and its affiliates are unable to provide the respective services, the Company will be required to obtain such services from other sources.

Selected Quarterly Financial Da

Selected Quarterly Financial Data (Unaudited)	12 Months Ended
	Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]
Selected Quarterly Financial Data (Unaudited)	Selected Quarterly Financial Data (Unaudited) Presented in the following table is a summary of the unaudited quarterly financial information for the years ended December 31, 2019 and 2018. The Company believes that all necessary adjustments, consisting only of normal recurring adjustments, have been included in the amounts stated below to present fairly, and in accordance with GAAP, the selected quarterly information (amounts in thousands, except shares and per share data): 2019 Fourth Third Second First Total revenue $ 69,434 $ 48,063 $ 46,937 $ 46,467 Total expenses (52,160 ) (45,773 ) (30,780 ) (32,271 ) Gain on real estate disposition 79 — — — Income from operations 17,353 2,290 16,157 14,196 Interest and other expense, net (15,566 ) (11,920 ) (9,893 ) (9,835 ) Net income (loss) attributable to common stockholders $ 1,787 $ (9,630 ) $ 6,264 $ 4,361 Net income (loss) per common share attributable to common stockholders: Basic $ 0.01 $ (0.07 ) $ 0.05 $ 0.03 Diluted $ 0.01 $ (0.07 ) $ 0.05 $ 0.03 Weighted average number of common shares outstanding: Basic 218,928,165 137,063,509 136,135,710 136,179,343 Diluted 218,955,915 137,063,509 136,161,037 136,204,843 2018 Fourth Third Second First Total revenue $ 46,571 $ 45,517 $ 43,951 $ 41,294 Total expenses (30,627 ) (28,863 ) (28,556 ) (26,049 ) Income from operations 15,944 16,654 15,395 15,245 Interest and other expense, net (9,478 ) (8,937 ) (8,209 ) (7,741 ) Net income attributable to common stockholders $ 6,466 $ 7,717 $ 7,186 $ 7,504 Net income per common share attributable to common stockholders: Basic $ 0.05 $ 0.06 $ 0.06 $ 0.06 Diluted $ 0.05 $ 0.06 $ 0.06 $ 0.06 Weighted average number of common shares outstanding: Basic 135,271,638 132,467,127 129,926,130 126,384,346 Diluted 135,297,138 132,491,755 129,948,432 126,401,940

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Distributions Paid to Stockholders The following table summarizes the Company's distributions paid on January 2, 2020, for the period from December 1, 2019 through December 31, 2019 (amounts in thousands): Payment Date Common Stock Cash DRIP Total Distribution January 2, 2020 Class A $ 5,442 $ 1,648 $ 7,090 January 2, 2020 Class I 323 215 538 January 2, 2020 Class T 628 715 1,343 January 2, 2020 Class T2 53 69 122 $ 6,446 $ 2,647 $ 9,093 The following table summarizes the Company's distributions paid on February 3, 2020, for the period from January 1, 2020 through January 31, 2020 (amounts in thousands): Payment Date Common Stock Cash DRIP Total Distribution February 3, 2020 Class A $ 5,431 $ 1,646 $ 7,077 February 3, 2020 Class I 324 213 537 February 3, 2020 Class T 631 712 1,343 February 3, 2020 Class T2 52 69 121 $ 6,438 $ 2,640 $ 9,078 The following table summarizes the Company's distributions paid on March 3, 2020, for the period from February 1, 2020 through February 29, 2020 (amounts in thousands): Payment Date Common Stock Cash DRIP Total Distribution March 3, 2020 Class A $ 5,060 $ 1,526 $ 6,586 March 3, 2020 Class I 299 197 496 March 3, 2020 Class T 595 660 1,255 March 3, 2020 Class T2 50 63 113 $ 6,004 $ 2,446 $ 8,450 Distributions Authorized The following tables summarize the daily distributions approved and authorized by the board of directors of the Company subsequent to December 31, 2019 : Authorization Date (1) Common Stock Daily Distribution Rate (1) Annualized Distribution Per Share February 24, 2020 Class A $ 0.001366120 $ 0.50 February 24, 2020 Class I $ 0.001366120 $ 0.50 February 24, 2020 Class T $ 0.001129781 $ 0.41 February 24, 2020 Class T2 $ 0.001129781 $ 0.41 (1) Distributions approved and authorized to stockholders of record as of the close of business on each day of the period commencing on March 1, 2020 and ending on May 31, 2020. The distributions will be calculated based on 366 days in the calendar year. The distributions declared for each record date in March 2020, April 2020 and May 2020 will be paid in April 2020, May 2020 and June 2020, respectively. The distributions will be payable to stockholders from legally available funds therefor. Acquisitions The following table summarizes the property acquired subsequent to December 31, 2019 and through March 24, 2020 : Property Date Acquired Contract Purchase Price Ownership Grimes Healthcare Facility 02/19/2020 $4,825,000 100% Amended and Restated Incentive Plan On March 6, 2020, the Company's board of directors approved the A&R Incentive Plan, pursuant to which the Company has the authority and power to grant awards of restricted shares of its Class A common stock to its directors, officers and employees (if the Company ever has employees), employees of the Advisor and its affiliates, employees of entities that provide services to the Company, directors of the Advisor or of entities that provide services to the Company, certain of the Company’s consultants and certain consultants to the Advisor and its affiliates or to entities that provide services to the Company. The Board has authorized a total of 5,000,000 Class A shares of common stock for issuance under the A&R Incentive Plan on a fully diluted basis at any time. Independent Director Compensation On March 6, 2020, the Company's board of directors determined to revise the amounts of restricted Class A shares of common stock the independent directors are entitled to receive each year as provided below. On March 10, 2020, the Company granted each independent director 2,415 shares of restricted Class A common stock, with a per share price of $8.65 , and beginning July 1, 2020 and each July 1 thereafter, the Company will grant each independent director $60,000 in restricted shares of Class A common stock. Restricted stock issued to the Company’s independent directors will vest over a three -year period following the first anniversary of the date of grant in increments of 33.34% per annum. On March 6, 2020, the Company's board of directors also approved the following annual compensation amounts for its independent directors, effective as of November 7, 2019: (i) a cash retainer of $90,000 per year (the chairperson of the audit committee will receive an additional $15,000 per year) plus (ii) $2,500 for each regularly scheduled quarterly meeting the director attends in person. On March 19, 2020, due to the current coronavirus (COVID-19) situation, the Company's board of directors revised the meeting fees to be paid to each independent director to include regularly scheduled quarterly meetings that are required to be held telephonically. Therefore, each independent director will receive $2,500 for each regularly scheduled quarterly meeting the director attends (whether the meeting is in person or telephonic).

SCHEDULE III - REAL ESTATE ASSE

SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION	12 Months Ended
	Dec. 31, 2019
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]
SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION	SCHEDULE III — REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION December 31, 2019 (in thousands) Initial Cost Cost Gross Amount Property Description Location Encumbrances Land Buildings and Land Buildings and Total Accumulated Year Year Date Houston Healthcare Facility, f.k.a. Cy Fair Surgical Center Houston, TX $ — (a) $ 762 $ 2,970 $ 106 $ 762 $ 3,076 $ 3,838 $ 551 1993 — 07/31/2014 Cincinnati Healthcare Facility, f.k.a. Mercy Healthcare Facility Cincinnati, OH — (a) 356 3,167 89 356 3,256 3,612 504 2001 — 10/29/2014 Winston-Salem Healthcare Facility, f.k.a. Winston-Salem, NC IMF Winston-Salem, NC — (a) 684 4,903 — 684 4,903 5,587 736 2004 — 12/17/2014 Stoughton Healthcare Facility, f.k.a. New England Sinai Medical Center Stoughton, MA — (a) 4,049 19,991 1,918 4,049 21,909 25,958 2,965 1973 1997 12/23/2014 Fort Worth Healthcare Facility, f.k.a. Baylor Surgical Hospital at Fort Worth Fort Worth, TX — (a) 8,297 35,615 — 8,297 35,615 43,912 4,707 2014 — 12/31/2014 Fort Worth Healthcare Facility II, f.k.a. Baylor Surgical Hospital Integrated Medical Facility Fort Worth, TX — (a) 367 1,587 164 367 1,751 2,118 399 2014 — 12/31/2014 Winter Haven Healthcare Facility Winter Haven, FL — (a) — 2,805 — — 2,805 2,805 386 2009 — 01/27/2015 Overland Park Healthcare Facility, f.k.a. Heartland Rehabilitation Hospital Overland Park, KS — (a) 1,558 20,549 — 1,558 20,549 22,107 2,633 2014 — 02/17/2015 Indianapolis Data Center Indianapolis, IN — (a) 524 6,422 37 524 6,459 6,983 789 2000 2014 04/01/2015 Clarion Healthcare Facility, f.k.a. Clarion IMF Clarion, PA — (a) 462 5,377 — 462 5,377 5,839 826 2012 — 06/01/2015 Webster Healthcare Facility, f.k.a. Post Acute Webster Rehabilitation Hospital Webster, TX — (a) 1,858 20,140 — 1,858 20,140 21,998 2,399 2015 — 06/05/2015 Eagan Data Center Eagan, MN — (a) 768 5,037 — 768 5,037 5,805 706 1998 2015 06/29/2015 Houston Healthcare Facility II, f.k.a. Houston Surgical Hospital and LTACH Houston, TX — 8,329 36,297 (17,360 ) 8,329 18,937 27,266 151 1950 2005/2008 06/30/2015 Augusta Healthcare Facility, f.k.a. KMO IMF - Augusta Augusta, ME — (a) 556 14,401 — 556 14,401 14,957 1,816 2010 — 07/22/2015 Cincinnati Healthcare Facility II, f.k.a. KMO IMF - Cincinnati I Cincinnati, OH — (a) 1,812 24,382 — 1,812 24,382 26,194 3,177 1960 2014 07/22/2015 Cincinnati Healthcare Facility III, f.k.a. KMO IMF - Cincinnati II Cincinnati, OH — (a) 446 10,239 4 446 10,243 10,689 1,214 2014 — 07/22/2015 Florence Healthcare Facility, f.k.a. KMO IMF - Florence Florence, KY — (a) 650 9,919 — 650 9,919 10,569 1,172 2014 — 07/22/2015 Oakland Healthcare Facility, f.k.a. KMO IMF - Oakland Oakland, ME — (a) 229 5,416 — 229 5,416 5,645 738 2014 — 07/22/2015 Wyomissing Healthcare Facility, f.k.a. Reading Surgical Hospital Wyomissing, PA — (a) 1,504 20,193 — 1,504 20,193 21,697 2,433 2007 — 07/24/2015 Luling Healthcare Facility, f.k.a. Post Acute Warm Springs Specialty Hospital of Luling Luling, TX — (a) 824 7,530 — 824 7,530 8,354 902 2002 — 07/30/2015 Minnetonka Data Center Minnetonka, MN — (a) 2,085 15,099 119 1,999 15,304 17,303 2,343 1985 2001/2006 08/28/2015 Omaha Healthcare Facility, f.k.a. Nebraska Healthcare Facility Omaha, NE — (a) 1,259 9,796 — 1,259 9,796 11,055 1,083 2014 — 10/14/2015 Initial Cost Cost Gross Amount Property Description Location Encumbrances Land Buildings and Land Buildings and Total Accumulated Year Year Date Sherman Healthcare Facility, f.k.a. Heritage Park - Sherman I Sherman, TX — (a) 1,679 23,926 — 1,679 23,926 25,605 2,564 2005 2010 11/20/2015 Sherman Healthcare Facility II, f.k.a. Heritage Park - Sherman II Sherman, TX — (a) 214 3,209 — 214 3,209 3,423 347 2005 — 11/20/2015 Fort Worth Healthcare Facility III, f.k.a. Baylor Surgery Center at Fort Worth Fort Worth, TX — (a) 3,120 9,312 — 3,120 9,312 12,432 990 1998 2007/2015 12/23/2015 Oklahoma City Healthcare Facility, f.k.a. HPI - Oklahoma City I Oklahoma City, OK 22,259 4,626 30,509 — 4,626 30,509 35,135 3,348 1985 1998/2003 12/29/2015 Oklahoma City Healthcare Facility II, f.k.a. HPI - Oklahoma City II Oklahoma City, OK — (a) 991 8,366 — 991 8,366 9,357 976 1994 1999 12/29/2015 Waco Data Center Waco, TX — (a) 873 8,233 — 873 8,233 9,106 842 1956 2009 12/30/2015 Edmond Healthcare Facility, f.k.a. HPI - Edmond Edmond, OK — (a) 796 3,199 — 796 3,199 3,995 372 2002 — 01/20/2016 Oklahoma City Healthcare Facility III, f.k.a. HPI - Oklahoma City IV Oklahoma City, OK — (a) 452 1,081 — 452 1,081 1,533 129 2006 — 01/27/2016 Oklahoma City Healthcare Facility IV, f.k.a. HPI - Oklahoma City III Oklahoma City, OK — (a) 368 2,344 — 368 2,344 2,712 273 2007 — 01/27/2016 Alpharetta Data Center, f.k.a. Alpharetta Data Center III Alpharetta, GA — (a) 3,395 11,081 25 3,395 11,106 14,501 1,193 1999 — 02/02/2016 Flint Data Center Flint, MI — (a) 111 7,001 — 111 7,001 7,112 735 1989 2016 02/02/2016 Newcastle Healthcare Facility, f.k.a. HPI - Newcastle Newcastle, OK — (a) 412 1,173 — 412 1,173 1,585 138 1995 1999 02/03/2016 Oklahoma City Healthcare Facility V, f.k.a. HPI - Oklahoma City V Oklahoma City, OK — (a) 541 12,445 — 541 12,445 12,986 1,423 2008 — 02/11/2016 Rancho Mirage Healthcare Facility, f.k.a. Vibra Rehabilitation Hospital Rancho Mirage, CA — 2,724 7,626 29,844 2,726 37,468 40,194 1,288 2018 — 03/01/2016 Oklahoma City Healthcare Facility VI, f.k.a. HPI - Oklahoma City VI Oklahoma City, OK — (a) 896 3,684 — 896 3,684 4,580 424 2007 — 03/07/2016 Franklin Data Center, f.k.a. Tennessee Data Center Franklin, TN — (a) 6,624 10,971 135 6,624 11,106 17,730 1,138 2016 2019 03/31/2016 Oklahoma City Healthcare Facility VII, f.k.a. HPI - Oklahoma City VII Oklahoma City, OK 24,547 3,203 32,380 — 3,203 32,380 35,583 3,009 2016 — 06/22/2016 Las Vegas Healthcare Facility, f.k.a. Post Acute Las Vegas Rehabilitation Hospital Las Vegas, NV — (a) 2,614 639 22,091 2,895 22,449 25,344 1,209 2017 — 06/24/2016 Somerset Data Center Somerset, NJ — (a) 906 10,466 — 906 10,466 11,372 1,071 1978 2016 06/29/2016 Oklahoma City Healthcare Facility VIII, f.k.a. Integris Lakeside Women's Hospital Oklahoma City, OK — (a) 2,002 15,384 — 2,002 15,384 17,386 1,410 1997 2008 06/30/2016 Hawthorne Data Center, f.k.a. AT&T Hawthorne Data Center Hawthorne, CA 39,749 16,498 57,312 — 16,498 57,312 73,810 4,797 1963 1983/2001 09/27/2016 McLean Data Center, f.k.a. McLean I McLean, VA 23,460 31,554 4,930 330 31,554 5,260 36,814 464 1966 1998 10/17/2016 McLean Data Center II, f.k.a. McLean II McLean, VA 27,540 20,392 22,727 105 20,392 22,832 43,224 1,883 1991 2019 10/17/2016 Marlton Healthcare Facility, f.k.a. Select Medical Rehabilitation Facility Marlton, NJ 31,145 — 57,154 5 — 57,159 57,159 4,467 1995 — 11/01/2016 Andover Data Center, f.k.a. Andover Data Center II Andover, MA — (a) 6,566 28,072 514 6,566 28,586 35,152 2,497 2000 — 11/08/2016 Grand Rapids Healthcare Facility Grand Rapids, MI 21,766 2,533 39,487 95 2,533 39,582 42,115 3,831 2008 — 12/07/2016 Corpus Christi Healthcare Facility, f.k.a. Corpus Christi Surgery Center Corpus Christi, TX — (a) 975 4,963 462 1,002 5,398 6,400 459 1992 — 12/22/2016 Initial Cost Cost Gross Amount Property Description Location Encumbrances Land Buildings and Land Buildings and Total Accumulated Year Year Date Chicago Data Center, f.k.a. Chicago Data Center II Downers Grove, IL — (a) 1,329 29,940 (545 ) 1,358 29,366 30,724 2,276 1987 2016 12/28/2016 Blythewood Data Center Blythewood, SC — (a) 612 17,714 27 634 17,719 18,353 1,375 1983 — 12/29/2016 Tempe Data Center Tempe, AZ — (a) 2,997 11,991 132 2,997 12,123 15,120 937 1977 2016 01/26/2017 Aurora Healthcare Facility Aurora, IL — (a) 973 9,632 — 973 9,632 10,605 726 2002 — 03/30/2017 Norwalk Data Center Norwalk, CT 34,200 10,125 43,360 94 10,125 43,454 53,579 3,096 2013 — 03/30/2017 Allen Healthcare Facility, f.k.a. Texas Rehab - Allen Allen, TX 13,136 857 20,582 — 857 20,582 21,439 1,547 2007 — 03/31/2017 Austin Healthcare Facility, f.k.a. Texas Rehab - Austin Austin, TX 20,861 1,368 32,039 — 1,368 32,039 33,407 2,408 2012 — 03/31/2017 Beaumont Healthcare Facility, f.k.a. Texas Rehab - Beaumont Beaumont, TX 5,863 946 8,372 — 946 8,372 9,318 633 1991 — 03/31/2017 Charlotte Data Center, f.k.a. Charlotte Data Center II Charlotte, NC — (a) 372 17,131 3,206 372 20,337 20,709 1,387 1989 2016 05/15/2017 Atlanta Data Center, f.k.a. 250 Williams Atlanta Data Center Atlanta, GA 116,200 19,159 129,778 6,397 19,159 136,175 155,334 12,264 1989 2007 06/15/2017 Sunnyvale Data Center Sunnyvale, CA — (a) 10,013 24,709 — 10,013 24,709 34,722 1,616 1992 1998 06/28/2017 San Antonio Healthcare Facility, f.k.a. Texas Rehab - San Antonio San Antonio, TX 10,490 1,813 11,706 — 1,813 11,706 13,519 807 2012 — 06/29/2017 Cincinnati Data Center Cincinnati, OH — (a) 1,556 8,966 — 1,556 8,966 10,522 637 1985 2010 06/30/2017 Silverdale Healthcare Facility Silverdale, WA — (a) 1,530 7,506 15 1,530 7,521 9,051 545 2005 — 08/25/2017 Silverdale Healthcare Facility II Silverdale, WA — (a) 1,542 4,981 — 1,542 4,981 6,523 383 2007 — 09/20/2017 King of Prussia Data Center King of Prussia, PA 11,961 1,015 17,413 — 1,015 17,413 18,428 1,031 1960 1997 09/28/2017 Tempe Data Center II Tempe, AZ — (a) — 15,803 — — 15,803 15,803 947 1998 — 09/29/2017 Houston Data Center Houston, TX 48,607 10,082 101,051 — 10,082 101,051 111,133 5,447 2013 — 11/16/2017 Saginaw Healthcare Facility Saginaw, MI — (a) 1,251 15,878 — 1,251 15,878 17,129 1,148 2002 — 12/21/2017 Elgin Data Center Elgin, IL 5,561 1,067 7,861 (421 ) 1,067 7,440 8,507 413 2000 — 12/22/2017 Oklahoma City Data Center Oklahoma City, OK — (a) 1,868 44,253 — 1,868 44,253 46,121 2,322 2008/2016 — 12/27/2017 Rancho Cordova Data Center, f.k.a. Rancho Cordova Data Center I Rancho Cordova, CA — (a) 1,760 32,109 — 1,760 32,109 33,869 1,464 1982 2008/2010 03/14/2018 Rancho Cordova Data Center II Rancho Cordova, CA — (a) 1,943 10,340 — 1,943 10,340 12,283 481 1984 2012 03/14/2018 Carrollton Healthcare Facility Carrollton, TX — (a) 1,995 5,870 — 1,995 5,870 7,865 278 2015 — 04/27/2018 Katy Healthcare Facility, f.k.a. Oceans Katy Behavioral Health Hospital Katy, TX — (a) 1,443 12,114 — 1,443 12,114 13,557 485 2015 — 06/08/2018 San Jose Data Center San Jose, CA — (a) 12,205 34,309 — 12,205 34,309 46,514 1,359 1999 2009 06/13/2018 Indianola Healthcare Facility, f.k.a. Indianola Healthcare I Indianola, IA — (a) 330 5,698 — 330 5,698 6,028 201 2014 — 09/26/2018 Indianola Healthcare Facility II, f.k.a. Indianola Healthcare II Indianola, IA — (a) 709 6,061 — 709 6,061 6,770 221 2011 — 09/26/2018 Canton Data Center Canton, OH — (a) 345 8,268 — 345 8,268 8,613 259 2008 — 10/03/2018 Benton Healthcare Facility, f.k.a. Benton Healthcare I (Benton) Benton, AR — (a) — 19,048 — — 19,048 19,048 625 1992/1999 — 10/17/2018 Benton Healthcare Facility II, f.k.a. Benton Healthcare III (Benton) Benton, AR — (a) — 1,647 — — 1,647 1,647 60 1983 — 10/17/2018 Initial Cost Cost Gross Amount Property Description Location Encumbrances Land Buildings and Land Buildings and Total Accumulated Year Year Date Bryant Healthcare Facility, f.k.a. Benton Healthcare II (Bryant) Bryant, AR — (a) 930 3,539 — 930 3,539 4,469 128 1995 — 10/17/2018 Hot Springs Healthcare Facility, f.k.a. Benton Healthcare IV (Hot Springs) Hot Springs, AR — (a) 384 2,077 — 384 2,077 2,461 78 2009 — 10/17/2018 Clive Healthcare Facility Clive, IA — (a) 336 22,332 — 336 22,332 22,668 789 2008 — 11/26/2018 Valdosta Healthcare Facility, f.k.a. Valdosta Healthcare I Valdosta, GA — (a) 659 5,626 — 659 5,626 6,285 199 2004 — 11/28/2018 Valdosta Healthcare Facility II, f.k.a. Valdosta Healthcare II Valdosta, GA — (a) 471 2,780 — 471 2,780 3,251 100 1992 — 11/28/2018 Bryant Healthcare Facility II, f.k.a. Bryant Healthcare Facility Bryant, AR — (a) 647 3,364 — 647 3,364 4,011 36 2016 — 08/16/2019 Laredo Healthcare Facility Laredo, TX — (a) — 12,137 — — 12,137 12,137 96 1998 — 09/19/2019 Laredo Healthcare Facility II Laredo, TX — (a) — 23,677 — — 23,677 23,677 187 1998 — 09/19/2019 Poplar Bluff Healthcare Facility Poplar Bluff, MO — (a) — 13,515 — — 13,515 13,515 107 2013 — 09/19/2019 Tucson Healthcare Facility Tucson, AZ — (a) — 5,998 — — 5,998 5,998 48 1998 — 09/19/2019 Akron Healthcare Facility Green, OH — (a) 3,503 38,512 — 3,503 38,512 42,015 214 2012 — 10/04/2019 Akron Healthcare Facility II Green, OH — (a) 1,085 10,277 — 1,085 10,277 11,362 69 2013 — 10/04/2019 Akron Healthcare Facility III Akron, OH — (a) 2,206 26,044 — 2,206 26,044 28,250 140 2008 — 10/04/2019 Alexandria Healthcare Facility Alexandria, LA — (a) — 5,076 — — 5,076 5,076 27 2007 — 10/04/2019 Appleton Healthcare Facility Appleton, WI — (a) 414 1,900 — 414 1,900 2,314 14 2011 — 10/04/2019 Austin Healthcare Facility II Austin, TX — (a) 3,229 7,534 (2,807 ) 2,195 5,761 7,956 32 2006 — 10/04/2019 Bellevue Healthcare Facility Green Bay, WI — (a) 567 1,269 — 567 1,269 1,836 9 2010 — 10/04/2019 Bonita Springs Healthcare Facility Bonita Springs, FL — (a) 1,199 4,373 — 1,199 4,373 5,572 24 2002 2005 10/04/2019 Bridgeton Healthcare Facility Bridgeton, MO — (a) — 39,740 — — 39,740 39,740 212 2012 — 10/04/2019 Covington Healthcare Facility Covington, LA — (a) 2,238 16,635 — 2,238 16,635 18,873 88 1984 — 10/04/2019 Crestview Healthcare Facility Crestview, FL — (a) 400 1,536 — 400 1,536 1,936 9 2004 2010 10/04/2019 Dallas Healthcare Facility Dallas, TX — (a) 6,072 27,457 — 6,072 27,457 33,529 144 2010 — 10/04/2019 Dallas Healthcare Facility II Dallas, TX — 3,611 26,907 (8,106 ) 2,662 19,750 22,412 — 1983 2013 10/04/2019 De Pere Healthcare Facility De Pere, WI — (a) 615 1,596 — 615 1,596 2,211 11 2005 — 10/04/2019 Denver Healthcare Facility Thornton, CO — (a) 3,586 32,363 — 3,586 32,363 35,949 175 1962 2018 10/04/2019 El Segundo Healthcare Facility El Segundo, CA — (a) 2,659 9,016 — 2,659 9,016 11,675 49 2009 — 10/04/2019 Fairlea Healthcare Facility Fairlea, WV — (a) 139 1,910 — 139 1,910 2,049 11 1999 — 10/04/2019 Fayetteville Healthcare Facility Fayetteville, AR — (a) 485 24,855 — 485 24,855 25,340 132 1994 2009 10/04/2019 Fort Myers Healthcare Facility Fort Myers, FL — (a) 2,153 2,387 — 2,153 2,387 4,540 16 1999 — 10/04/2019 Fort Myers Healthcare Facility II Fort Myers, FL — (a) 3,557 11,064 — 3,557 11,064 14,621 69 2010 — 10/04/2019 Fort Walton Beach Healthcare Facility Fort Walton Beach, FL — (a) 385 3,182 — 385 3,182 3,567 18 2005 — 10/04/2019 Frankfort Healthcare Facility Frankfort, KY — (a) 342 950 — 342 950 1,292 6 1993 — 10/04/2019 Frisco Healthcare Facility Frisco, TX — (a) — 22,114 4,200 — 26,314 26,314 125 2010 — 10/04/2019 Goshen Healthcare Facility Goshen, IN — (a) 383 5,355 — 383 5,355 5,738 31 2010 — 10/04/2019 Grapevine Healthcare Facility Grapevine, TX — 1,726 26,849 — 1,726 26,849 28,575 144 2007 — 10/04/2019 Initial Cost Cost Gross Amount Property Description Location Encumbrances Land Buildings and Land Buildings and Total Accumulated Year Year Date Hammond Healthcare Facility Hammond, LA — (a) 2,693 23,750 — 2,693 23,750 26,443 131 2006 — 10/04/2019 Hammond Healthcare Facility II Hammond, LA — (a) 950 12,147 — 950 12,147 13,097 66 2004 — 10/04/2019 Harlingen Healthcare Facility Harlingen, TX — — 10,628 — — 10,628 10,628 61 2007 — 10/04/2019 Henderson Healthcare Facility Henderson, NV — (a) 839 2,390 — 839 2,390 3,229 14 2000 — 10/04/2019 Houston Healthcare Facility III Houston, TX — (a) 752 5,832 — 752 5,832 6,584 31 1998 2018 10/04/2019 Howard Healthcare Facility Howard, WI — (a) 529 1,818 — 529 1,818 2,347 13 2011 — 10/04/2019 Jacksonville Healthcare Facility Jacksonville, FL — (a) 1,233 6,173 — 1,233 6,173 7,406 35 2009 — 10/04/2019 Lafayette Healthcare Facility Lafayette, LA — (a) 4,819 35,424 — 4,819 35,424 40,243 191 2004 — 10/04/2019 Lakewood Ranch Healthcare Facility Lakewood Ranch, FL — (a) 636 1,784 — 636 1,784 2,420 13 2008 — 10/04/2019 Las Vegas Healthcare Facility II Las Vegas, NV — (a) 651 5,323 — 651 5,323 5,974 18 2007 — 10/04/2019 Lehigh Acres Healthcare Facility Lehigh Acres, FL — (a) 441 2,956 — 441 2,956 3,397 17 2002 — 10/04/2019 Lubbock Healthcare Facility Lubbock, TX — (a) 5,210 39,939 — 5,210 39,939 45,149 212 2003 — 10/04/2019 Manitowoc Healthcare Facility Manitowoc, WI — (a) 257 1,733 — 257 1,733 1,990 12 2003 — 10/04/2019 Manitowoc Healthcare Facility II Manitowoc, WI — (a) 250 11,231 — 250 11,231 11,481 66 1964 2010 10/04/2019 Marinette Healthcare Facility Marinette, WI — (a) 208 1,002 — 208 1,002 1,210 7 2008 — 10/04/2019 New Bedford Healthcare Facility New Bedford, MA — (a) 2,464 26,297 — 2,464 26,297 28,761 143 1942 1995 10/04/2019 New Braunfels Healthcare Facility New Braunfels, TX — (a) 2,568 11,386 — 2,568 11,386 13,954 61 2007 — 10/04/2019 North Smithfield Healthcare Facility North Smithfield, RI — (a) 1,309 14,024 — 1,309 14,024 15,333 80 1965 2000 10/04/2019 Oklahoma City Healthcare Facility IX Oklahoma City, OK — (a) 1,316 9,822 — 1,316 9,822 11,138 60 2007 — 10/04/2019 Oshkosh Healthcare Facility Oshkosh, WI — (a) 414 2,043 — 414 2,043 2,457 14 2010 — 10/04/2019 Palm Desert Healthcare Facility Palm Desert, CA — (a) 582 5,927 — 582 5,927 6,509 36 2005 — 10/04/2019 Rancho Mirage Healthcare Facility II Rancho Mirage, CA — (a) 2,286 5,481 — 2,286 5,481 7,767 32 2008 — 10/04/2019 San Antonio Healthcare Facility II San Antonio, TX — 5,935 23,411 221 5,935 23,632 29,567 128 2013 — 10/04/2019 San Antonio Healthcare Facility III San Antonio, TX — (a) 1,824 22,809 — 1,824 22,809 24,633 120 2012 — 10/04/2019 San Antonio Healthcare Facility IV San Antonio, TX — (a) — 31,694 — — 31,694 31,694 167 1987 — 10/04/2019 San Antonio Healthcare Facility V San Antonio, TX — (a) 3,273 19,697 — 3,273 19,697 22,970 110 2017 — 10/04/2019 Santa Rosa Beach Healthcare Facility Santa Rosa Beach, FL — (a) 741 3,049 — 741 3,049 3,790 16 2003 — 10/04/2019 Savannah Healthcare Facility Savannah, GA — (a) 2,300 20,186 — 2,300 20,186 22,486 107 2014 — 10/04/2019 St. Louis Healthcare Facility Creve Coeur, MO — (a) 1,164 8,052 — 1,164 8,052 9,216 45 2005 2007 10/04/2019 Sturgeon Bay Healthcare Facility Sturgeon Bay, WI — (a) 248 700 — 248 700 948 5 2007 — 10/04/2019 Victoria Healthcare Facility Victoria, TX — (a) 328 12,908 — 328 12,908 13,236 70 2013 — 10/04/2019 Victoria Healthcare Facility II Victoria, TX — (a) 446 12,986 — 446 12,986 13,432 70 1998 — 10/04/2019 Webster Healthcare Facility II Webster, TX — (a) 7,371 243,983 2,505 7,371 246,488 253,859 1,274 2014 2019 10/04/2019 Wilkes-Barre Healthcare Facility Mountain Top, PA — (a) 821 4,139 — 821 4,139 4,960 26 2012 — 10/04/2019 Yucca Valley Healthcare Facility Yucca Valley, CA — (a) 901 4,788 — 901 4,788 5,689 31 2009 — 10/04/2019 Tucson Healthcare Facility II Tucson, AZ — — — 1,764 — 1,764 1,764 — (e) (e) 12/26/2019 Tucson Healthcare Facility III Tucson, AZ — 1,763 — 1,152 1,763 1,152 2,915 — (e) (e) 12/27/2019 $ 457,345 $ 345,152 $ 2,505,097 $ 46,517 $ 343,444 $ 2,553,322 $ 2,896,766 $ 128,304 (a) Property collateralized under the unsecured credit facility. As of December 31, 2019, 128 commercial properties were collateralized under the credit facility and the Company had $908,000,000 aggregate principal amount outstanding thereunder. (b) The reduction to costs capitalized subsequent to acquisition primarily include impairment charges, property dispositions and other adjustments. (c) The aggregated cost for federal income tax purposes is approximately $3,138,568,000 (unaudited). (d) The Company’s assets are depreciated or amortized using the straight-line method over the useful lives of the assets by class. Generally, buildings and improvements are depreciated over 15 - 40 years and tenant improvements are depreciated over the shorter of lease term or expected useful life. (e) As of December 31, 2019, the property was under construction; therefore, depreciation is not applicable. NOTES TO SCHEDULE III — REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION December 31, 2019 (in thousands) Year Ended December 31, 2019 2018 2017 Real Estate: Balance at beginning of year $ 1,758,326 $ 1,551,194 $ 915,521 Additions: Acquisitions 1,151,827 195,328 601,546 Improvements 15,084 11,804 34,127 Deductions: Impairment (25,501 ) — — Dispositions (2,807 ) — — Other adjustments (163 ) — — Balance at end of year $ 2,896,766 $ 1,758,326 $ 1,551,194 Accumulated Depreciation: Balance at beginning of year $ (84,594 ) $ (45,789 ) $ (18,521 ) Additions: Depreciation (48,215 ) (38,805 ) (27,268 ) Deductions: Impairment 4,501 — — Dispositions 4 — — Balance at end of year $ (128,304 ) $ (84,594 ) $ (45,789 )

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation The accompanying consolidated financial statements include the accounts of the Company, the Operating Partnership, and all wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the consolidated financial statements and accompanying notes in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates are made and evaluated on an ongoing basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates.
Restricted Cash	Restricted Cash Restricted cash consists of restricted cash held in escrow and restricted bank deposits. Restricted cash held in escrow includes cash held by lenders in escrow accounts for tenant and capital improvements, repairs and maintenance and other lender reserves for certain properties, in accordance with the respective lender’s loan agreement. Restricted bank deposits consist of tenant receipts for certain properties which are required to be deposited into lender-controlled accounts in accordance with the respective lender's loan agreement. Restricted cash held in escrow and restricted bank deposits are reported in other assets, net in the accompanying consolidated balance sheets . See Note 7—"Other Assets, Net."
Deferred Financing Costs	Deferred Financing Costs Deferred financing costs are loan fees, legal fees and other third-party costs associated with obtaining financing. These costs are amortized over the terms of the respective financing agreements using the effective interest method. Unamortized deferred financing costs are generally expensed when the associated debt is refinanced or repaid before maturity unless specific rules are met that would allow for the carryover of such costs to the refinanced debt. Costs incurred in seeking financing transactions that do not close are expensed in the period in which it is determined that the financing will not close. Deferred financing costs are recorded as a reduction of the related debt on the accompanying consolidated balance sheets . Deferred financing costs related to a revolving line of credit are recorded in other assets, net , on the accompanying consolidated balance sheets .
Leasing Commission Fees	Leasing Commission Fees Leasing commission fees are fees incurred for the initial lease-up, leasing-up of newly constructed properties or re-leasing to existing tenants. Leasing commission fees are capitalized in other assets, net , in the accompanying consolidated balance sheets and amortized over the terms of the related leases.
Investment in Real Estate	Investment in Real Estate Real estate costs related to the acquisition, development, construction and improvement of properties are capitalized. Repair and maintenance costs are expensed as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset in determining the appropriate useful life. Real estate assets, other than land, are depreciated or amortized on a straight-line basis over each asset’s useful life. The Company anticipates the estimated useful lives of its assets by class as follows: Buildings and improvements 15 – 40 years Tenant improvements Shorter of lease term or expected useful life Furniture, fixtures, and equipment 3 – 10 years
Allocation of Purchase Price of Real Estate	Allocation of Purchase Price of Real Estate Upon the acquisition of real properties, the Company evaluates whether the acquisition is a business combination or an asset acquisition. For both business combinations and asset acquisitions we allocate the purchase price of properties to acquired tangible assets, consisting of land, buildings and improvements, and acquired intangible assets and liabilities, consisting of the value of above-market and below-market leases and the value of in-place leases. For asset acquisitions, the Company capitalizes transaction costs and allocates the purchase price using a relative fair value method allocating all accumulated costs. For business combinations, the Company expenses transaction costs incurred and allocates the purchase price based on the estimated fair value of each separately identifiable asset and liability. Acquisition fees and costs associated with transactions determined to be asset acquisitions are capitalized in total real estate, net in the accompanying consolidated balance sheets. For the years ended December 31, 2019, 2018 and 2017, all of the Company's acquisitions were determined to be asset acquisitions. The fair values of the tangible assets of an acquired property (which includes land, buildings and improvements) are determined by valuing the property as if it were vacant, and the “as-if-vacant” value is then allocated to land and buildings and improvements based on management’s determination of the relative fair value of these assets. Management determines the as-if-vacant fair value of a property using methods similar to those used by independent appraisers. Factors considered by management in performing these analyses include an estimate of carrying costs during the expected lease-up periods considering current market conditions and costs to execute similar leases, including leasing commissions and other related costs. In estimating carrying costs, management includes real estate taxes, insurance, and other operating expenses during the expected lease-up periods based on current market conditions. The fair values of above-market and below-market in-place leases are recorded based on the present value (using an interest rate which reflects the risks associated with the leases acquired) of the difference between (i) the contractual amounts to be paid pursuant to the in-place leases and (ii) an estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease including any fixed rate bargain renewal periods, with respect to a below-market lease. The above-market and below-market lease values are capitalized as intangible lease assets or liabilities. Above-market lease values are amortized as an adjustment of rental revenue over the remaining terms of the respective leases. Below-market leases are amortized as an adjustment of rental revenue over the remaining terms of the respective leases, including any fixed rate bargain renewal periods. If a lease were to be terminated prior to its stated expiration, all unamortized amounts of above-market and below-market in-place lease values related to that lease would be recorded as an adjustment to rental revenue. The fair values of in-place leases include an estimate of direct costs associated with obtaining a new tenant and opportunity costs associated with lost rentals that are avoided by acquiring an in-place lease. Direct costs associated with obtaining a new tenant include commissions, tenant improvements, and other direct costs and are estimated based on management’s consideration of current market costs to execute a similar lease. The value of opportunity costs is calculated using the contractual amounts to be paid pursuant to the in-place leases over a market absorption period for a similar lease. These lease intangibles are amortized to depreciation and amortization expense over the remaining terms of the respective leases. If a lease were to be terminated prior to its stated expiration, all unamortized amounts of in-place lease assets relating to that lease would be expensed.
Impairment of Long Lived Assets	Impairment of Long-Lived Assets The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate and related intangible assets may not be recoverable. When indicators of potential impairment suggest that the carrying value of real estate and related intangible assets may not be recoverable, the Company assesses the recoverability of the assets by estimating whether the Company will recover the carrying value of the assets through its undiscounted future cash flows and their eventual disposition. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of the assets, the Company will record an impairment loss to the extent that the carrying value exceeds the estimated fair value of the assets. When developing estimates of expected future cash flows, the Company makes certain assumptions regarding future market rental income amounts subsequent to the expiration of current lease arrangements, property operating expenses, terminal capitalization and discount rates, the expected number of months it takes to re-lease the property, required tenant improvements and the number of years the property will be held for investment. The use of alternative assumptions in the future cash flow analysis could result in a different determination of the property’s future cash flows and a different conclusion regarding the existence of an impairment, the extent of such loss, if any, as well as the carrying value of the real estate and related assets. In addition, the Company estimates the fair value of the assets by applying a market approach using comparable sales for certain properties. The use of alternative assumptions in the market approach analysis could result in a different determination of the property’s estimated fair value and a different conclusion regarding the existence of an impairment, the extent of such loss, if any, as well as the carrying value of the real estate and related assets. Impairment of Real Estate During the third quarter ended September 30, 2019, real estate assets related to one healthcare property were determined to be impaired due to a tenant of the property, which was experiencing financial difficulty, vacating its space, and a second tenant indicating its desire to terminate its lease early, which the Company determined would be consistent with its strategic plans for the property. On November 8, 2019, the Company terminated the lease with the second tenant. The aggregate carrying amount of the assets of $40,266,000 exceeded their fair value. The carrying value of the property was reduced to its estimated fair value of $27,266,000 , resulting in an impairment charge of $13,000,000 . In addition, during the fourth quarter ended December 31, 2019, real estate assets related to another healthcare property with an aggregate carrying amount of $30,412,000 were reduced to their estimated fair value of $22,412,000 , resulting in an impairment charge of $8,000,000 based on a letter of intent from a prospective buyer to purchase the property. Impairment charges are recorded as impairment loss on real estate in the consolidated statements of comprehensive (loss) income . During the years ended December 31, 2018 and 2017, no impairment losses were recorded on real estate. See Note 13—"Fair Value" for further discussion. Impairment of Acquired Intangible Assets and Acquired Intangible Liabilities During the year ended December 31, 2019 , the Company wrote off a below-market lease intangible liability in the amount of approximately $212,000 , by accelerating the amortization of the acquired intangible liability related to one tenant in the healthcare property discussed above. During the year ended December 31, 2019 , the Company recognized impairments of in-place lease intangible assets in the amount of approximately $3,195,000 , by accelerating the amortization of the acquired intangible assets related to two tenants in the healthcare property discussed above. During the years ended December 31, 2018 and 2017, no impairment losses were recorded on acquired intangible assets or intangible liabilities.
Fair Value	Fair Value Accounting Standards Codification, or ASC, 820, Fair Value Measurements and Disclosures , or ASC 820, defines fair value, establishes a framework for measuring fair value in accordance with GAAP and expands disclosures about fair value measurements. ASC 820 emphasizes that fair value is intended to be a market-based measurement, as opposed to a transaction-specific measurement. Fair value is defined by ASC 820 as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Depending on the nature of the asset or liability, various techniques and assumptions can be used to estimate the fair value. Assets and liabilities are measured using inputs from three levels of the fair value hierarchy, as follows: Level 1—Inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. An active market is defined as a market in which transactions for the assets or liabilities occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2—Inputs other than quoted prices for similar assets and liabilities in active markets that are observable for the asset or liability (i.e., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data correlation or other means (market corroborated inputs). Level 3—Unobservable inputs, only used to the extent that observable inputs are not available, reflect the Company’s assumptions about the pricing of an asset or liability. The following describes the methods the Company used to estimate the fair value of the Company’s financial assets and liabilities: Cash and cash equivalents, restricted cash, tenant receivables, prepaid and other assets, accounts payable and accrued liabilities —The Company considered the carrying values of these financial instruments, assets and liabilities, to approximate fair value because of the short period of time between origination of the instruments and their expected realization. Notes payable—Fixed Rate —The fair value is estimated by discounting the expected cash flows on notes payable at current rates at which management believes similar loans would be made considering the terms and conditions of the loan and prevailing market interest rates. Credit facility—Fixed Rate —The fair value is estimated by discounting the expected cash flows on the fixed rate credit facility at current rates at which management believes similar borrowings would be made considering the terms and conditions of the borrowings and prevailing market interest rates. Credit facility—Variable Rate —The fair value of the Company's variable rate credit facility is estimated based on the interest rates currently offered to the Company by financial institutions. The carrying value of the variable rate credit facility approximates fair value as the interest is calculated at the London Interbank Offered Rate, plus an applicable margin. The interest rate resets to market on a monthly basis. Derivative instruments —The Company’s derivative instruments consist of interest rate swaps. These swaps are carried at fair value to comply with the provisions of ASC 820. The fair value of these instruments is determined using interest rate market pricing models. The Company incorporated credit valuation adjustments to appropriately reflect the Company’s nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. Considerable judgment is necessary to develop estimated fair values of financial assets and liabilities. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize, or be liable for on disposition of the financial assets and liabilities. See additional discussion in Note 13—"Fair Value."
Revenue Recognition, Tenant Receivables and Allowance for Uncollectible Accounts	Revenue Recognition, Tenant Receivables and Allowance for Uncollectible Accounts Effective January 1, 2018, the Company recognizes non-rental related revenue in accordance with ASC 606, Revenue from Contracts with Customers , or ASC 606. The Company has identified its primary revenue streams as rental income from leasing arrangements and tenant reimbursements, which are outside the scope of ASC 606. The core principle of ASC 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Non-rental revenue, subject to ASC 606, is immaterial to the Company's consolidated financial statements. Effective January 1, 2019, the majority of the Company's revenue is derived from rental revenue which is accounted for in accordance with ASC 842, Leases, or ASC 842. In accordance with ASC 842, minimum rental revenue is recognized on a straight-line basis over the term of the related lease (including rent holidays). For lease arrangements when it is not probable that the Company will collect all or substantially all of the remaining lease payments under the term of the lease, rental revenue is limited to the lesser of the rental revenue that would be recognized on a straight-line basis or the lease payments that have been collected from the lessee. Differences between rental revenue recognized and amounts contractually due under the lease agreements are credited or charged to straight-line rent receivable or straight-line rent liability, as applicable. Tenant reimbursements, which are comprised of additional amounts recoverable from tenants for common area maintenance expenses and certain other recoverable expenses, are recognized when the services are provided and the performance obligations are satisfied. Prior to the adoption of ASC 842, tenant receivables and straight-line rent receivables were carried net of the provision for credit losses. The provision for credit losses was established for estimated losses resulting from the inability of certain tenants to meet the contractual obligations under their lease agreements. The Company’s determination of the adequacy of these provisions was based primarily upon evaluations of historical loss experience, the tenant’s financial condition, security deposits, letters of credit, lease guarantees, current economic conditions and other relevant factors. Effective January 1, 2019, upon adoption of ASC 842, the Company is no longer recording a provision for credit losses but is, instead, assessing whether or not it is probable that the Company will collect all or substantially all of the remaining lease payments under the term of the lease. When it is not probable that the Company will collect all or substantially all of the remaining lease payments under the term of the lease, rental revenue is limited to the lesser of the rental revenue that would be recognized on a straight-line basis or the lease payments that have been collected from the lessee. During the year ended December 31, 2019 , the Company recorded $672,000 in bad debt expenses as a reduction of rental revenue in the accompanying consolidated statements of comprehensive (loss) income .
Notes Receivable	Notes Receivable Notes receivable are reported at their outstanding principal balance, net of any unearned income, unamortized deferred fees and costs and allowances for loan losses. The Company evaluates the collectability of both interest and principal on each note receivable to determine whether it is collectible, primarily through the evaluation of credit quality indicators, such as the tenant's financial condition, collateral, evaluations of historical loss experience, current economic conditions and other relevant factors, including contractual terms of repayments. Evaluating a note receivable for potential impairment requires management to exercise judgment. The use of alternative assumptions in evaluating a note receivable could result in a different determination of the note's estimated fair value and a different conclusion regarding the existence of an impairment, the extent of such loss, if any, as well as the carrying value of the note receivable. As part of the REIT Merger, the Company acquired one note receivable in the amount of $2,700,000 . The principal balance of the Company's note receivable is secured by its collateral.
Earnings Per Share	Earnings Per Share The Company calculates basic earnings per share by dividing net income attributable to common stockholders for the period by the weighted average shares of its common stock outstanding for that period. Diluted earnings per share are computed based on the weighted average number of shares outstanding and all potentially dilutive securities. Shares of non-vested restricted common stock give rise to potentially dilutive shares of common stock. During the years ended December 31, 2019 , 2018 and 2017, diluted earnings per share reflected the effect of approximately 24,000 , 24,000 and 18,000 of non-vested shares of restricted common stock that were outstanding as of such period, respectively.
Reportable Segments	Reportable Segments ASC 280, Segment Reporting , establishes standards for reporting financial and descriptive information about an enterprise’s reportable segments. As of December 31, 2019 and 2018, the Company operated through two reportable business segments­— real estate investments in data centers and healthcare. With the continued expansion of the Company’s portfolio, segregation of the Company’s operations into two reporting segments is useful in assessing the performance of the Company’s business in the same way that management reviews performance and makes operating decisions. See Note 12—"Segment Reporting" for further discussion on the reportable segments of the Company.
Derivative Instruments and Hedging Activities	Derivative Instruments and Hedging Activities As required by ASC 815, Derivatives and Hedging , or ASC 815, the Company records all derivative instruments at fair value as assets and liabilities on its consolidated balance sheets . The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge of a net investment in a foreign operation. For derivative instruments not designated as hedging instruments, the income or loss is recognized in the consolidated statements of comprehensive (loss) income during such period. In accordance with the fair value measurement guidance Accounting Standards Update, or ASU, 2011-04, Fair Value Measurement , the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio. The Company is exposed to variability in expected future cash flows that are attributable to interest rate changes in the normal course of business. The Company’s primary strategy in entering into derivative contracts is to add stability to future cash flows by managing its exposure to interest rate movements. The Company utilizes derivative instruments, including interest rate swaps, to effectively convert some of its variable rate debt to fixed rate debt. The Company does not enter into derivative instruments for speculative purposes. In accordance with ASC 815, the Company designates interest rate swap contracts as cash flow hedges of floating-rate borrowings. For derivative instruments that are designated and qualify as cash flow hedges, the gains or losses on the derivative instruments are reported as a component of other comprehensive (loss) income in the consolidated statements of comprehensive (loss) income and are reclassified into earnings in the same line item associated with the forecasted transaction in the same period during which the hedged transactions affect earnings. See additional discussion in Note 14—"Derivative Instruments and Hedging Activities."
Concentration of Credit Risk and Significant Leases	Concentration of Credit Risk and Significant Leases As of December 31, 2019 , the Company had cash on deposit, including restricted cash, in certain financial institutions that had deposits in excess of current federally insured levels. The Company limits its cash investments to financial institutions with high credit standings; therefore, the Company believes it is not exposed to any significant credit risk on its cash deposits. To date, the Company has not experienced a loss or lack of access to cash in its accounts. As of December 31, 2019 , the Company owned real estate investments in two micropolitan statistical areas and 67 metropolitan statistical areas, or MSA, one MSA of which accounted for 10.0% or more of rental revenue. Real estate investments located in the Atlanta-Sandy Springs-Roswell, Georgia MSA accounted for 15.0% of rental revenue for the year ended December 31, 2019 . As of December 31, 2019 , the Company had no exposure to tenant concentration that accounted for 10.0% or more of rental revenue for the year ended December 31, 2019 .
Share Repurchase Program	Share Repurchase Program The Company’s share repurchase program allows for repurchases of shares of the Company’s common stock when certain criteria are met. The share repurchase program provides that all repurchases during any calendar year, including those redeemable upon death or a Qualifying Disability of a stockholder, are limited to those that can be funded with equivalent proceeds raised from the DRIP during the prior calendar year and other operating funds, if any, as the board of directors, in its sole discretion, may reserve for this purpose. Repurchases of shares of the Company’s common stock are at the sole discretion of the Company’s board of directors, provided, however, that the Company will limit the number of shares repurchased during any calendar year to 5.0% of the number of shares of common stock outstanding as of December 31 st of the previous calendar year. In addition, the Company’s board of directors, in its sole discretion, may suspend (in whole or in part) the share repurchase program at any time, and may amend, reduce, terminate or otherwise change the share repurchase program upon 30 days' prior notice to the Company’s stockholders for any reason it deems appropriate. In connection with entering into the Merger Agreement, on April 10, 2019, the Company's board of directors approved the Sixth Amended and Restated Share Repurchase Program, or the Sixth Amended & Restated SRP, which became effective on May 11, 2019, and was applied beginning with repurchases made on the 2019 third quarter repurchase date. Under the Sixth Amended & Restated SRP, the Company only repurchased shares of common stock (Class A shares, Class I shares, Class T Shares and Class T2 shares) in connection with the death, qualifying disability, or involuntary exigent circumstance (as determined by the Company's board of directors in its sole discretion) of a stockholder, subject to certain terms and conditions specified in the Sixth Amended & Restated SRP. In connection with the REIT Merger, on October 2, 2019, the Company's board of directors approved an amended share repurchase program, or the Amended SRP. The Amended SRP applied to all eligible stockholders, beginning with repurchases made on the first quarter repurchase date of 2020, which was January 30, 2020 . For purposes of determining whether any former REIT I stockholder qualifies for participation under the Amended SRP, former REIT I stockholders received full credit for the time they held REIT I common stock prior to the closing of the REIT Merger. Subject to the terms and limitations of the Amended SRP, including, but not limited to, quarterly share limitations, an annual 5.0% share limitation, and DRIP funding limitations, the Amended SRP may be available to any stockholder as a potential means of interim liquidity. The Company will honor valid repurchase requests approximately 30 days following the end of the applicable quarter. See PART II, "Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities " for further discussion. During the year ended December 31, 2019 , the Company repurchased 2,557,298 Class A shares, Class I shares, Class T shares and Class T2 shares of common stock ( 1,910,894 Class A shares, 189,947 Class I shares, 451,058 Class T shares and 5,399 Class T2 shares), or 1.87% of shares outstanding as of December 31, 2018, for an aggregate purchase price of approximately $23,655,000 (an average of $9.25 per share). During the year ended December 31, 2018 , the Company repurchased 4,700,554 Class A shares, Class I shares and Class T shares of common stock ( 4,117,566 Class A shares, 71,180 Class I shares and 511,808 Class T shares), or 3.80% of shares outstanding as of December 31, 2017, for an aggregate purchase price of approximately $43,230,000 (an average of $9.20 per share).
Distribution Policy and Distributions Payable	Distribution Policy and Distributions Payable In order to maintain its status as a REIT, the Company is required to make distributions each taxable year equal to at least 90% of its REIT taxable income, computed without regard to the dividends paid deduction and excluding capital gains. To the extent funds are available, the Company intends to continue to pay regular distributions to stockholders. Distributions are paid to stockholders of record as of the applicable record dates. Distributions are payable to stockholders from legally available funds therefor. The Company declared distributions per share of common stock in the amounts of $0.58 , $0.63 and $0.62 for the years ended December 31, 2019 , 2018 and 2017, respectively. As of December 31, 2019 , the Company had distributions payable of approximately $9,093,000 . Of these distributions payable, approximately $6,446,000 was paid in cash and approximately $2,647,000 was reinvested in shares of common stock pursuant to the DRIP on January 2, 2020. Distributions to stockholders are determined by the board of directors of the Company and are dependent upon a number of factors, including funds available for the payment of distributions, financial condition, the timing of property acquisitions, capital expenditure requirements, and annual distribution requirements in order to maintain the Company’s status as a REIT under the Code. See Note 21—"Subsequent Events" for further discussion.
Income Taxes	Income Taxes The Company currently qualifies and is taxed as a REIT under Sections 856 through 860 of the Code. Accordingly, it will generally not be subject to corporate U.S. federal or state income tax to the extent that it makes qualifying distributions to stockholders, and provided it satisfies, on a continuing basis, through actual investment and operating results, the REIT requirements, including certain asset, income, distribution and stock ownership tests. If the Company fails to qualify as a REIT, and does not qualify for certain statutory relief provisions, it would be subject to U.S. federal, state and local income taxes and may be precluded from qualifying as a REIT for the subsequent four taxable years following the year in which it lost its REIT qualification, unless the Internal Revenue Service grants the Company relief under certain statutory provisions. Accordingly, failure to qualify as a REIT could have a material adverse impact on the results of operations and amounts available for distribution to stockholders. The dividends paid deduction of a REIT for qualifying dividends paid to its stockholders is computed using the Company’s taxable income as opposed to net income reported in the consolidated financial statements. Taxable income, generally, will differ from net income reported in the consolidated financial statements because the determination of taxable income is based on tax provisions and not financial accounting principles. The Company has concluded that there was no impact related to uncertain tax positions from results of operations of the Company for the years ended December 31, 2019, 2018 and 2017. The United States of America is the jurisdiction for the Company, and the earliest tax year subject to examination is 2016.
Recent Accounting Pronouncements	Recently Adopted Accounting Pronouncements Leases In February 2016, the Financial Accounting Standards Board, or FASB established ASC 842, by issuing ASU 2016-02, Leases , which replaces the guidance previously outlined in ASC 840, Leases . The new standard increases transparency by requiring the recognition by lessees of right-of-use, or ROU, assets and lease liabilities on the balance sheet for all leases with a term of greater than 12 months, regardless of lease classification. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. Effective January 1, 2019, the Company adopted ASC 842, using the modified retrospective approach. Consequently, financial information is not updated, and the disclosures required under the new standard are not provided for dates and periods before January 1, 2019. Further, the Company reduces the ROU assets and operating lease liabilities over the remaining lease term and presents the reduction of ROU assets - operating leases and accretion of operating lease liabilities as a single line item within operating activities in the consolidated statement of cash flow for the year ended December 31, 2019 . The Company elected the package of practical expedients, which permits it to not reassess (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) any initial direct costs for any existing leases as of the effective date. The Company did not elect the hindsight practical expedient, which permits entities to use hindsight in determining the lease term and assessing impairment. Lessor As a lessor, the Company's recognition of rental revenue remained unchanged, except for the accounting for initial direct costs related to lease negotiations. Effective January 1, 2019, indirect leasing costs, such as legal costs related to lease negotiations no longer meet the definition of capitalized initial direct costs under ASC 842 and are recorded in general and administrative expenses in the consolidated statements of comprehensive (loss) income , and are no longer capitalized. In July 2018, the FASB issued ASU 2018-11, Targeted Improvements , to simplify the guidance, that allows lessors to combine non-lease components with the related lease components if both the timing and pattern of transfer are the same for the non-lease component and related lease component, and the lease component would be classified as an operating lease. The single combined component is accounted for under ASC 842 if the lease component is the predominant component and is accounted for under ASC 606, if the non-lease components are the predominant components. Lessors are permitted to apply the practical expedient to all existing leases on a retrospective or prospective basis. The Company elected the practical expedient to combine its lease and non-lease components that meet the defined criteria and is accounting for the combined lease components under ASC 842. As a result, the Company is no longer presenting rental revenue and tenant reimbursements related to common area maintenance and other expense recoveries separately in the consolidated statements of comprehensive (loss) income . In December 2018, the FASB issued ASU 2018-20, Narrow-Scope Improvements for Lessors , that allows lessors to make an accounting policy election not to evaluate whether real estate taxes and other similar taxes imposed by a governmental authority on a specific lease revenue-producing transaction are the primary obligation of the lessor as owner of the underlying leased asset. A lessor that makes this election excludes these taxes from the measurement of lease revenue and the associated expense. ASU 2018-20 also requires lessors to (1) exclude lessor costs paid directly by lessees to third parties on the lessor’s behalf from variable payments and, therefore, variable lease revenue and (2) include lessor costs that are paid by the lessor and reimbursed by the lessee in the measurement of variable lease revenue and the associated expense. The Company adopted ASU 2018-20 effective January 1, 2019. The adoption of this standard resulted in a decrease of approximately $1,593,000 during the year ended December 31, 2019 , in rental revenue and rental expense, as the aforementioned real estate tax payments are paid by a lessee directly to a third party, and, therefore, are no longer presented on a gross basis in the Company's consolidated statements of comprehensive (loss) income . The adoption of this standard had no impact on the Company's net income attributable to common stockholders . Lessee The Company is a lessee on 17 ground leases, of which four do not have corresponding operating lease liabilities because the Company did not have future payment obligations at the acquisition of these leases. The Company recognized a ROU asset and operating lease liability for the other 13 ground leases on the Company's consolidated balance sheet due to the adoption of ASC 842. See Note 6—"Leases" for further discussion. Derivatives and Hedging In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities , or ASU 2017-12. The objectives of ASU 2017-12 are to (i) improve the transparency and understandability of information conveyed to financial statement users about an entity’s risk management activities by better aligning the entity’s financial reporting for hedging relationships with those risk management activities and (ii) reduce the complexity of and simplify the application of hedge accounting by preparers. On January 1, 2019, the Company adopted ASU 2017-12. As a result of the adoption of ASU 2017-12, the cumulative ineffectiveness gain of $103,000 previously recognized on existing cash flow hedges was reclassified to accumulated other comprehensive income (loss) from accumulated distributions in excess of earnings . In October 2018, the FASB issued ASU 2018-16, Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes , or ASU 2018-16. ASU 2018-16 permits the use of the OIS rate based on SOFR as a United States benchmark interest rate for hedge accounting purposes under Topic 815. ASU 2018-16 was effective upon adoption of ASU 2017-12. The Company adopted ASU 2018-16 on January 1, 2019, and its provisions did not have an impact on its consolidated financial statements; however, the provisions may impact existing agreements, new contracts and transactions not yet contemplated, in the future. The Company is not able to predict when the current London Interbank Offered Rate, or LIBOR, will cease to be available or when there will be sufficient liquidity in the SOFR markets. Disclosure Update and Simplification In July 2019, the FASB issued ASU 2019-07, Codification Updates to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Final Rule Releases No. 33-10532, Disclosure Update and Simplification, and Nos. 33-10231 and 33-10442, Investment Company Reporting Modernization, and Miscellaneous Updates, or ASU 2019-07. ASU 2019-07 clarifies or improves the disclosure and presentation requirements of a variety of codification topics by aligning them with the SEC's regulations, thereby eliminating redundancies and making the codification easier to apply. ASU 2019-07 was effective upon issuance and did not have an impact on the Company's consolidated financial statements. Recently Issued Accounting Pronouncements Not Yet Adopted Fair Value Measurement In August 2018, the FASB issued ASU 2018-13 , Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement , or ASU 2018-13. ASU 2018-13 removes certain disclosure requirements, including the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between the levels and the valuation processes for Level 3 fair value measurements. ASU 2018-13 also adds certain disclosure requirements, including the requirement to disclose the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, and interim periods therein. Early adoption is permitted. The Company does not anticipate ASU 2018-13 to have a material impact to the Company's consolidated financial statements.
Reclassifications	Reclassifications Certain prior period amounts have been reclassified to conform to the current financial statement presentation, primarily related to the recently adopted accounting pronouncements discussed within this note. Amounts previously disclosed as rental and parking revenue and tenant reimbursements during the years ended December 31, 2018, and 2017, are now included in rental revenue and will no longer be presented separately on the consolidated statements of comprehensive (loss) income .

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Reconciliation of Cash, Cash Equivalents and Restricted Cash	The following table presents a reconciliation of the beginning of year and end of year cash, cash equivalents and restricted cash reported within the consolidated balance sheets to the totals shown in the consolidated statements of cash flows (amounts in thousands): Year Ended Beginning of year: 2019 2018 2017 Cash and cash equivalents 68,360 74,803 50,446 Restricted cash 11,167 10,944 6,463 Cash, cash equivalents and restricted cash $ 79,527 $ 85,747 $ 56,909 End of year: Cash and cash equivalents 69,342 68,360 74,803 Restricted cash 10,888 11,167 10,944 Cash, cash equivalents and restricted cash $ 80,230 $ 79,527 $ 85,747
Schedule of Estimated Useful Lives of Assets by Class	The Company anticipates the estimated useful lives of its assets by class as follows: Buildings and improvements 15 – 40 years Tenant improvements Shorter of lease term or expected useful life Furniture, fixtures, and equipment 3 – 10 years

Acquisitions and Dispositions (

Acquisitions and Dispositions (Tables)	12 Months Ended
	Dec. 31, 2019
Real Estate [Abstract]
Schedule of Consideration Transferred for Properties Acquired	The following table summarizes the consideration transferred for the 2019 Acquisitions during the year ended December 31, 2019 : Property Description Date Acquired Ownership Percentage Purchase Price Bryant Healthcare Facility II, f.k.a. Bryant Healthcare Facility 8/16/2019 100% $ 4,408 TAM Healthcare Facilities (1) 9/19/2019 100% 65,443 REIT Merger (2) 10/04/2019 100% 1,229,365 Tucson Healthcare Facility II (3) 12/26/2019 100% 651 Tucson Healthcare Facility III (4) 12/27/2019 100% 1,763 Total $ 1,301,630 (1) The TAM Healthcare Facilities consists of four properties. U pon acquisition of the TAM Healthcare Facilities, the Company entered into four ground lease agreements. See further discussion in Note 6—"Leases." (2) The REIT Merger consists of 60 healthcare properties. See further discussion below. (3) The Tucson Healthcare Facility II was acquired as a development healthcare property. The purchase price was recorded as a ground leasehold asset in the amount of $651,000 . U pon acquisition of the Tucson Healthcare Facility II, the Company entered into a ground lease agreement. See further discussion in Note 6—"Leases" . At the closing date, the Company funded $1,764,000 for the construction of the development property. (4) The Tucson Healthcare Facility III was acquired as a development healthcare property and the purchase price was recorded as land in the amount of $1,763,000 . At the closing date, the Company funded $1,152,000 for the construction of the development property.
Schedule of Allocation of Acquisitions	The following table summarizes the Company's purchase price allocation of the 2019 Acquisitions during the year ended December 31, 2019 (amounts in thousands): Total Land $ 98,723 Buildings and improvements 1,047,755 In-place leases 141,407 Tenant improvements 5,349 Ground leasehold assets (1) 3,731 Above-market leases 17,906 Total assets acquired $ 1,314,871 Ground lease liabilities (1) (6,048 ) Below-market leases (7,193 ) Total liabilities acquired (13,241 ) Net assets acquired $ 1,301,630 (1) Represents a component of the ROU assets- operating leases.
Schedule of Consideration Transferred for REIT Merger	The following summarizes the consideration transferred for the REIT I stockholders for the REIT Merger on October 4, 2019, exclusive of acquisition fees and costs and the payoff of REIT I debt (amounts in thousands): Total Consideration Value of Company's Class A common stock issued to REIT I stockholders (1) $ 774,010 Cash consideration paid 178,758 Total consideration transferred $ 952,768 (1) The Company issued 83,676,775 shares of its Class A common stock to REIT I stockholders.

Acquired Intangible Assets, N_2

Acquired Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2019
Finite-Lived Intangible Assets, Net [Abstract]
Schedule of Acquired Intangible Assets, Net	Acquired intangible assets, net, consisted of the following as of December 31, 2019 and 2018 (amounts in thousands, except weighted average life amounts): December 31, 2019 December 31, 2018 In-place leases, net of accumulated amortization of $62,252 and $41,143, respectively (with a weighted average remaining life of 10.4 years and 10.1 years, respectively) $ 266,856 $ 151,135 Above-market leases, net of accumulated amortization of $1,912 and $899, respectively (with a weighted average remaining life of 10.5 years and 5.1 years, respectively) 18,603 1,710 Ground leasehold assets, net of accumulated amortization of $0 and $39, respectively (with a weighted average remaining life of 0.0 years and 83.5 years, respectively) — (1) 1,359 $ 285,459 $ 154,204 (1) On January 1, 2019, as part of the adoption of ASC 842, as discussed in Note 2—"Summary of Significant Accounting Policies - Recently Adopted Accounting Pronouncements," the Company reclassified the ground leasehold assets balance from acquired intangible assets, net, to right-of-use assets - operating leases within the consolidated balance sheet.
Schedule of Estimated Future Amortization Expense of Acquired Intangible Assets	Estimated amortization expense on the acquired intangible assets as of December 31, 2019 , for each of the next five years ending December 31 and thereafter, are as follows (amounts in thousands): Year Amount 2020 $ 33,211 2021 32,409 2022 30,071 2023 28,094 2024 26,019 Thereafter 135,655 $ 285,459

Acquired Intangible Liabiliti_2

Acquired Intangible Liabilities, Net (Tables)	12 Months Ended
	Dec. 31, 2019
Intangible Lease Liabilities, Net [Abstract]
Schedule of Acquired Intangible Liabilities, Net	Acquired intangible liabilities, net, consisted of the following as of December 31, 2019 and 2018 (amounts in thousands, except weighted average life amounts): December 31, 2019 December 31, 2018 Below-market leases, net of accumulated amortization of $12,332 and $7,592, respectively (with a weighted average remaining life of 16.1 years and 17.6 years, respectively) $ 59,538 $ 57,606
Schedule of Estimated Future Amortization of Acquired Intangible Liabilities	Estimated amortization of the acquired intangible liabilities as of December 31, 2019 , for each of the next five years ending December 31 and thereafter, are as follows (amounts in thousands): Year Amount 2020 $ 5,486 2021 5,458 2022 4,394 2023 3,779 2024 3,677 Thereafter 36,744 $ 59,538

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2019
Leases [Abstract]
Schedule of Future Minimum Rent to Lessor from Operating Leases	Future minimum rent to be received from the Company's investments in real estate assets under the terms of non-cancelable operating leases in effect as of December 31, 2019 , including optional renewal periods, for each of the next five years ending December 31 and thereafter, are as follows (amounts in thousands): Year Amount 2020 $ 224,837 2021 231,052 2022 235,334 2023 234,949 2024 230,179 Thereafter 1,619,494 $ 2,775,845
Schedule of Future Minimum Rent from Lessee for Ground Leases	The future minimum rent payments, discounted by the Company's adjusted incremental borrowing rates, under non-cancelable ground leases, as of December 31, 2019 , for each of the next five years ending December 31 and thereafter, are as follows (amounts in thousands): Year Amount 2020 $ 1,633 2021 1,634 2022 1,634 2023 1,638 2024 1,687 Thereafter 136,719 Total undiscounted rental payments 144,945 Less imputed interest (113,941 ) Total operating lease liabilities $ 31,004
Schedule of Future Minimum Rent from Lessee for Ground Leases - ASC 840	The following represents approximate future minimum rent payments under non-cancelable ground leases by year as of December 31, 2018, and for each of the next five years ending December 31 and thereafter, are as follows (amounts in thousands): Year Amount 2019 $ 123 2020 123 2021 123 2022 123 2023 123 Thereafter 2,246 Total undiscounted rental payments $ 2,861

Other Assets, Net (Tables)

Other Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2019
Other Assets [Abstract]
Schedule of Other Assets, Net	Other assets, net, consisted of the following as of December 31, 2019 and 2018 (amounts in thousands): December 31, 2019 December 31, 2018 Deferred financing costs, related to the revolver portion of the credit facility, net of accumulated amortization of $5,696 and $4,686, respectively $ 2,623 $ 3,053 Leasing commissions, net of accumulated amortization of $240 and $82, respectively 10,288 5,006 Restricted cash 10,888 11,167 Tenant receivables 7,750 6,080 Note receivable 2,700 — Straight-line rent receivable 46,892 32,685 Prepaid and other assets 4,709 3,338 Derivative assets 884 6,204 $ 86,734 $ 67,533

Accounts Payable and Other Li_2

Accounts Payable and Other Liabilities (Tables)	12 Months Ended
	Dec. 31, 2019
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Other Liabilities	Accounts payable and other liabilities consisted of the following as of December 31, 2019 and December 31, 2018 (amounts in thousands): December 31, 2019 December 31, 2018 Accounts payable and accrued expenses $ 11,448 $ 9,188 Accrued interest expense 5,185 3,219 Accrued property taxes 3,537 2,309 Distributions payable to stockholders 9,093 7,317 Tenant deposits 1,500 875 Deferred rental income 9,003 6,647 Derivative liabilities 5,588 — $ 45,354 $ 29,555

Notes Payable (Tables)

Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2019
Debt Instrument [Line Items]
Schedule of Notes Payable	The following table summarizes the notes payable balances as of December 31, 2019 and 2018 (amounts in thousands): Interest Rates December 31, 2019 December 31, 2018 Range Weighted Maturity Date Fixed rate notes payable $ 219,567 $ 220,351 4.0% - 4.8% 4.3% 12/11/2021 - 7/1/2027 Variable rate notes payable fixed through interest rate swaps 237,778 247,435 3.7% - 5.1% 4.5% 10/28/2021 - 11/16/2022 Total notes payable, principal amount outstanding 457,345 467,786 Unamortized deferred financing costs related to notes payable (2,500 ) (3,441 ) Total notes payable, net of deferred financing costs $ 454,845 $ 464,345
Notes Payable [Member]
Debt Instrument [Line Items]
Schedule of Future Principal Payments Due on Notes Payable	The principal payments due on the notes payable as of December 31, 2019 , for each of the next five years ending December 31 and thereafter, are as follows (amounts in thousands): Year Amount 2020 $ 3,925 2021 146,025 2022 166,209 2023 2,710 2024 27,360 Thereafter 111,116 $ 457,345

Credit Facility (Tables)

Credit Facility (Tables)	12 Months Ended
	Dec. 31, 2019
Debt Instrument [Line Items]
Schedule of Credit Facility	The Company's outstanding credit facility as of December 31, 2019 and 2018 consisted of the following (amounts in thousands): December 31, 2019 December 31, 2018 Variable rate revolving line of credit $ 108,000 $ 105,000 Variable rate term loan fixed through interest rate swaps 250,000 100,000 Variable rate term loans 550,000 150,000 Total credit facility, principal amount outstanding 908,000 355,000 Unamortized deferred financing costs related to the term loan credit facility (7,385 ) (2,489 ) Total credit facility, net of deferred financing costs $ 900,615 $ 352,511
Unsecured Credit Facility [Member]
Debt Instrument [Line Items]
Schedule of Future Principal Payments Due on Credit Facility	The principal payments due on the credit facility as of December 31, 2019 , for each of the next five years ending December 31, are as follows (amounts in thousands): Year Amount 2020 $ — 2021 — 2022 108,000 2023 280,000 2024 520,000 $ 908,000

Related-Party Transactions an_2

Related-Party Transactions and Arrangements (Tables)	12 Months Ended
	Dec. 31, 2019
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following table details amounts incurred in connection with the Company's related parties transactions as described above for the years ended December 31, 2019 , 2018 and 2017 (amounts in thousands): Incurred Year Ended Fee Entity 2019 2018 2017 Distribution and servicing fees SC Distributors, LLC $ (563 ) (1) $ 368 $ 9,617 Acquisition fees and costs Carter Validus Advisors II, LLC and its affiliates 26,072 4,272 11,979 Asset management fees Carter Validus Advisors II, LLC and its affiliates 16,475 13,114 9,963 Property management fees Carter Validus Real Estate Management Services II, LLC 5,403 4,391 3,246 Operating expense reimbursement Carter Validus Advisors II, LLC and its affiliates 4,492 2,692 2,101 Leasing commission fees Carter Validus Real Estate Management Services II, LLC 1,241 497 907 Construction management fees Carter Validus Real Estate Management Services II, LLC 276 243 719 Total $ 53,396 $ 25,577 $ 38,532 (1) Reduction of distribution and servicing fees is a result of repurchases of Class T and Class T2 shares of common stock. The following table details amounts payable to affiliates in connection with the Company's related parties transactions as described above as of December 31, 2019 and 2018 (amounts in thousands): Payable December 31, 2019 December 31, 2018 Fee Entity Other offering costs reimbursement Carter Validus Advisors II, LLC and its affiliates $ — $ 89 Distribution and servicing fees SC Distributors, LLC 6,210 10,218 Acquisition fees and costs Carter Validus Advisors II, LLC and its affiliates — 32 Asset management fees Carter Validus Advisors II, LLC and its affiliates 2,100 1,182 Property management fees Carter Validus Real Estate Management Services II, LLC 433 420 Operating expense reimbursement Carter Validus Advisors II, LLC and its affiliates 518 421 Leasing commission fees Carter Validus Real Estate Management Services II, LLC 299 25 Construction management fees Carter Validus Real Estate Management Services II, LLC 199 40 Total $ 9,759 $ 12,427

Segment Reporting (Tables)

Segment Reporting (Tables)	12 Months Ended
	Dec. 31, 2019
Segment Reporting [Abstract]
Schedule of Information for Reportable Segments	Summary information for the reportable segments during the years ended December 31, 2019 , 2018 and 2017 is as follows (amounts in thousands): Data Center Healthcare Year Ended December 31, 2019 Revenue: Rental revenue $ 109,689 $ 101,212 $ 210,901 Expenses: Rental expenses (30,270 ) (10,714 ) (40,984 ) Segment net operating income $ 79,419 $ 90,498 169,917 Expenses: General and administrative expenses (8,421 ) Asset management fees (16,475 ) Depreciation and amortization (74,104 ) Impairment loss on real estate - healthcare (21,000 ) Gain on real estate disposition 79 Income from operations 49,996 Interest and other expense, net (47,214 ) Net income attributable to common stockholders $ 2,782 Data Center Healthcare Year Ended December 31, 2018 Revenue: Rental revenue $ 103,226 $ 74,107 $ 177,333 Expenses: Rental expenses (27,289 ) (10,038 ) (37,327 ) Segment net operating income $ 75,937 $ 64,069 140,006 Expenses: General and administrative expenses (5,396 ) Asset management fees (13,114 ) Depreciation and amortization (58,258 ) Income from operations 63,238 Interest and other expense, net (34,365 ) Net income attributable to common stockholders $ 28,873 Data Center Healthcare Year Ended Revenue: Rental revenue $ 62,377 $ 62,710 $ 125,087 Expenses: Rental expenses (17,571 ) (8,525 ) (26,096 ) Segment net operating income $ 44,806 $ 54,185 98,991 Expenses: General and administrative expenses (4,069 ) Asset management fees (9,963 ) Depreciation and amortization (41,133 ) Income from operations 43,826 Interest and other expense, net (22,547 ) Net income attributable to common stockholders $ 21,279
Schedule of Assets by Reportable Segments	Assets by each reportable segment as of December 31, 2019 and 2018 are as follows (amounts in thousands): December 31, 2019 December 31, 2018 Assets by segment: Data centers $ 989,953 $ 1,001,357 Healthcare 2,184,450 900,114 All other 65,131 62,358 Total assets $ 3,239,534 $ 1,963,829
Schedule of Capital Additions, Acquisitions and Dispositions by Reportable Segments	Capital additions, acquisitions and dispositions on a cash basis by reportable segments for the years ended December 31, 2019 , 2018 and 2017 are as follows (amounts in thousands): Year Ended 2019 2018 2017 Capital additions by segment: Data Centers $ 7,004 $ 2,763 $ 197 Healthcare 5,837 12,820 32,314 Total 12,841 15,583 32,511 Acquisitions by segment: Data Centers — 112,181 472,241 Healthcare 528,259 105,151 132,131 Total 528,259 217,332 604,372 Dispositions by segment: Data Centers — — — Healthcare (2,882 ) — — Total (2,882 ) — — Total capital additions, acquisitions and dispositions $ 538,218 $ 232,915 $ 636,883

Fair Value (Tables)

Fair Value (Tables)	12 Months Ended
	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following tables show the fair value of the Company’s financial assets and liabilities that are required to be measured at fair value on a recurring basis as of December 31, 2019 and 2018 (amounts in thousands): December 31, 2019 Fair Value Hierarchy Quoted Prices in Active Significant Other Significant Total Fair Assets: Derivative assets $ — $ 884 $ — $ 884 Total assets at fair value $ — $ 884 $ — $ 884 Liabilities: Derivative liabilities $ — $ 5,588 $ — $ 5,588 Total liabilities at fair value $ — $ 5,588 $ — $ 5,588 December 31, 2018 Fair Value Hierarchy Quoted Prices in Active Significant Other Significant Total Fair Assets: Derivative assets $ — $ 6,204 $ — $ 6,204 Total assets at fair value $ — $ 6,204 $ — $ 6,204
Schedule of Fair Value, Real Estate Assets Measured on Non-Recurring Basis	The following table shows the fair value of the Company's real estate assets measured at fair value on a non-recurring basis as of December 31, 2019 (amounts in thousands): December 31, 2019 Fair Value Hierarchy Quoted Prices in Active Significant Other Significant Re-Measured Balance Total Losses (1) Real estate assets $ — $ 22,412 $ — $ 22,412 $ 8,000 (1) Total losses are included in impairment loss on real estate in the consolidated statements of comprehensive (loss) income .

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	12 Months Ended
	Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of the Notional Amount and Fair Value of Derivative Instruments	The following table summarizes the notional amount and fair value of the Company’s derivative instruments (amounts in thousands): Derivatives Balance Effective Maturity December 31, 2019 December 31, 2018 Outstanding Fair Value of Outstanding Fair Value of Asset (Liability) Asset (Liability) Interest rate swaps Other assets, net/ 07/01/2016 to (1) 12/22/2020 to $ 637,778 $ 884 $ (5,588 ) $ 347,435 $ 6,204 $ — (1) During the year ended December 31, 2019 , the Company entered into two interest rate swap agreements, with an effective date of April 1, 2019, which effectively fixed LIBOR related to $150,000,000 of the term loans of the credit facility and three interest rate swap agreements, with an effective date of January 1, 2020, which will effectively fix LIBOR related to $150,000,000 of the term loans of the credit facility.
Schedule of Income and Losses Recognized on Derivative Instruments	The table below summarizes the amount of (loss) income recognized on the interest rate derivatives designated as cash flow hedges for the years ended December 31, 2019 , 2018 and 2017 (amounts in thousands): Derivatives in Cash Flow Hedging Relationships Amount of (Loss) Income Recognized Location of (Loss) Income Amount of Income (Loss) Total Amount of Interest and Other Expense, Net Presented in Consolidated Statements of Comprehensive (Loss) Income Year Ended December 31, 2019 Interest rate swaps $ (9,305 ) Interest and other expense, net $ 1,602 $ 47,214 Total $ (9,305 ) $ 1,602 Year Ended December 31, 2018 Interest rate swaps $ 3,208 Interest and other expense, net $ 818 $ 34,365 Total $ 3,208 $ 818 Year Ended December 31, 2017 Interest rate swaps $ 1,484 Interest and other expense, net $ (1,386 ) $ 22,547 Total $ 1,484 $ (1,386 )
Schedule of Offsetting of Derivative Assets	The following tables present the effect on the Company’s financial position had the Company made the election to offset its derivative positions as of December 31, 2019 and 2018 (amounts in thousands): Offsetting of Derivative Assets Gross Amounts Not Offset in the Balance Sheet Gross Gross Amounts Net Amounts of Financial Instruments Cash Collateral Net December 31, 2019 $ 884 $ — $ 884 $ (5 ) $ — $ 879 December 31, 2018 $ 6,204 $ — $ 6,204 $ — $ — $ 6,204
Schedule of Offsetting of Derivative Liabilities	Offsetting of Derivative Liabilities Gross Amounts Not Offset in the Balance Sheet Gross Gross Amounts Net Amounts of Financial Instruments Cash Collateral Net December 31, 2019 $ 5,588 $ — $ 5,588 $ (5 ) $ — $ 5,583 December 31, 2018 $ — $ — $ — $ — $ — $ —

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Amounts Recognized in Accumulated Other Comprehensive Income (Loss)	The following table presents a rollforward of amounts recognized in accumulated other comprehensive income (loss) by component for the years ended December 31, 2019 , 2018 and 2017 (amounts in thousands): Unrealized Income (Loss) on Derivative Balance as of December 31, 2016 $ 840 Other comprehensive income before reclassification 1,484 Amount of loss reclassified from accumulated other comprehensive income to net income (effective portion) 1,386 Other comprehensive income 2,870 Balance as of December 31, 2017 3,710 Other comprehensive income before reclassification 3,208 Amount of income reclassified from accumulated other comprehensive income to net income (effective portion) (818 ) Other comprehensive income 2,390 Balance as of December 31, 2018 6,100 Cumulative effect of accounting change 103 Balance as of January 1, 2019 6,203 Other comprehensive loss before reclassification (9,305 ) Amount of income reclassified from accumulated other comprehensive income to net income (including missed forecast) (1,602 ) Other comprehensive loss (10,907 ) Balance as of December 31, 2019 $ (4,704 )
Schedule of Reclassifications Out of Accumulated Other Comprehensive Income (Loss)	The following table presents reclassifications out of accumulated other comprehensive income (loss) for the years ended December 31, 2019 , 2018 and 2017(amounts in thousands): Details about Accumulated Other Amounts Reclassified from Affected Line Items in the Consolidated Statements of Comprehensive (Loss) Income Year Ended 2019 2018 2017 Interest rate swap contracts $ (1,602 ) $ (818 ) $ 1,386 Interest and other expense, net

Stock-based Compensation (Table

Stock-based Compensation (Tables)	12 Months Ended
	Dec. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Nonvested Shares of Restricted Common Stock Activity	A summary of the status of the nonvested shares of restricted Class A common stock as of December 31, 2018 and the changes for the year ended December 31, 2019 is presented below: Restricted Stock Shares Nonvested at December 31, 2018 25,500 Vested (9,750 ) Granted 12,000 Nonvested at December 31, 2019 27,750

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Schedule of Characterization of Distributions Paid to Stockholders	The following table shows the character of distributions the Company paid on a percentage basis during the years ended December 31, 2019, 2018 and 2017: Year Ended December 31, Character of Class A Distributions: 2019 2018 2017 Ordinary dividends 17.93 % 41.38 % 36.49 % Capital gain distributions 0.38 % — % — % Nontaxable distributions 81.69 % 58.62 % 63.51 % Total 100.00 % 100.00 % 100.00 % Year Ended December 31, Character of Class I Distributions: 2019 2018 2017 Ordinary dividends 17.93 % 41.38 % 36.49 % Capital gain distributions 0.38 % — % — % Nontaxable distributions 81.69 % 58.62 % 63.51 % Total 100.00 % 100.00 % 100.00 % Year Ended December 31, Character of Class T Distributions: 2019 2018 2017 Ordinary dividends 4.79 % 33.01 % 25.93 % Capital gain distributions 0.43 % — % — % Nontaxable distributions 94.78 % 66.99 % 74.07 % Total 100.00 % 100.00 % 100.00 % Year Ended December 31, Character of Class T2 Distributions: 2019 2018 2017 Ordinary dividends 4.79 % 33.01 % — % Capital gain distributions 0.43 % — % — % Nontaxable distributions 94.78 % 66.99 % — % Total 100.00 % 100.00 % — %

Selected Quarterly Financial _2

Selected Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]
Schedule of Selected Quarterly Financial Data (Unaudited)	Presented in the following table is a summary of the unaudited quarterly financial information for the years ended December 31, 2019 and 2018. The Company believes that all necessary adjustments, consisting only of normal recurring adjustments, have been included in the amounts stated below to present fairly, and in accordance with GAAP, the selected quarterly information (amounts in thousands, except shares and per share data): 2019 Fourth Third Second First Total revenue $ 69,434 $ 48,063 $ 46,937 $ 46,467 Total expenses (52,160 ) (45,773 ) (30,780 ) (32,271 ) Gain on real estate disposition 79 — — — Income from operations 17,353 2,290 16,157 14,196 Interest and other expense, net (15,566 ) (11,920 ) (9,893 ) (9,835 ) Net income (loss) attributable to common stockholders $ 1,787 $ (9,630 ) $ 6,264 $ 4,361 Net income (loss) per common share attributable to common stockholders: Basic $ 0.01 $ (0.07 ) $ 0.05 $ 0.03 Diluted $ 0.01 $ (0.07 ) $ 0.05 $ 0.03 Weighted average number of common shares outstanding: Basic 218,928,165 137,063,509 136,135,710 136,179,343 Diluted 218,955,915 137,063,509 136,161,037 136,204,843 2018 Fourth Third Second First Total revenue $ 46,571 $ 45,517 $ 43,951 $ 41,294 Total expenses (30,627 ) (28,863 ) (28,556 ) (26,049 ) Income from operations 15,944 16,654 15,395 15,245 Interest and other expense, net (9,478 ) (8,937 ) (8,209 ) (7,741 ) Net income attributable to common stockholders $ 6,466 $ 7,717 $ 7,186 $ 7,504 Net income per common share attributable to common stockholders: Basic $ 0.05 $ 0.06 $ 0.06 $ 0.06 Diluted $ 0.05 $ 0.06 $ 0.06 $ 0.06 Weighted average number of common shares outstanding: Basic 135,271,638 132,467,127 129,926,130 126,384,346 Diluted 135,297,138 132,491,755 129,948,432 126,401,940

Subsequent Events (Tables)

Subsequent Events (Tables)	12 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
Schedule of Subsequent Events	Distributions Paid to Stockholders The following table summarizes the Company's distributions paid on January 2, 2020, for the period from December 1, 2019 through December 31, 2019 (amounts in thousands): Payment Date Common Stock Cash DRIP Total Distribution January 2, 2020 Class A $ 5,442 $ 1,648 $ 7,090 January 2, 2020 Class I 323 215 538 January 2, 2020 Class T 628 715 1,343 January 2, 2020 Class T2 53 69 122 $ 6,446 $ 2,647 $ 9,093 The following table summarizes the Company's distributions paid on February 3, 2020, for the period from January 1, 2020 through January 31, 2020 (amounts in thousands): Payment Date Common Stock Cash DRIP Total Distribution February 3, 2020 Class A $ 5,431 $ 1,646 $ 7,077 February 3, 2020 Class I 324 213 537 February 3, 2020 Class T 631 712 1,343 February 3, 2020 Class T2 52 69 121 $ 6,438 $ 2,640 $ 9,078 The following table summarizes the Company's distributions paid on March 3, 2020, for the period from February 1, 2020 through February 29, 2020 (amounts in thousands): Payment Date Common Stock Cash DRIP Total Distribution March 3, 2020 Class A $ 5,060 $ 1,526 $ 6,586 March 3, 2020 Class I 299 197 496 March 3, 2020 Class T 595 660 1,255 March 3, 2020 Class T2 50 63 113 $ 6,004 $ 2,446 $ 8,450 Distributions Authorized The following tables summarize the daily distributions approved and authorized by the board of directors of the Company subsequent to December 31, 2019 : Authorization Date (1) Common Stock Daily Distribution Rate (1) Annualized Distribution Per Share February 24, 2020 Class A $ 0.001366120 $ 0.50 February 24, 2020 Class I $ 0.001366120 $ 0.50 February 24, 2020 Class T $ 0.001129781 $ 0.41 February 24, 2020 Class T2 $ 0.001129781 $ 0.41 (1) Distributions approved and authorized to stockholders of record as of the close of business on each day of the period commencing on March 1, 2020 and ending on May 31, 2020. The distributions will be calculated based on 366 days in the calendar year. The distributions declared for each record date in March 2020, April 2020 and May 2020 will be paid in April 2020, May 2020 and June 2020, respectively. The distributions will be payable to stockholders from legally available funds therefor. Acquisitions The following table summarizes the property acquired subsequent to December 31, 2019 and through March 24, 2020 : Property Date Acquired Contract Purchase Price Ownership Grimes Healthcare Facility 02/19/2020 $4,825,000 100%

Organization and Business Ope_2

Organization and Business Operations (Details)	Dec. 31, 2019registration_statementproperty	Nov. 30, 2018initial_public_offering
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of real estate properties owned | property	152
Number of public offerings | initial_public_offering		2
Number of registration statements on Form S-3 | registration_statement	2

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Narrative) (Details)	Jan. 02, 2020USD ($)	Dec. 31, 2019USD ($)metropolitanleasemicropolitantenant	Sep. 30, 2019USD ($)	Jun. 30, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Sep. 30, 2018USD ($)	Jun. 30, 2018USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2019USD ($)metropolitanleasesegmentmicropolitantenant$ / sharesshares	Dec. 31, 2018USD ($)segment$ / sharesshares	Dec. 31, 2017USD ($)$ / sharesshares	Jan. 01, 2019USD ($)
Summary of Significant Accounting Policies [Line Items]
Real estate assets, carrying amount		$ 2,768,462,000				$ 1,673,732,000				$ 2,768,462,000	$ 1,673,732,000
Impairment loss on real estate		8,000,000	$ 13,000,000							21,000,000	0	$ 0
Accelerated amortization of acquired intangible liabilities										$ 212,000	0	0
Number of tenants with impaired acquired intangible liabilities | tenant										1
Impairment of acquired intangible assets											0	$ 0
Number of tenants with impaired acquired intangible assets | tenant										2
Bad debt expense										$ 672,000
Note receivable		$ 2,700,000				0				$ 2,700,000	$ 0
Diluted earnings per share outstanding adjustment (in shares) | shares										24,000	24,000	18,000
Number of reportable business segments | segment										2	2
Number of micropolitan statistical areas with owned real estate investments | micropolitan		2								2
Number of metropolitan statistical areas with owned real estate investments | metropolitan		67								67
Maximum number of shares available for repurchase during any calendar year, as percentage of common stock outstanding at end of prior year										5.00%
Period of notice required for changes to share repurchase program										30 days
Repurchase of common stock, percentage										1.87%	3.80%
Repurchase of common stock										$ 23,655,000	$ 43,230,000	$ 17,159,000
Distributions declared per common share (in dollars per share) | $ / shares										$ 0.58	$ 0.63	$ 0.62
Distributions payable to stockholders		$ 9,093,000				7,317,000				$ 9,093,000	$ 7,317,000
Cash Distribution										49,494,000	40,296,000	$ 28,994,000
Common stock issued through distribution reinvestment plan										39,934,000	40,938,000	32,264,000
Impact related to uncertain tax positions										0	0	0
Cumulative effect of accounting change													$ 0
Rental revenue		$ 69,434,000	48,063,000	$ 46,937,000	$ 46,467,000	$ 46,571,000	$ 45,517,000	$ 43,951,000	$ 41,294,000	210,901,000	177,333,000	125,087,000
Rental expenses										$ 40,984,000	$ 37,327,000	$ 26,096,000
Number of operating ground leases | lease		17								17
Number of operating ground leases without corresponding operating lease liabilities | lease		4								4
Number of operating ground leases with corresponding operating lease liabilities | lease		13								13
Accounting Standards Update 2018-20 [Member]
Summary of Significant Accounting Policies [Line Items]
Rental revenue										$ (1,593,000)
Rental expenses										$ (1,593,000)
Subsequent Event [Member] | December 1, 2019 To December 31, 2019 [Member]
Summary of Significant Accounting Policies [Line Items]
Cash Distribution	$ 6,446,000
Common stock issued through distribution reinvestment plan	2,647,000
Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Repurchase of common stock (in shares) | shares										2,557,298	4,700,554	1,880,820
Repurchase of common stock										$ 25,000	$ 47,000	$ 18,000
Common stock issued through distribution reinvestment plan										$ 43,000	$ 44,000	$ 35,000
Accumulated Other Comprehensive Income (Loss) [Member]
Summary of Significant Accounting Policies [Line Items]
Cumulative effect of accounting change													103,000
Accumulated Other Comprehensive Income (Loss) [Member] | Accounting Standards Update 2017-12 [Member]
Summary of Significant Accounting Policies [Line Items]
Cumulative effect of accounting change													103,000
Accumulated Distributions in Excess of Earnings [Member]
Summary of Significant Accounting Policies [Line Items]
Cumulative effect of accounting change													(103,000)
Accumulated Distributions in Excess of Earnings [Member] | Accounting Standards Update 2017-12 [Member]
Summary of Significant Accounting Policies [Line Items]
Cumulative effect of accounting change													$ (103,000)
Class A, I, T and T2 shares [Member] | Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Repurchase of common stock (in shares) | shares										2,557,298
Repurchase of common stock										$ 23,655,000
Repurchase of common stock, average price per share (in dollars per share) | $ / shares										$ 9.25
Class A shares [Member] | Subsequent Event [Member] | December 1, 2019 To December 31, 2019 [Member]
Summary of Significant Accounting Policies [Line Items]
Cash Distribution	5,442,000
Common stock issued through distribution reinvestment plan	1,648,000
Class A shares [Member] | Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Repurchase of common stock (in shares) | shares										1,910,894	4,117,566
Class I shares [Member] | Subsequent Event [Member] | December 1, 2019 To December 31, 2019 [Member]
Summary of Significant Accounting Policies [Line Items]
Cash Distribution	323,000
Common stock issued through distribution reinvestment plan	215,000
Class I shares [Member] | Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Repurchase of common stock (in shares) | shares										189,947	71,180
Class T shares [Member] | Subsequent Event [Member] | December 1, 2019 To December 31, 2019 [Member]
Summary of Significant Accounting Policies [Line Items]
Cash Distribution	628,000
Common stock issued through distribution reinvestment plan	715,000
Class T shares [Member] | Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Repurchase of common stock (in shares) | shares										451,058	511,808
Class T2 shares [Member] | Subsequent Event [Member] | December 1, 2019 To December 31, 2019 [Member]
Summary of Significant Accounting Policies [Line Items]
Cash Distribution	53,000
Common stock issued through distribution reinvestment plan	$ 69,000
Class T2 shares [Member] | Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Repurchase of common stock (in shares) | shares										5,399
Class A, I and T shares [Member] | Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Repurchase of common stock (in shares) | shares											4,700,554
Repurchase of common stock											$ 43,230,000
Repurchase of common stock, average price per share (in dollars per share) | $ / shares											$ 9.20
Rental Revenue [Member] | Geographic Concentration Risk [Member]
Summary of Significant Accounting Policies [Line Items]
Number of metropolitan statistical areas with owned real estate investments | metropolitan		1								1
Rental Revenue [Member] | Geographic Concentration Risk [Member] | Atlanta-Sandy Springs-Roswell, Georgia MSA [Member]
Summary of Significant Accounting Policies [Line Items]
Concentration risk, percentage										15.00%
Rental Revenue [Member] | Customer Concentration Risk [Member]
Summary of Significant Accounting Policies [Line Items]
Number of tenants | tenant		0								0
In-place leases [Member]
Summary of Significant Accounting Policies [Line Items]
Impairment of acquired intangible assets										$ 3,195,000
Fair Value, Measurements, Nonrecurring [Member]
Summary of Significant Accounting Policies [Line Items]
Real estate assets, fair value		$ 22,412,000								22,412,000
Impairment loss on real estate										8,000,000
Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Measurements, Nonrecurring [Member]
Summary of Significant Accounting Policies [Line Items]
Real estate assets, carrying amount		30,412,000	40,266,000							30,412,000
Real estate assets, fair value		$ 22,412,000	$ 27,266,000							$ 22,412,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Reconciliation of Cash, Cash Equivalents and Restricted Cash) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Accounting Policies [Abstract]
Cash and cash equivalents	$ 69,342	$ 68,360	$ 74,803	$ 50,446
Restricted cash	10,888	11,167	10,944	6,463
Cash, cash equivalents and restricted cash	$ 80,230	$ 79,527	$ 85,747	$ 56,909

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Schedule of Estimated Useful Lives of Assets by Class) (Details)	12 Months Ended
	Dec. 31, 2019
Building and improvements [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	15 years
Building and improvements [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	40 years
Furniture, fixtures, and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Furniture, fixtures, and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	10 years

Acquisitions and Dispositions_2

Acquisitions and Dispositions (Narrative) (Details)	Oct. 04, 2019$ / shares	Dec. 31, 2019USD ($)$ / shares	Sep. 30, 2019USD ($)	Jun. 30, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)property$ / shares	Dec. 31, 2018USD ($)$ / shares	Dec. 31, 2017USD ($)	Nov. 26, 2019USD ($)
Real Estate [Line Items]
Number of real estate properties acquired | property						67
Capitalized acquisition fees and costs						$ 30,546,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.01				$ 0.01	$ 0.01
Sale price of real estate disposition									$ 3,106,000
Proceeds from real estate disposition						$ 2,882,000	$ 0	$ 0
Gain on real estate disposition		$ 79,000	$ 0	$ 0	$ 0	$ 79,000	$ 0	$ 0
REIT Merger [Member]
Real Estate [Line Items]
Number of real estate properties acquired | property						60
Common stock, par value (in dollars per share) | $ / shares	$ 0.01
Business acquisition, cash paid per common share (in dollars per share) | $ / shares	$ 1
Business acquisition, stock conversion ratio	0.4681
Maximum [Member]
Real Estate [Line Items]
Acquisition fees and costs (% of contract purchase price)						6.00%

Acquisitions and Dispositions_3

Acquisitions and Dispositions (Schedule of Consideration Transferred for Properties Acquired) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)leaseproperty	Dec. 31, 2018USD ($)
Business Acquisition [Line Items]
Purchase Price	$ 1,301,630
Number of real estate properties owned | property	152
Number of operating ground leases entered into during the reporting period | lease	11
Ground leasehold asset	$ 3,731
Construction in progress	2,916	$ 0
Land	$ 98,723
Bryant Healthcare Facility II, f.k.a. Bryant Healthcare Facility [Member]
Business Acquisition [Line Items]
Date Acquired	Aug. 16, 2019
Ownership Percentage	100.00%
Purchase Price	$ 4,408
TAM Healthcare Facilities [Member]
Business Acquisition [Line Items]
Date Acquired	Sep. 19, 2019
Ownership Percentage	100.00%
Purchase Price	$ 65,443
Number of real estate properties owned | property	4
Number of operating ground leases entered into during the reporting period | lease	4
REIT Merger [Member]
Business Acquisition [Line Items]
Date Acquired	Oct. 4, 2019
Ownership Percentage	100.00%
Purchase Price	$ 1,229,365
Number of real estate properties owned | property	60
Tucson Healthcare Facility II [Member]
Business Acquisition [Line Items]
Date Acquired	Dec. 26, 2019
Ownership Percentage	100.00%
Purchase Price	$ 651
Ground leasehold asset	651
Construction in progress	$ 1,764
Tucson Healthcare Facility III [Member]
Business Acquisition [Line Items]
Date Acquired	Dec. 27, 2019
Ownership Percentage	100.00%
Purchase Price	$ 1,763
Construction in progress	1,152
Land	$ 1,763

Acquisitions and Dispositions_4

Acquisitions and Dispositions (Schedule of Allocation of Acquisitions) (Details) $ in Thousands	Dec. 31, 2019USD ($)
Real Estate [Abstract]
Land	$ 98,723
Buildings and improvements	1,047,755
In-place leases	141,407
Tenant improvements	5,349
Ground leasehold assets	3,731
Above-market leases	17,906
Total assets acquired	1,314,871
Ground lease liabilities	(6,048)
Below-market leases	(7,193)
Total liabilities acquired	(13,241)
Net assets acquired	$ 1,301,630

Acquisitions and Dispositions_5

Acquisitions and Dispositions (Schedule of Consideration Transferred for the REIT Merger) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Business Acquisition [Line Items]
Equity consideration transferred in the REIT Merger	$ 774,010	$ 0	$ 0
Cash consideration paid	178,758
Business Combination, Consideration Transferred	952,768
Common Stock [Member]
Business Acquisition [Line Items]
Equity consideration transferred in the REIT Merger	$ 837
Issuance of common stock in connection with the REIT Merger (in shares)	83,676,775

Acquired Intangible Assets, N_3

Acquired Intangible Assets, Net (Narrative) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)intangible_asset	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Acquired intangible asset, weighted average remaining life	10 years 4 months 24 days	10 years 7 months 6 days
Amortization of acquired intangible assets	$ 26,699	$ 19,919	$ 14,167
Impairment of acquired intangible assets		$ 0	$ 0
In-place leases [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Acquired intangible asset, weighted average remaining life	10 years 4 months 24 days	10 years 1 month 6 days
Impairment of acquired intangible assets	$ 3,195
Number of impaired acquired intangible assets | intangible_asset	2

Acquired Intangible Assets, N_4

Acquired Intangible Assets, Net (Schedule of Acquired Intangible Assets, Net) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Acquired Finite-Lived Intangible Assets [Line Items]
Acquired intangible asset, net of accumulated amortization	$ 285,459	$ 154,204
Acquired intangible asset, accumulated amortization	$ 64,164	$ 42,081
Acquired intangible asset, weighted average remaining life	10 years 4 months 24 days	10 years 7 months 6 days
In-place leases [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Acquired intangible asset, net of accumulated amortization	$ 266,856	$ 151,135
Acquired intangible asset, accumulated amortization	$ 62,252	$ 41,143
Acquired intangible asset, weighted average remaining life	10 years 4 months 24 days	10 years 1 month 6 days
Above-market leases [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Acquired intangible asset, net of accumulated amortization	$ 18,603	$ 1,710
Acquired intangible asset, accumulated amortization	$ 1,912	$ 899
Acquired intangible asset, weighted average remaining life	10 years 6 months	5 years 1 month 6 days
Ground leasehold assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Acquired intangible asset, net of accumulated amortization		$ 1,359
Acquired intangible asset, accumulated amortization		$ 39
Acquired intangible asset, weighted average remaining life		83 years 6 months

Acquired Intangible Assets, N_5

Acquired Intangible Assets, Net (Schedule of Estimated Future Amortization Expense of Acquired Intangible Assets) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets, Net [Abstract]
2020	$ 33,211
2021	32,409
2022	30,071
2023	28,094
2024	26,019
Thereafter	135,655
Acquired intangible assets, net	$ 285,459	$ 154,204

Acquired Intangible Liabiliti_3

Acquired Intangible Liabilities, Net (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Intangible Lease Liabilities, Net [Abstract]
Amortization of below-market leases	$ 5,261	$ 4,832	$ 2,126
Accelerated amortization of acquired intangible liabilities	$ 212	$ 0	$ 0

Acquired Intangible Liabiliti_4

Acquired Intangible Liabilities, Net (Schedule of Acquired Intangible Liabilities, Net) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Intangible Lease Liabilities, Net [Abstract]
Below-market leases, net of accumulated amortization of $12,332 and $7,592, respectively (with a weighted average remaining life of 16.1 years and 17.6 years, respectively)	$ 59,538	$ 57,606
Below-market leases, accumulated amortization	$ 12,332	$ 7,592
Below market leases, weighted average remaining life	16 years 1 month 6 days	17 years 7 months 6 days

Acquired Intangible Liabiliti_5

Acquired Intangible Liabilities, Net (Schedule of Estimated Future Amortization of Acquired Intangible Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Intangible Lease Liabilities, Net [Abstract]
2020	$ 5,486
2021	5,458
2022	4,394
2023	3,779
2024	3,677
Thereafter	36,744
Acquired intangible liabilities, net	$ 59,538	$ 57,606

Leases (Narrative) (Details)

Leases (Narrative) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)lease	Jan. 01, 2019	Dec. 31, 2018
Lessee, Lease, Description [Line Items]
Number of operating ground leases	17
Number of operating ground leases without corresponding operating lease liabilities	4
Number of operating ground leases entered into during the reporting period	11
Operating lease liabilities | $	$ 31,004
Operating lease, weighted average remaining lease term	50 years 8 months 9 days		27 years 2 months
2019 Acquisitions [Member]
Lessee, Lease, Description [Line Items]
Operating lease liabilities | $	$ 22,265
REIT Merger [Member]
Lessee, Lease, Description [Line Items]
Number of operating ground leases entered into during the reporting period	6
Minimum [Member]
Lessee, Lease, Description [Line Items]
Operating lease, weighted average incremental borrowing rate, percent		5.00%
Maximum [Member]
Lessee, Lease, Description [Line Items]
Operating lease, weighted average incremental borrowing rate, percent		6.60%

Leases (Schedule of Future Mini

Leases (Schedule of Future Minimum Rent to Lessor from Operating Leases) (Details) $ in Thousands	Dec. 31, 2019USD ($)
Leases [Abstract]
2020	$ 224,837
2021	231,052
2022	235,334
2023	234,949
2024	230,179
Thereafter	1,619,494
Total	$ 2,775,845

Leases (Schedule of Future Mi_2

Leases (Schedule of Future Minimum Rent from Lessee for Ground Leases) (Details) $ in Thousands	Dec. 31, 2019USD ($)
Leases [Abstract]
2020	$ 1,633
2021	1,634
2022	1,634
2023	1,638
2024	1,687
Thereafter	136,719
Total undiscounted rental payments	144,945
Less imputed interest	(113,941)
Total operating lease liabilities	$ 31,004

Leases (Schedule of Future Mi_3

Leases (Schedule of Future Minimum Rent from Lessee for Ground Leases - ASC 840) (Details) $ in Thousands	Dec. 31, 2018USD ($)
Leases [Abstract]
2019	$ 123
2020	123
2021	123
2022	123
2023	123
Thereafter	2,246
Total undiscounted rental payments	$ 2,861

Other Assets, Net (Narrative) (

Other Assets, Net (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Other Assets [Abstract]
Amortization of deferred financing costs related to the revolver portion of the credit facility	$ 1,010	$ 1,260	$ 1,637
Amortization of leasing commissions	$ 158	$ 76	$ 6

Other Assets, Net (Schedule of

Other Assets, Net (Schedule of Other Assets, Net) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Other Assets [Abstract]
Deferred financing costs, related to the revolver portion of the credit facility, net of accumulated amortization of $5,696 and $4,686, respectively	$ 2,623	$ 3,053
Leasing commissions, net of accumulated amortization of $240 and $82, respectively	10,288	5,006
Restricted cash	10,888	11,167	$ 10,944	$ 6,463
Tenant receivables	7,750	6,080
Note receivable	2,700	0
Straight-line rent receivable	46,892	32,685
Prepaid and other assets	4,709	3,338
Derivative assets	884	6,204
Total other assets, net	86,734	67,533
Deferred financing costs, related to the revolver portion of the secured credit facility, accumulated amortization	5,696	4,686
Leasing commissions, accumulated amortization	$ 240	$ 82

Accounts Payable and Other Li_3

Accounts Payable and Other Liabilities (Schedule of Accounts Payable and Other Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Payables and Accruals [Abstract]
Accounts payable and accrued expenses	$ 11,448	$ 9,188
Accrued interest expense	5,185	3,219
Accrued property taxes	3,537	2,309
Distributions payable to stockholders	9,093	7,317
Tenant deposits	1,500	875
Deferred rental income	9,003	6,647
Derivative liabilities	5,588	0
Total accounts payable and other liabilities	$ 45,354	$ 29,555

Notes Payable (Narrative) (Deta

Notes Payable (Narrative) (Details) - USD ($) $ in Thousands	Dec. 10, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Notes payable, principal amount outstanding		$ 457,345	$ 467,786
Payments on notes payable		$ 10,441	$ 349	$ 43
Note Payable One [Member]
Debt Instrument [Line Items]
Notes payable, principal amount outstanding	$ 30,266
Payments on notes payable	$ 8,500
Notes Payable [Member]
Debt Instrument [Line Items]
Weighted Average Interest Rate		4.40%

Notes Payable (Schedule of Note

Notes Payable (Schedule of Notes Payable) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Notes payable, principal amount outstanding	$ 457,345	$ 467,786
Unamortized deferred financing costs related to notes payable	(2,500)	(3,441)
Notes payable, net of deferred financing costs	454,845	464,345
Fixed Rate [Member]
Debt Instrument [Line Items]
Notes payable, principal amount outstanding	$ 219,567	220,351
Weighted Average Interest Rate	4.30%
Fixed Rate [Member] | Minimum [Member]
Debt Instrument [Line Items]
Interest Rate	4.00%
Maturity Date	Dec. 11, 2021
Fixed Rate [Member] | Maximum [Member]
Debt Instrument [Line Items]
Interest Rate	4.80%
Maturity Date	Jul. 1, 2027
Variable Rate, Subject To Interest Rate Swap [Member]
Debt Instrument [Line Items]
Notes payable, principal amount outstanding	$ 237,778	$ 247,435
Weighted Average Interest Rate	4.50%
Variable Rate, Subject To Interest Rate Swap [Member] | Minimum [Member]
Debt Instrument [Line Items]
Interest Rate	3.70%
Maturity Date	Oct. 28, 2021
Variable Rate, Subject To Interest Rate Swap [Member] | Maximum [Member]
Debt Instrument [Line Items]
Interest Rate	5.10%
Maturity Date	Nov. 16, 2022

Notes Payable (Schedule of Futu

Notes Payable (Schedule of Future Principal Payments Due on Notes Payable) (Details) - Notes Payable [Member] $ in Thousands	Dec. 31, 2019USD ($)
Debt Instrument [Line Items]
2020	$ 3,925
2021	146,025
2022	166,209
2023	2,710
2024	27,360
Thereafter	111,116
Total	$ 457,345

Credit Facility (Narrative) (De

Credit Facility (Narrative) (Details)	3 Months Ended		5 Months Ended	9 Months Ended	12 Months Ended
	Mar. 27, 2020USD ($)	Apr. 10, 2019	Dec. 31, 2019USD ($)extension	Dec. 31, 2019USD ($)	Dec. 31, 2019USD ($)interest_rate_swap_agreement	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Jan. 01, 2020USD ($)	Aug. 07, 2019USD ($)	Aug. 06, 2019USD ($)	Apr. 01, 2019USD ($)
Line of Credit Facility [Line Items]
Credit facility, draws					$ 605,000,000	$ 155,000,000	$ 240,000,000
Credit facility, repayments					52,000,000	20,000,000	240,000,000
Credit facility, outstanding principal balance			$ 908,000,000	$ 908,000,000	908,000,000	355,000,000
Credit facility, recourse debt restriction percentage		15.00%		17.50%
Credit facility, maximum commitments available			780,000,000	$ 780,000,000	780,000,000					$ 700,000,000
Credit facility, revolving loan to term loan conversion					30,000,000	0	0
Credit facility, maximum commitments available after available increase			1,600,000,000	1,600,000,000	1,600,000,000
Investment in real estate					528,259,000	217,332,000	$ 604,372,000
Cash consideration paid					$ 178,758,000
Credit facility, threshold percentage for unused portion of lenders' commitments					50.00%
Minimum [Member]
Line of Credit Facility [Line Items]
Credit facility, unused portion, commitment fee percentage					0.15%
Maximum [Member]
Line of Credit Facility [Line Items]
Credit facility, unused portion, commitment fee percentage					0.25%
Acquisition Costs And Fees [Member]
Line of Credit Facility [Line Items]
Investment in real estate					$ 27,350,000
London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Credit facility, basis spread on variable rate					1.75%
London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Credit facility, basis spread on variable rate					2.25%
Base Rate [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Credit facility, basis spread on variable rate					0.75%
Base Rate [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Credit facility, basis spread on variable rate					1.25%
REIT I Debt [Member]
Line of Credit Facility [Line Items]
Investment in real estate					$ 248,580,000
Variable Rate [Member]
Line of Credit Facility [Line Items]
Credit facility, outstanding principal balance			$ 658,000,000	$ 658,000,000	$ 658,000,000	255,000,000
Variable Rate [Member] | Unsecured Credit Facility [Member]
Line of Credit Facility [Line Items]
Debt, interest rate			3.90%	3.90%	3.90%
Variable Rate, Subject To Interest Rate Swap [Member]
Line of Credit Facility [Line Items]
Credit facility, outstanding principal balance			$ 250,000,000	$ 250,000,000	$ 250,000,000	100,000,000
Variable Rate, Subject To Interest Rate Swap [Member] | Unsecured Credit Facility [Member]
Line of Credit Facility [Line Items]
Debt, interest rate			4.20%	4.20%	4.20%
Variable Rate, Subject To Interest Rate Swap [Member] | Minimum [Member]
Line of Credit Facility [Line Items]
Debt, interest rate			3.70%	3.70%	3.70%
Variable Rate, Subject To Interest Rate Swap [Member] | Maximum [Member]
Line of Credit Facility [Line Items]
Debt, interest rate			5.10%	5.10%	5.10%
Subsequent Event [Member]
Line of Credit Facility [Line Items]
Credit facility, draws	$ 95,000,000
Subsequent Event [Member] | Coronavirus Precautionary Measures [Member]
Line of Credit Facility [Line Items]
Credit facility, draws	75,000,000
Subsequent Event [Member] | Grimes Healthcare Facility [Member]
Line of Credit Facility [Line Items]
Credit facility, draws	$ 20,000,000
Bridge Facility [Member]
Line of Credit Facility [Line Items]
Credit facility, maximum commitments available									$ 475,000,000
Term Loan [Member]
Line of Credit Facility [Line Items]
Credit facility, maximum commitments available			$ 280,000,000	$ 280,000,000	$ 280,000,000
Credit facility, maturity date			Apr. 27, 2023
Term Loan [Member] | Variable Rate [Member]
Line of Credit Facility [Line Items]
Credit facility, outstanding principal balance			$ 550,000,000	550,000,000	550,000,000	150,000,000
Term Loan [Member] | Variable Rate, Subject To Interest Rate Swap [Member]
Line of Credit Facility [Line Items]
Credit facility, outstanding principal balance			250,000,000	250,000,000	250,000,000	100,000,000					$ 150,000,000
Term Loan [Member] | Subsequent Event [Member] | Variable Rate, Subject To Interest Rate Swap [Member]
Line of Credit Facility [Line Items]
Credit facility, outstanding principal balance								$ 150,000,000
Revolving Line of Credit [Member]
Line of Credit Facility [Line Items]
Credit facility, maximum commitments available			$ 500,000,000	500,000,000	500,000,000
Credit facility, maturity date			Apr. 27, 2022
Credit facility, number of maturity extension periods | extension			1
Credit facility, extension period			12 months
Revolving Line of Credit [Member] | Variable Rate [Member]
Line of Credit Facility [Line Items]
Credit facility, outstanding principal balance			$ 108,000,000	108,000,000	108,000,000	$ 105,000,000
Senior Unsecured Term Loan [Member]
Line of Credit Facility [Line Items]
Credit facility, maximum commitments available			$ 520,000,000	$ 520,000,000	$ 520,000,000
Credit facility, maturity date			Dec. 31, 2024
Effective April 1, 2019 [Member]
Line of Credit Facility [Line Items]
Number of interest rate swap agreements entered into during period | interest_rate_swap_agreement					2
Effective January 1, 2020 [Member]
Line of Credit Facility [Line Items]
Number of interest rate swap agreements entered into during period | interest_rate_swap_agreement					3

Credit Facility (Schedule of Cr

Credit Facility (Schedule of Credit Facility) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Apr. 01, 2019	Dec. 31, 2018
Line of Credit Facility [Line Items]
Credit facility, principal amount outstanding	$ 908,000		$ 355,000
Unamortized deferred financing costs related to the term loan credit facility	(7,385)		(2,489)
Credit facility, net of deferred financing costs	900,615		352,511
Variable Rate [Member]
Line of Credit Facility [Line Items]
Credit facility, principal amount outstanding	658,000		255,000
Variable Rate [Member] | Revolving Line of Credit [Member]
Line of Credit Facility [Line Items]
Credit facility, principal amount outstanding	108,000		105,000
Variable Rate [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Credit facility, principal amount outstanding	550,000		150,000
Variable Rate, Subject To Interest Rate Swap [Member]
Line of Credit Facility [Line Items]
Credit facility, principal amount outstanding	250,000		100,000
Variable Rate, Subject To Interest Rate Swap [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Credit facility, principal amount outstanding	$ 250,000	$ 150,000	$ 100,000

Credit Facility (Schedule of Fu

Credit Facility (Schedule of Future Principal Payments Due on Credit Facility) (Details) - Unsecured Credit Facility [Member] $ in Thousands	Dec. 31, 2019USD ($)
Debt Instrument [Line Items]
2020	$ 0
2021	0
2022	108,000
2023	280,000
2024	520,000
Total	$ 908,000

Related-Party Transactions an_3

Related-Party Transactions and Arrangements (Narrative) (Details)	Dec. 31, 2019USD ($)employee	Oct. 04, 2019USD ($)	Dec. 31, 2019employee	Oct. 03, 2019	Dec. 31, 2019USD ($)employee	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)
Related Party Transaction [Line Items]
Number of employees | employee	0		0		0
Annual cumulative, non-compounded return on capital threshold to investors			8.00%	6.00%
Expenses incurred from transactions with related party					$ 53,396,000	$ 25,577,000	$ 38,532,000
Operating Partnership Contribution [Member]
Related Party Transaction [Line Items]
Aggregate purchase price		$ 1,066
Disposition Fees [Member]
Related Party Transaction [Line Items]
Expenses incurred from transactions with related party	$ 0
Subordinated Participation In Net Sale Proceeds [Member]
Related Party Transaction [Line Items]
Expenses incurred from transactions with related party	0
Subordinated Incentive Listing Fee [Member]
Related Party Transaction [Line Items]
Expenses incurred from transactions with related party	0
Subordinated Termination Fee [Member]
Related Party Transaction [Line Items]
Expenses incurred from transactions with related party	$ 0
Maximum [Member]
Related Party Transaction [Line Items]
Disposition fee (% of contract sales price)					6.00%
Carter Validus Advisors II, LLC And/Or Its Affiliates [Member]
Related Party Transaction [Line Items]
Acquisition fee (% of contract purchase price of each property or asset acquired)					2.00%
Acquisition expenses reimbursed (% of purchase price of each property or real estate-related investment)	0.01%
Subordinated participation in net sale proceeds, percentage					15.00%
Subordinated incentive listing fee, percentage					15.00%
Subordinated termination fee, percentage					15.00%
Carter Validus Advisors II, LLC And/Or Its Affiliates [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Disposition fee (% of contract sales price)					1.00%
Disposition fee (% of third party brokerage commission)					50.00%
Carter Validus Advisors II, LLC [Member]
Related Party Transaction [Line Items]
Monthly asset management fee (% of aggregate asset value)					0.0625%
Carter Validus Advisors II, LLC [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Operating expense reimbursement (% of average invested assets)					2.00%
Operating expense reimbursement ( % of net income)					25.00%
Carter Validus Real Estate Management Services II, LLC [Member]
Related Party Transaction [Line Items]
Property management fee (% of gross revenues from properties managed)					3.00%
Oversight fee (% of gross revenues from properties managed)					1.00%
Construction management fee (% of project costs)					5.00%

Related-Party Transactions an_4

Related-Party Transactions and Arrangements (Schedule of Related Party Transactions) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Related Party Transaction [Line Items]
Incurred	$ 53,396	$ 25,577	$ 38,532
Payable	9,759	12,427
SC Distributors, LLC [Member] | Distribution and Servicing Fees [Member]
Related Party Transaction [Line Items]
Incurred		368	9,617
Incurred	(563)
Payable	6,210	10,218
Carter Validus Advisors II, LLC And/Or Its Affiliates [Member] | Other Offering Costs Reimbursement [Member]
Related Party Transaction [Line Items]
Payable	0	89
Carter Validus Advisors II, LLC And/Or Its Affiliates [Member] | Acquisition Fees and Costs [Member]
Related Party Transaction [Line Items]
Incurred	26,072	4,272	11,979
Payable	0	32
Carter Validus Advisors II, LLC And/Or Its Affiliates [Member] | Asset Management Fees [Member]
Related Party Transaction [Line Items]
Incurred	16,475	13,114	9,963
Payable	2,100	1,182
Carter Validus Advisors II, LLC And/Or Its Affiliates [Member] | Operating Expense Reimbursement [Member]
Related Party Transaction [Line Items]
Incurred	4,492	2,692	2,101
Payable	518	421
Carter Validus Real Estate Management Services II, LLC [Member] | Property Management Fees [Member]
Related Party Transaction [Line Items]
Incurred	5,403	4,391	3,246
Payable	433	420
Carter Validus Real Estate Management Services II, LLC [Member] | Leasing Commission Fees [Member]
Related Party Transaction [Line Items]
Incurred	1,241	497	907
Payable	299	25
Carter Validus Real Estate Management Services II, LLC [Member] | Construction Management Fees [Member]
Related Party Transaction [Line Items]
Incurred	276	243	$ 719
Payable	$ 199	$ 40

Segment Reporting (Narrative) (

Segment Reporting (Narrative) (Details)	3 Months Ended								12 Months Ended
	Dec. 31, 2019USD ($)	Sep. 30, 2019USD ($)	Jun. 30, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Sep. 30, 2018USD ($)	Jun. 30, 2018USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2019USD ($)segment	Dec. 31, 2018USD ($)segment	Dec. 31, 2017USD ($)
Segment Reporting Information [Line Items]
Number of reportable business segments | segment									2	2
Rental revenue	$ 69,434,000	$ 48,063,000	$ 46,937,000	$ 46,467,000	$ 46,571,000	$ 45,517,000	$ 43,951,000	$ 41,294,000	$ 210,901,000	$ 177,333,000	$ 125,087,000
Intersegment Elimination [Member]
Segment Reporting Information [Line Items]
Rental revenue									$ 0	$ 0	$ 0

Segment Reporting (Schedule of

Segment Reporting (Schedule of Information for Reportable Segments) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Segment Reporting Information [Line Items]
Rental revenue	$ 69,434	$ 48,063	$ 46,937	$ 46,467	$ 46,571	$ 45,517	$ 43,951	$ 41,294	$ 210,901	$ 177,333	$ 125,087
Rental expenses									(40,984)	(37,327)	(26,096)
Income from operations	17,353	2,290	16,157	14,196	15,944	16,654	15,395	15,245	49,996	63,238	43,826
General and administrative expenses									(8,421)	(5,396)	(4,069)
Asset management fees									(16,475)	(13,114)	(9,963)
Depreciation and amortization									(74,104)	(58,258)	(41,133)
Impairment loss on real estate - healthcare	(8,000)	(13,000)							(21,000)	0	0
Gain on real estate disposition	79	0	0	0					79	0	0
Interest and other expense, net	(15,566)	(11,920)	(9,893)	(9,835)	(9,478)	(8,937)	(8,209)	(7,741)	(47,214)	(34,365)	(22,547)
Net income attributable to common stockholders	$ 1,787	$ (9,630)	$ 6,264	$ 4,361	$ 6,466	$ 7,717	$ 7,186	$ 7,504	2,782	28,873	21,279
Operating Segments [Member]
Segment Reporting Information [Line Items]
Rental revenue									210,901	177,333	125,087
Rental expenses									(40,984)	(37,327)	(26,096)
Income from operations									169,917	140,006	98,991
Operating Segments [Member] | Data Centers [Member]
Segment Reporting Information [Line Items]
Rental revenue									109,689	103,226	62,377
Rental expenses									(30,270)	(27,289)	(17,571)
Income from operations									79,419	75,937	44,806
Operating Segments [Member] | Healthcare [Member]
Segment Reporting Information [Line Items]
Rental revenue									101,212	74,107	62,710
Rental expenses									(10,714)	(10,038)	(8,525)
Income from operations									$ 90,498	$ 64,069	$ 54,185

Segment Reporting (Schedule o_2

Segment Reporting (Schedule of Assets by Reportable Segments) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Assets by segment [Line Items]
Total assets	$ 3,239,534	$ 1,963,829
Operating Segments [Member] | Data Centers [Member]
Assets by segment [Line Items]
Total assets	989,953	1,001,357
Operating Segments [Member] | Healthcare [Member]
Assets by segment [Line Items]
Total assets	2,184,450	900,114
All Other [Member]
Assets by segment [Line Items]
Total assets	$ 65,131	$ 62,358

Segment Reporting (Schedule o_3

Segment Reporting (Schedule of Capital Additions, Acquisitions and Dispositions by Reportable Segments) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Capital additions and acquisitions by segment [Line Items]
Capital additions by segment:	$ 12,841	$ 15,583	$ 32,511
Acquisitions by segment:	528,259	217,332	604,372
Dispositions by segment:	(2,882)	0	0
Total capital additions, acquisitions and dispositions	538,218	232,915	636,883
Operating Segments [Member] | Data Centers [Member]
Capital additions and acquisitions by segment [Line Items]
Capital additions by segment:	7,004	2,763	197
Acquisitions by segment:	0	112,181	472,241
Dispositions by segment:	0	0	0
Operating Segments [Member] | Healthcare [Member]
Capital additions and acquisitions by segment [Line Items]
Capital additions by segment:	5,837	12,820	32,314
Acquisitions by segment:	528,259	105,151	132,131
Dispositions by segment:	$ (2,882)	$ 0	$ 0

Fair Value (Narrative) (Details

Fair Value (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Fair Value [Line Items]
Notes payable, principal amount outstanding	$ 457,345		$ 457,345	$ 467,786
Credit facility, principal amount outstanding	908,000		908,000	355,000
Note receivable, outstanding principal balance	2,700		2,700	0
Real estate assets, carrying amount	2,768,462		2,768,462	1,673,732
Impairment loss on real estate	8,000	$ 13,000	21,000	0	$ 0
Fair Value, Measurements, Nonrecurring [Member]
Fair Value [Line Items]
Real estate assets, fair value	22,412		22,412
Impairment loss on real estate			8,000
Fixed Rate [Member]
Fair Value [Line Items]
Notes payable, principal amount outstanding	219,567		219,567	220,351
Variable Rate, Fixed Through Interest Rate Swaps [Member]
Fair Value [Line Items]
Notes payable, principal amount outstanding	237,778		237,778	247,435
Credit facility, principal amount outstanding	250,000		250,000	100,000
Variable Rate [Member]
Fair Value [Line Items]
Credit facility, principal amount outstanding	658,000		658,000	255,000
Significant Other Observable Inputs (Level 2) [Member] | Fair Value, Measurements, Nonrecurring [Member]
Fair Value [Line Items]
Real estate assets, carrying amount	30,412	40,266	30,412
Real estate assets, fair value	22,412	$ 27,266	22,412
Estimate of Fair Value Measurement [Member] | Significant Other Observable Inputs (Level 2) [Member] | Fixed Rate [Member]
Fair Value [Line Items]
Notes payable, fair value disclosure	222,816		222,816	214,282
Estimate of Fair Value Measurement [Member] | Significant Other Observable Inputs (Level 2) [Member] | Variable Rate, Fixed Through Interest Rate Swaps [Member]
Fair Value [Line Items]
Notes payable, fair value disclosure	238,555		238,555	241,739
Credit facility, fair value disclosure	$ 251,907		$ 251,907	$ 96,146

Fair Value (Schedule of Fair Va

Fair Value (Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Assets:
Derivative assets	$ 884	$ 6,204
Liabilities:
Derivative liabilities	5,588	0
Recurring basis [Member]
Assets:
Derivative assets	884	6,204
Total assets at fair value	884	6,204
Liabilities:
Derivative liabilities	5,588
Total liabilities at fair value	5,588
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Recurring basis [Member]
Assets:
Derivative assets	0	0
Total assets at fair value	0	0
Liabilities:
Derivative liabilities	0
Total liabilities at fair value	0
Significant Other Observable Inputs (Level 2) [Member] | Recurring basis [Member]
Assets:
Derivative assets	884	6,204
Total assets at fair value	884	6,204
Liabilities:
Derivative liabilities	5,588
Total liabilities at fair value	5,588
Significant Unobservable Inputs (Level 3) [Member] | Recurring basis [Member]
Assets:
Derivative assets	0	0
Total assets at fair value	0	$ 0
Liabilities:
Derivative liabilities	0
Total liabilities at fair value	$ 0

Fair Value (Schedule of Fair _2

Fair Value (Schedule of Fair Value, Real Estate Assets Measured on Non-Recurring Basis) (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Losses	$ 8,000	$ 13,000	$ 21,000	$ 0	$ 0
Fair Value, Measurements, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Real estate assets, fair value	22,412		22,412
Total Losses			8,000
Fair Value, Measurements, Nonrecurring [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Real estate assets, fair value	0		0
Fair Value, Measurements, Nonrecurring [Member] | Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Real estate assets, fair value	22,412	$ 27,266	22,412
Fair Value, Measurements, Nonrecurring [Member] | Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Real estate assets, fair value	$ 0		$ 0

Derivative Instruments and He_3

Derivative Instruments and Hedging Activities (Narrative) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Loss on hedged forecasted transaction becoming probable not to occur	$ 92
Additional amount expected to be reclassified from AOCI into earnings during next twelve months	1,352
Derivatives in a net liability position	$ 5,926

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities (Schedule of the Notional Amount and Fair Value of Derivative Instruments) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)interest_rate_swap_agreement	Jan. 01, 2020USD ($)	Apr. 01, 2019USD ($)	Dec. 31, 2018USD ($)
Derivatives, Fair Value [Line Items]
Fair Value of Asset	$ 884			$ 6,204
Fair Value of (Liability)	(5,588)			0
Credit facility, principal amount outstanding	908,000			355,000
Variable Rate, Fixed Through Interest Rate Swaps [Member]
Derivatives, Fair Value [Line Items]
Credit facility, principal amount outstanding	250,000			100,000
Term Loan [Member] | Variable Rate, Fixed Through Interest Rate Swaps [Member]
Derivatives, Fair Value [Line Items]
Credit facility, principal amount outstanding	250,000		$ 150,000	100,000
Term Loan [Member] | Variable Rate, Fixed Through Interest Rate Swaps [Member] | Subsequent Event [Member]
Derivatives, Fair Value [Line Items]
Credit facility, principal amount outstanding		$ 150,000
Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Outstanding Notional Amount	$ 637,778			347,435
Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member] | Minimum [Member]
Derivatives, Fair Value [Line Items]
Effective Dates	Jul. 1, 2016
Maturity Dates	Dec. 22, 2020
Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member] | Maximum [Member]
Derivatives, Fair Value [Line Items]
Effective Dates	Jan. 1, 2020
Maturity Dates	Dec. 31, 2024
Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member] | Other Assets, Net [Member]
Derivatives, Fair Value [Line Items]
Fair Value of Asset	$ 884			6,204
Interest Rate Swaps [Member] | Designated as Hedging Instrument [Member] | Accounts Payable and Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Fair Value of (Liability)	$ (5,588)			$ 0
Effective April 1, 2019 [Member]
Derivatives, Fair Value [Line Items]
Number of interest rate swap agreements entered into during period | interest_rate_swap_agreement	2
Effective January 1, 2020 [Member]
Derivatives, Fair Value [Line Items]
Number of interest rate swap agreements entered into during period | interest_rate_swap_agreement	3

Derivative Instruments and He_5

Derivative Instruments and Hedging Activities (Schedule of Income and Losses Recognized on Derivative Instruments) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (Loss) Income Recognized in OCI on Derivatives									$ (9,305)	$ 3,208	$ 1,484
Amount of Income (Loss) Reclassified From Accumulated Other Comprehensive Income to Net Income									1,602	818	(1,386)
Interest and other expense, net	$ 15,566	$ 11,920	$ 9,893	$ 9,835	$ 9,478	$ 8,937	$ 8,209	$ 7,741	47,214	34,365	22,547
Interest Rate Swaps [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (Loss) Income Recognized in OCI on Derivatives									(9,305)	3,208	1,484
Interest Rate Swaps [Member] | Interest and Other Expense, Net [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Income (Loss) Reclassified From Accumulated Other Comprehensive Income to Net Income									$ 1,602	$ 818	$ (1,386)

Derivative Instruments and He_6

Derivative Instruments and Hedging Activities (Schedule of Offsetting of Derivative Assets) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gross Amounts of Recognized Assets	$ 884	$ 6,204
Gross Amounts Offset in the Balance Sheet	0	0
Net Amounts of Assets Presented in the Balance Sheet	884	6,204
Gross Amounts Not Offset in the Balance Sheet, Financial Instruments Collateral	(5)	0
Gross Amounts Not Offset in the Balance Sheet, Cash Collateral	0	0
Net Amount	$ 879	$ 6,204

Derivative Instruments and He_7

Derivative Instruments and Hedging Activities (Schedule of Offsetting of Derivative Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gross Amounts of Recognized Liabilities	$ 5,588	$ 0
Gross Amounts Offset in the Balance Sheet	0	0
Net Amounts of Liabilities Presented in the Balance Sheet	5,588	0
Gross Amounts Not Offset in the Balance Sheet, Financial Instruments Collateral	(5)	0
Gross Amounts Not Offset in the Balance Sheet, Cash Collateral	0	0
Net Amount	$ 5,583	$ 0

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) (Schedule of Amounts Recognized in Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Jan. 01, 2019
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	$ 1,047,383
Cumulative effect of accounting change				$ 0
Beginning Balance	1,738,417	$ 1,047,383
Ending Balance	1,738,417	1,047,383
Unrealized Income (Loss) on Derivative Instruments [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning Balance	6,100	3,710	$ 840
Cumulative effect of accounting change				103
Beginning Balance	(4,704)	6,100	3,710	$ 6,203
Other comprehensive (loss) income before reclassification	(9,305)	3,208	1,484
Amount of (income) loss reclassified from accumulated other comprehensive income to net income	(1,602)	(818)	1,386
Other comprehensive (loss) income	(10,907)	2,390	2,870
Ending Balance	$ (4,704)	$ 6,100	$ 3,710

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Loss) (Schedule of Reclassifications Out of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest and other expense, net	$ 15,566	$ 11,920	$ 9,893	$ 9,835	$ 9,478	$ 8,937	$ 8,209	$ 7,741	$ 47,214	$ 34,365	$ 22,547
Interest Rate Swaps [Member] | Unrealized Income (Loss) on Derivative Instruments [Member] | Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest and other expense, net									$ (1,602)	$ (818)	$ 1,386

Stock-based Compensation (Narra

Stock-based Compensation (Narrative) (Details) - Class A shares [Member] - 2014 Restricted Share Plan [Member] - Restricted Stock [Member] - USD ($)	Sep. 25, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of authorized and reserved shares of common stock under plan (in shares)		300,000
Award vesting period under plan		4 years
Number of shares awarded to independent board members upon re-election	12,000	12,000
Grant date fair value, per share (in dollars per share)		$ 9.25
Unrecognized compensation expense		$ 215,000	$ 192,000
Unrecognized compensation expense, weighted average period of recognition		2 years 3 months
Fair value of nonvested shares of restricted common stock		$ 240,038	235,875
Stock-based compensation expense		$ 89,000	$ 90,000	$ 76,000

Stock-based Compensation (Sched

Stock-based Compensation (Schedule of Nonvested Shares of Restricted Common Stock Activity) (Details) - Class A shares [Member] - 2014 Restricted Share Plan [Member] - Restricted Stock [Member] - shares	Sep. 25, 2019	Dec. 31, 2019
Summary of Restricted Common Stock Activity, Nonvested, Number of Shares [Roll Forward]
Beginning balance (in shares)		25,500
Vested (in shares)		(9,750)
Granted (in shares)	12,000	12,000
Ending balance (in shares)		27,750

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Impact related to uncertain tax positions from the results of operations		$ 0	$ 0	$ 0
Interest expense or penalties related to unrecognized tax benefits	$ 0

Income Taxes (Schedule of Chara

Income Taxes (Schedule of Characterization of Distributions Paid to Stockholders) (Details)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Class A shares [Member]
Income Taxes [Line Items]
Ordinary dividends (as a percent)	17.93%	41.38%	36.49%
Capital gain distributions (as a percent)	0.38%	0.00%	0.00%
Nontaxable distributions (as a percent)	81.69%	58.62%	63.51%
Total (as a percent)	100.00%	100.00%	100.00%
Class I shares [Member]
Income Taxes [Line Items]
Ordinary dividends (as a percent)	17.93%	41.38%	36.49%
Capital gain distributions (as a percent)	0.38%	0.00%	0.00%
Nontaxable distributions (as a percent)	81.69%	58.62%	63.51%
Total (as a percent)	100.00%	100.00%	100.00%
Class T shares [Member]
Income Taxes [Line Items]
Ordinary dividends (as a percent)	4.79%	33.01%	25.93%
Capital gain distributions (as a percent)	0.43%	0.00%	0.00%
Nontaxable distributions (as a percent)	94.78%	66.99%	74.07%
Total (as a percent)	100.00%	100.00%	100.00%
Class T2 shares [Member]
Income Taxes [Line Items]
Ordinary dividends (as a percent)	4.79%	33.01%	0.00%
Capital gain distributions (as a percent)	0.43%	0.00%	0.00%
Nontaxable distributions (as a percent)	94.78%	66.99%	0.00%
Total (as a percent)	100.00%	100.00%	0.00%

Commitments and Contingencies (

Commitments and Contingencies (Details)	Dec. 31, 2019case
Commitments and Contingencies Disclosure [Abstract]
Number of pending legal proceedings to which the Company is a party	0

Selected Quarterly Financial _3

Selected Quarterly Financial Data (Unaudited) (Schedule of Selected Quarterly Financial Data (Unaudited)) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Selected Quarterly Financial Information [Abstract]
Total revenue	$ 69,434	$ 48,063	$ 46,937	$ 46,467	$ 46,571	$ 45,517	$ 43,951	$ 41,294	$ 210,901	$ 177,333	$ 125,087
Total expenses	(52,160)	(45,773)	(30,780)	(32,271)	(30,627)	(28,863)	(28,556)	(26,049)	(160,984)	(114,095)	(81,261)
Gain on real estate disposition	79	0	0	0					79	0	0
Income from operations	17,353	2,290	16,157	14,196	15,944	16,654	15,395	15,245	49,996	63,238	43,826
Interest and other expense, net	(15,566)	(11,920)	(9,893)	(9,835)	(9,478)	(8,937)	(8,209)	(7,741)	(47,214)	(34,365)	(22,547)
Net income (loss) attributable to common stockholders	$ 1,787	$ (9,630)	$ 6,264	$ 4,361	$ 6,466	$ 7,717	$ 7,186	$ 7,504	$ 2,782	$ 28,873	$ 21,279
Net income (loss) per common share attributable to common stockholders:
Basic (in dollars per share)	$ 0.01	$ (0.07)	$ 0.05	$ 0.03	$ 0.05	$ 0.06	$ 0.06	$ 0.06	$ 0.02	$ 0.22	$ 0.21
Diluted (in dollars per share)	$ 0.01	$ (0.07)	$ 0.05	$ 0.03	$ 0.05	$ 0.06	$ 0.06	$ 0.06	$ 0.02	$ 0.22	$ 0.21
Weighted average number of common shares outstanding:
Basic (in shares)	218,928,165	137,063,509	136,135,710	136,179,343	135,271,638	132,467,127	129,926,130	126,384,346	157,247,345	131,040,645	101,714,148
Diluted (in shares)	218,955,915	137,063,509	136,161,037	136,204,843	135,297,138	132,491,755	129,948,432	126,401,940	157,271,668	131,064,388	101,731,944

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details) - USD ($)	Mar. 10, 2020	Sep. 25, 2019	Dec. 31, 2019	Mar. 19, 2020	Mar. 06, 2020
Restricted Stock [Member] | 2014 Restricted Share Plan [Member] | Class A shares [Member]
Subsequent Event [Line Items]
Number of authorized and reserved shares of common stock under plan (in shares)			300,000
Granted (in shares)		12,000	12,000
Grant date fair value, per share (in dollars per share)			$ 9.25
Award vesting period under plan			4 years
Subsequent Event [Member] | Annual Retainer [Member] | Independent Director [Member]
Subsequent Event [Line Items]
Compensation arrangement, amount					$ 90,000
Subsequent Event [Member] | Additional Annual Retainer [Member] | Chairman of Audit Committee [Member]
Subsequent Event [Line Items]
Compensation arrangement, amount					15,000
Subsequent Event [Member] | Quarterly In-Person Board Meeting [Member] | Independent Director [Member]
Subsequent Event [Line Items]
Compensation arrangement, amount					$ 2,500
Subsequent Event [Member] | Quarterly In-Person or Telephonic Board Meeting [Member] | Independent Director [Member]
Subsequent Event [Line Items]
Compensation arrangement, amount				$ 2,500
Subsequent Event [Member] | Restricted Stock [Member] | 2014 Restricted Share Plan [Member] | Class A shares [Member]
Subsequent Event [Line Items]
Number of authorized and reserved shares of common stock under plan (in shares)					5,000,000
Granted (in shares)	2,415
Grant date fair value, per share (in dollars per share)	$ 8.65
Grant date, value of shares awarded per annum	$ 60,000
Award vesting period under plan	3 years
Award vesting under plan (as %)	33.34%

Subsequent Events (Schedule of

Subsequent Events (Schedule of Subsequent Events - Distributions Paid to Stockholders) (Details) - USD ($) $ in Thousands	Mar. 03, 2020	Feb. 03, 2020	Jan. 02, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Subsequent Event [Line Items]
Cash Distribution				$ 49,494	$ 40,296	$ 28,994
Common stock issued through distribution reinvestment plan				$ 39,934	$ 40,938	$ 32,264
Subsequent Event [Member] | December 1, 2019 To December 31, 2019 [Member]
Subsequent Event [Line Items]
Cash Distribution			$ 6,446
Common stock issued through distribution reinvestment plan			2,647
Total Distribution			9,093
Subsequent Event [Member] | December 1, 2019 To December 31, 2019 [Member] | Class A shares [Member]
Subsequent Event [Line Items]
Cash Distribution			5,442
Common stock issued through distribution reinvestment plan			1,648
Total Distribution			7,090
Subsequent Event [Member] | December 1, 2019 To December 31, 2019 [Member] | Class I shares [Member]
Subsequent Event [Line Items]
Cash Distribution			323
Common stock issued through distribution reinvestment plan			215
Total Distribution			538
Subsequent Event [Member] | December 1, 2019 To December 31, 2019 [Member] | Class T shares [Member]
Subsequent Event [Line Items]
Cash Distribution			628
Common stock issued through distribution reinvestment plan			715
Total Distribution			1,343
Subsequent Event [Member] | December 1, 2019 To December 31, 2019 [Member] | Class T2 shares [Member]
Subsequent Event [Line Items]
Cash Distribution			53
Common stock issued through distribution reinvestment plan			69
Total Distribution			$ 122
Subsequent Event [Member] | January 1, 2020 To January 31, 2020 [Member]
Subsequent Event [Line Items]
Cash Distribution		$ 6,438
Common stock issued through distribution reinvestment plan		2,640
Total Distribution		9,078
Subsequent Event [Member] | January 1, 2020 To January 31, 2020 [Member] | Class A shares [Member]
Subsequent Event [Line Items]
Cash Distribution		5,431
Common stock issued through distribution reinvestment plan		1,646
Total Distribution		7,077
Subsequent Event [Member] | January 1, 2020 To January 31, 2020 [Member] | Class I shares [Member]
Subsequent Event [Line Items]
Cash Distribution		324
Common stock issued through distribution reinvestment plan		213
Total Distribution		537
Subsequent Event [Member] | January 1, 2020 To January 31, 2020 [Member] | Class T shares [Member]
Subsequent Event [Line Items]
Cash Distribution		631
Common stock issued through distribution reinvestment plan		712
Total Distribution		1,343
Subsequent Event [Member] | January 1, 2020 To January 31, 2020 [Member] | Class T2 shares [Member]
Subsequent Event [Line Items]
Cash Distribution		52
Common stock issued through distribution reinvestment plan		69
Total Distribution		$ 121
Subsequent Event [Member] | February 1, 2020 To February 29, 2020 [Member]
Subsequent Event [Line Items]
Cash Distribution	$ 6,004
Common stock issued through distribution reinvestment plan	2,446
Total Distribution	8,450
Subsequent Event [Member] | February 1, 2020 To February 29, 2020 [Member] | Class A shares [Member]
Subsequent Event [Line Items]
Cash Distribution	5,060
Common stock issued through distribution reinvestment plan	1,526
Total Distribution	6,586
Subsequent Event [Member] | February 1, 2020 To February 29, 2020 [Member] | Class I shares [Member]
Subsequent Event [Line Items]
Cash Distribution	299
Common stock issued through distribution reinvestment plan	197
Total Distribution	496
Subsequent Event [Member] | February 1, 2020 To February 29, 2020 [Member] | Class T shares [Member]
Subsequent Event [Line Items]
Cash Distribution	595
Common stock issued through distribution reinvestment plan	660
Total Distribution	1,255
Subsequent Event [Member] | February 1, 2020 To February 29, 2020 [Member] | Class T2 shares [Member]
Subsequent Event [Line Items]
Cash Distribution	50
Common stock issued through distribution reinvestment plan	63
Total Distribution	$ 113

Subsequent Events (Schedule o_2

Subsequent Events (Schedule of Subsequent Events - Distributions Authorized) (Details) - $ / shares	Feb. 24, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Subsequent Event [Line Items]
Daily Distribution Rate (in dollars per share)		$ 0.58	$ 0.63	$ 0.62
Subsequent Event [Member] | Class A shares [Member] | March 1, 2020 To May 31, 2020 [Member]
Subsequent Event [Line Items]
Daily Distribution Rate (in dollars per share)	$ 0.001366120
Annualized Distribution Per Share (in dollars per share)	0.50
Subsequent Event [Member] | Class I shares [Member] | March 1, 2020 To May 31, 2020 [Member]
Subsequent Event [Line Items]
Daily Distribution Rate (in dollars per share)	0.001366120
Annualized Distribution Per Share (in dollars per share)	0.50
Subsequent Event [Member] | Class T shares [Member] | March 1, 2020 To May 31, 2020 [Member]
Subsequent Event [Line Items]
Daily Distribution Rate (in dollars per share)	0.001129781
Annualized Distribution Per Share (in dollars per share)	0.41
Subsequent Event [Member] | Class T2 shares [Member] | March 1, 2020 To May 31, 2020 [Member]
Subsequent Event [Line Items]
Daily Distribution Rate (in dollars per share)	0.001129781
Annualized Distribution Per Share (in dollars per share)	$ 0.41
Subsequent Event [Member] | Class A, I, T and T2 shares [Member] | March 1, 2020 To May 31, 2020 [Member]
Subsequent Event [Line Items]
Number of days, distribution calculation	366 days

Subsequent Events (Schedule o_3

Subsequent Events (Schedule of Subsequent Events - Acquisitions) (Details) - USD ($)	Feb. 19, 2020	Dec. 31, 2019
Subsequent Event [Line Items]
Contract Purchase Price		$ 1,301,630,000
Subsequent Event [Member] | Grimes Healthcare Facility [Member]
Subsequent Event [Line Items]
Date Acquired	Feb. 19, 2020
Contract Purchase Price	$ 4,825,000
Ownership Percentage	100.00%

SCHEDULE III - REAL ESTATE AS_2

SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION (SCHEDULE OF REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 457,345
Initial Cost, Land	345,152
Initial Cost, Buildings and Improvements	2,505,097
Cost Capitalized Subsequent to Acquisition	46,517
Gross Amount Carried at Close of Period, Land	343,444
Gross Amount Carried at Close of Period, Buildings and Improvements	2,553,322
Gross Amount Carried at Close of Period, Total	2,896,766	$ 1,758,326	$ 1,551,194	$ 915,521
Accumulated Depreciation	128,304	$ 84,594	$ 45,789	$ 18,521
Houston Healthcare Facility, f.k.a. Cy Fair Surgical Center [Member] | Houston, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	762
Initial Cost, Buildings and Improvements	2,970
Cost Capitalized Subsequent to Acquisition	106
Gross Amount Carried at Close of Period, Land	762
Gross Amount Carried at Close of Period, Buildings and Improvements	3,076
Gross Amount Carried at Close of Period, Total	3,838
Accumulated Depreciation	551
Cincinnati Healthcare Facility, f.k.a. Mercy Healthcare Facility [Member] | Cincinnati, OH [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	356
Initial Cost, Buildings and Improvements	3,167
Cost Capitalized Subsequent to Acquisition	89
Gross Amount Carried at Close of Period, Land	356
Gross Amount Carried at Close of Period, Buildings and Improvements	3,256
Gross Amount Carried at Close of Period, Total	3,612
Accumulated Depreciation	504
Winston-Salem Healthcare Facility, f.k.a. Winston-Salem, NC IMF [Member] | Winston-Salem, NC [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	684
Initial Cost, Buildings and Improvements	4,903
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	684
Gross Amount Carried at Close of Period, Buildings and Improvements	4,903
Gross Amount Carried at Close of Period, Total	5,587
Accumulated Depreciation	736
Stoughton Healthcare Facility, f.k.a. New England Sinai Medical Center [Member] | Stoughton, MA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	4,049
Initial Cost, Buildings and Improvements	19,991
Cost Capitalized Subsequent to Acquisition	1,918
Gross Amount Carried at Close of Period, Land	4,049
Gross Amount Carried at Close of Period, Buildings and Improvements	21,909
Gross Amount Carried at Close of Period, Total	25,958
Accumulated Depreciation	2,965
Fort Worth Healthcare Facility, f.k.a. Baylor Surgical Hospital at Fort Worth [Member] | Fort Worth, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	8,297
Initial Cost, Buildings and Improvements	35,615
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	8,297
Gross Amount Carried at Close of Period, Buildings and Improvements	35,615
Gross Amount Carried at Close of Period, Total	43,912
Accumulated Depreciation	4,707
Fort Worth Healthcare Facility II, f.k.a. Baylor Surgical Hospital Integrated Medical Facility [Member] | Fort Worth, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	367
Initial Cost, Buildings and Improvements	1,587
Cost Capitalized Subsequent to Acquisition	164
Gross Amount Carried at Close of Period, Land	367
Gross Amount Carried at Close of Period, Buildings and Improvements	1,751
Gross Amount Carried at Close of Period, Total	2,118
Accumulated Depreciation	399
Winter Haven Healthcare Facility [Member] | Winter Haven, FL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	2,805
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	2,805
Gross Amount Carried at Close of Period, Total	2,805
Accumulated Depreciation	386
Overland Park Healthcare Facility, f.k.a. Heartland Rehabilitation Hospital [Member] | Overland Park, KS [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,558
Initial Cost, Buildings and Improvements	20,549
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,558
Gross Amount Carried at Close of Period, Buildings and Improvements	20,549
Gross Amount Carried at Close of Period, Total	22,107
Accumulated Depreciation	2,633
Indianapolis Data Center [Member] | Indianapolis, IN [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	524
Initial Cost, Buildings and Improvements	6,422
Cost Capitalized Subsequent to Acquisition	37
Gross Amount Carried at Close of Period, Land	524
Gross Amount Carried at Close of Period, Buildings and Improvements	6,459
Gross Amount Carried at Close of Period, Total	6,983
Accumulated Depreciation	789
Clarion Healthcare Facility, f.k.a. Clarion IMF [Member] | Clarion, PA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	462
Initial Cost, Buildings and Improvements	5,377
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	462
Gross Amount Carried at Close of Period, Buildings and Improvements	5,377
Gross Amount Carried at Close of Period, Total	5,839
Accumulated Depreciation	826
Webster Healthcare Facility, f.k.a. Post Acute Webster Rehabilitation Hospital [Member] | Webster, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,858
Initial Cost, Buildings and Improvements	20,140
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,858
Gross Amount Carried at Close of Period, Buildings and Improvements	20,140
Gross Amount Carried at Close of Period, Total	21,998
Accumulated Depreciation	2,399
Eagan Data Center [Member] | Eagan, MN [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	768
Initial Cost, Buildings and Improvements	5,037
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	768
Gross Amount Carried at Close of Period, Buildings and Improvements	5,037
Gross Amount Carried at Close of Period, Total	5,805
Accumulated Depreciation	706
Houston Healthcare Facility II, f.k.a. Houston Surgical Hospital and LTACH [Member] | Houston, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	8,329
Initial Cost, Buildings and Improvements	36,297
Cost Capitalized Subsequent to Acquisition	(17,360)
Gross Amount Carried at Close of Period, Land	8,329
Gross Amount Carried at Close of Period, Buildings and Improvements	18,937
Gross Amount Carried at Close of Period, Total	27,266
Accumulated Depreciation	151
Augusta Healthcare Facility, f.k.a. KMO IMF - Augusta [Member] | Augusta, ME [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	556
Initial Cost, Buildings and Improvements	14,401
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	556
Gross Amount Carried at Close of Period, Buildings and Improvements	14,401
Gross Amount Carried at Close of Period, Total	14,957
Accumulated Depreciation	1,816
Cincinnati Healthcare Facility II, f.k.a. KMO IMF - Cincinnati I [Member] | Cincinnati, OH [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,812
Initial Cost, Buildings and Improvements	24,382
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,812
Gross Amount Carried at Close of Period, Buildings and Improvements	24,382
Gross Amount Carried at Close of Period, Total	26,194
Accumulated Depreciation	3,177
Cincinnati Healthcare Facility III, f.k.a. KMO IMF - Cincinnati II [Member] | Cincinnati, OH [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	446
Initial Cost, Buildings and Improvements	10,239
Cost Capitalized Subsequent to Acquisition	4
Gross Amount Carried at Close of Period, Land	446
Gross Amount Carried at Close of Period, Buildings and Improvements	10,243
Gross Amount Carried at Close of Period, Total	10,689
Accumulated Depreciation	1,214
Florence Healthcare Facility, f.k.a. KMO IMF - Florence [Member] | Florence, KY [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	650
Initial Cost, Buildings and Improvements	9,919
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	650
Gross Amount Carried at Close of Period, Buildings and Improvements	9,919
Gross Amount Carried at Close of Period, Total	10,569
Accumulated Depreciation	1,172
Oakland Healthcare Facility, f.k.a. KMO IMF - Oakland [Member] | Oakland, ME [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	229
Initial Cost, Buildings and Improvements	5,416
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	229
Gross Amount Carried at Close of Period, Buildings and Improvements	5,416
Gross Amount Carried at Close of Period, Total	5,645
Accumulated Depreciation	738
Wyomissing Healthcare Facility, f.k.a. Reading Surgical Hospital [Member] | Wyomissing, PA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,504
Initial Cost, Buildings and Improvements	20,193
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,504
Gross Amount Carried at Close of Period, Buildings and Improvements	20,193
Gross Amount Carried at Close of Period, Total	21,697
Accumulated Depreciation	2,433
Luling Healthcare Facility, f.k.a. Post Acute Warm Springs Specialty Hospital of Luling [Member] | Luling, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	824
Initial Cost, Buildings and Improvements	7,530
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	824
Gross Amount Carried at Close of Period, Buildings and Improvements	7,530
Gross Amount Carried at Close of Period, Total	8,354
Accumulated Depreciation	902
Minnetonka Data Center [Member] | Minnetonka, MN [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,085
Initial Cost, Buildings and Improvements	15,099
Cost Capitalized Subsequent to Acquisition	119
Gross Amount Carried at Close of Period, Land	1,999
Gross Amount Carried at Close of Period, Buildings and Improvements	15,304
Gross Amount Carried at Close of Period, Total	17,303
Accumulated Depreciation	2,343
Omaha Healthcare Facility, f.k.a. Nebraska Healthcare Facility [Member] | Omaha, NE [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,259
Initial Cost, Buildings and Improvements	9,796
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,259
Gross Amount Carried at Close of Period, Buildings and Improvements	9,796
Gross Amount Carried at Close of Period, Total	11,055
Accumulated Depreciation	1,083
Sherman Healthcare Facility, f.k.a. Heritage Park - Sherman I [Member] | Sherman, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,679
Initial Cost, Buildings and Improvements	23,926
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,679
Gross Amount Carried at Close of Period, Buildings and Improvements	23,926
Gross Amount Carried at Close of Period, Total	25,605
Accumulated Depreciation	2,564
Sherman Healthcare Facility II, f.k.a. Heritage Park - Sherman II [Member] | Sherman, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	214
Initial Cost, Buildings and Improvements	3,209
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	214
Gross Amount Carried at Close of Period, Buildings and Improvements	3,209
Gross Amount Carried at Close of Period, Total	3,423
Accumulated Depreciation	347
Fort Worth Healthcare Facility III, f.k.a. Baylor Surgery Center at Fort Worth [Member] | Fort Worth, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	3,120
Initial Cost, Buildings and Improvements	9,312
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	3,120
Gross Amount Carried at Close of Period, Buildings and Improvements	9,312
Gross Amount Carried at Close of Period, Total	12,432
Accumulated Depreciation	990
Oklahoma City Healthcare Facility, f.k.a. HPI - Oklahoma City I [Member] | Oklahoma City, OK [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	22,259
Initial Cost, Land	4,626
Initial Cost, Buildings and Improvements	30,509
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	4,626
Gross Amount Carried at Close of Period, Buildings and Improvements	30,509
Gross Amount Carried at Close of Period, Total	35,135
Accumulated Depreciation	3,348
Oklahoma City Healthcare Facility II, f.k.a. HPI - Oklahoma City II [Member] | Oklahoma City, OK [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	991
Initial Cost, Buildings and Improvements	8,366
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	991
Gross Amount Carried at Close of Period, Buildings and Improvements	8,366
Gross Amount Carried at Close of Period, Total	9,357
Accumulated Depreciation	976
Waco Data Center [Member] | Waco, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	873
Initial Cost, Buildings and Improvements	8,233
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	873
Gross Amount Carried at Close of Period, Buildings and Improvements	8,233
Gross Amount Carried at Close of Period, Total	9,106
Accumulated Depreciation	842
Edmond Healthcare Facility, f.k.a. HPI - Edmond [Member] | Edmond, OK [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	796
Initial Cost, Buildings and Improvements	3,199
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	796
Gross Amount Carried at Close of Period, Buildings and Improvements	3,199
Gross Amount Carried at Close of Period, Total	3,995
Accumulated Depreciation	372
Oklahoma City Healthcare Facility III, f.k.a. HPI - Oklahoma City IV [Member] | Oklahoma City, OK [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	452
Initial Cost, Buildings and Improvements	1,081
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	452
Gross Amount Carried at Close of Period, Buildings and Improvements	1,081
Gross Amount Carried at Close of Period, Total	1,533
Accumulated Depreciation	129
Oklahoma City Healthcare Facility IV, f.k.a. HPI - Oklahoma City III [Member] | Oklahoma City, OK [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	368
Initial Cost, Buildings and Improvements	2,344
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	368
Gross Amount Carried at Close of Period, Buildings and Improvements	2,344
Gross Amount Carried at Close of Period, Total	2,712
Accumulated Depreciation	273
Alpharetta Data Center, f.k.a. Alpharetta Data Center III [Member] | Alpharetta, GA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	3,395
Initial Cost, Buildings and Improvements	11,081
Cost Capitalized Subsequent to Acquisition	25
Gross Amount Carried at Close of Period, Land	3,395
Gross Amount Carried at Close of Period, Buildings and Improvements	11,106
Gross Amount Carried at Close of Period, Total	14,501
Accumulated Depreciation	1,193
Flint Data Center [Member] | Flint, MI [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	111
Initial Cost, Buildings and Improvements	7,001
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	111
Gross Amount Carried at Close of Period, Buildings and Improvements	7,001
Gross Amount Carried at Close of Period, Total	7,112
Accumulated Depreciation	735
Newcastle Healthcare Facility, f.k.a. HPI - Newcastle [Member] | Newcastle, OK [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	412
Initial Cost, Buildings and Improvements	1,173
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	412
Gross Amount Carried at Close of Period, Buildings and Improvements	1,173
Gross Amount Carried at Close of Period, Total	1,585
Accumulated Depreciation	138
Oklahoma City Healthcare Facility V, f.k.a. HPI - Oklahoma City V [Member] | Oklahoma City, OK [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	541
Initial Cost, Buildings and Improvements	12,445
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	541
Gross Amount Carried at Close of Period, Buildings and Improvements	12,445
Gross Amount Carried at Close of Period, Total	12,986
Accumulated Depreciation	1,423
Rancho Mirage Healthcare Facility, f.k.a. Vibra Rehabilitation Hospital [Member] | Rancho Mirage, CA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,724
Initial Cost, Buildings and Improvements	7,626
Cost Capitalized Subsequent to Acquisition	29,844
Gross Amount Carried at Close of Period, Land	2,726
Gross Amount Carried at Close of Period, Buildings and Improvements	37,468
Gross Amount Carried at Close of Period, Total	40,194
Accumulated Depreciation	1,288
Oklahoma City Healthcare Facility VI, f.k.a. HPI - Oklahoma City VI [Member] | Oklahoma City, OK [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	896
Initial Cost, Buildings and Improvements	3,684
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	896
Gross Amount Carried at Close of Period, Buildings and Improvements	3,684
Gross Amount Carried at Close of Period, Total	4,580
Accumulated Depreciation	424
Franklin Data Center, f.k.a. Tennessee Data Center [Member] | Franklin, TN [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	6,624
Initial Cost, Buildings and Improvements	10,971
Cost Capitalized Subsequent to Acquisition	135
Gross Amount Carried at Close of Period, Land	6,624
Gross Amount Carried at Close of Period, Buildings and Improvements	11,106
Gross Amount Carried at Close of Period, Total	17,730
Accumulated Depreciation	1,138
Oklahoma City Healthcare Facility VII, f.k.a. HPI - Oklahoma City VII [Member] | Oklahoma City, OK [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	24,547
Initial Cost, Land	3,203
Initial Cost, Buildings and Improvements	32,380
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	3,203
Gross Amount Carried at Close of Period, Buildings and Improvements	32,380
Gross Amount Carried at Close of Period, Total	35,583
Accumulated Depreciation	3,009
Las Vegas Healthcare Facility, f.k.a. Post Acute Las Vegas Rehabilitation Hospital [Member] | Las Vegas, NV [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,614
Initial Cost, Buildings and Improvements	639
Cost Capitalized Subsequent to Acquisition	22,091
Gross Amount Carried at Close of Period, Land	2,895
Gross Amount Carried at Close of Period, Buildings and Improvements	22,449
Gross Amount Carried at Close of Period, Total	25,344
Accumulated Depreciation	1,209
Somerset Data Center [Member] | Somerset, NJ [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	906
Initial Cost, Buildings and Improvements	10,466
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	906
Gross Amount Carried at Close of Period, Buildings and Improvements	10,466
Gross Amount Carried at Close of Period, Total	11,372
Accumulated Depreciation	1,071
Oklahoma City Healthcare Facility VIII, f.k.a. Integris Lakeside Women's Hospital [Member] | Oklahoma City, OK [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,002
Initial Cost, Buildings and Improvements	15,384
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	2,002
Gross Amount Carried at Close of Period, Buildings and Improvements	15,384
Gross Amount Carried at Close of Period, Total	17,386
Accumulated Depreciation	1,410
Hawthorne Data Center, f.k.a. AT&T Hawthorne Data Center [Member] | Hawthorne, CA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	39,749
Initial Cost, Land	16,498
Initial Cost, Buildings and Improvements	57,312
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	16,498
Gross Amount Carried at Close of Period, Buildings and Improvements	57,312
Gross Amount Carried at Close of Period, Total	73,810
Accumulated Depreciation	4,797
McLean Data Center, f.k.a. McLean I [Member] | McLean, VA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	23,460
Initial Cost, Land	31,554
Initial Cost, Buildings and Improvements	4,930
Cost Capitalized Subsequent to Acquisition	330
Gross Amount Carried at Close of Period, Land	31,554
Gross Amount Carried at Close of Period, Buildings and Improvements	5,260
Gross Amount Carried at Close of Period, Total	36,814
Accumulated Depreciation	464
McLean Data Center II, f.k.a. McLean II [Member] | McLean, VA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	27,540
Initial Cost, Land	20,392
Initial Cost, Buildings and Improvements	22,727
Cost Capitalized Subsequent to Acquisition	105
Gross Amount Carried at Close of Period, Land	20,392
Gross Amount Carried at Close of Period, Buildings and Improvements	22,832
Gross Amount Carried at Close of Period, Total	43,224
Accumulated Depreciation	1,883
Marlton Healthcare Facility, f.k.a. Select Medical Rehabilitation Facility [Member] | Marlton, NJ [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	31,145
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	57,154
Cost Capitalized Subsequent to Acquisition	5
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	57,159
Gross Amount Carried at Close of Period, Total	57,159
Accumulated Depreciation	4,467
Andover Data Center, f.k.a. Andover Data Center II [Member] | Andover, MA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	6,566
Initial Cost, Buildings and Improvements	28,072
Cost Capitalized Subsequent to Acquisition	514
Gross Amount Carried at Close of Period, Land	6,566
Gross Amount Carried at Close of Period, Buildings and Improvements	28,586
Gross Amount Carried at Close of Period, Total	35,152
Accumulated Depreciation	2,497
Grand Rapids Healthcare Facility [Member] | Grand Rapids, MI [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	21,766
Initial Cost, Land	2,533
Initial Cost, Buildings and Improvements	39,487
Cost Capitalized Subsequent to Acquisition	95
Gross Amount Carried at Close of Period, Land	2,533
Gross Amount Carried at Close of Period, Buildings and Improvements	39,582
Gross Amount Carried at Close of Period, Total	42,115
Accumulated Depreciation	3,831
Corpus Christi Healthcare Facility, f.k.a. Corpus Christi Surgery Center [Member] | Corpus Christi, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	975
Initial Cost, Buildings and Improvements	4,963
Cost Capitalized Subsequent to Acquisition	462
Gross Amount Carried at Close of Period, Land	1,002
Gross Amount Carried at Close of Period, Buildings and Improvements	5,398
Gross Amount Carried at Close of Period, Total	6,400
Accumulated Depreciation	459
Chicago Data Center, f.k.a. Chicago Data Center II [Member] | Downers Grove, IL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,329
Initial Cost, Buildings and Improvements	29,940
Cost Capitalized Subsequent to Acquisition	(545)
Gross Amount Carried at Close of Period, Land	1,358
Gross Amount Carried at Close of Period, Buildings and Improvements	29,366
Gross Amount Carried at Close of Period, Total	30,724
Accumulated Depreciation	2,276
Blythewood Data Center [Member] | Blythewood, SC [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	612
Initial Cost, Buildings and Improvements	17,714
Cost Capitalized Subsequent to Acquisition	27
Gross Amount Carried at Close of Period, Land	634
Gross Amount Carried at Close of Period, Buildings and Improvements	17,719
Gross Amount Carried at Close of Period, Total	18,353
Accumulated Depreciation	1,375
Tempe Data Center [Member] | Tempe, AZ [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,997
Initial Cost, Buildings and Improvements	11,991
Cost Capitalized Subsequent to Acquisition	132
Gross Amount Carried at Close of Period, Land	2,997
Gross Amount Carried at Close of Period, Buildings and Improvements	12,123
Gross Amount Carried at Close of Period, Total	15,120
Accumulated Depreciation	937
Aurora Healthcare Facility [Member] | Aurora, IL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	973
Initial Cost, Buildings and Improvements	9,632
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	973
Gross Amount Carried at Close of Period, Buildings and Improvements	9,632
Gross Amount Carried at Close of Period, Total	10,605
Accumulated Depreciation	726
Norwalk Data Center [Member] | Norwalk, CT [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	34,200
Initial Cost, Land	10,125
Initial Cost, Buildings and Improvements	43,360
Cost Capitalized Subsequent to Acquisition	94
Gross Amount Carried at Close of Period, Land	10,125
Gross Amount Carried at Close of Period, Buildings and Improvements	43,454
Gross Amount Carried at Close of Period, Total	53,579
Accumulated Depreciation	3,096
Allen Healthcare Facility, f.k.a. Texas Rehab - Allen [Member] | Allen, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	13,136
Initial Cost, Land	857
Initial Cost, Buildings and Improvements	20,582
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	857
Gross Amount Carried at Close of Period, Buildings and Improvements	20,582
Gross Amount Carried at Close of Period, Total	21,439
Accumulated Depreciation	1,547
Austin Healthcare Facility, f.k.a. Texas Rehab - Austin [Member] | Austin, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	20,861
Initial Cost, Land	1,368
Initial Cost, Buildings and Improvements	32,039
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,368
Gross Amount Carried at Close of Period, Buildings and Improvements	32,039
Gross Amount Carried at Close of Period, Total	33,407
Accumulated Depreciation	2,408
Beaumont Healthcare Facility, f.k.a. Texas Rehab - Beaumont | Beaumont, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	5,863
Initial Cost, Land	946
Initial Cost, Buildings and Improvements	8,372
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	946
Gross Amount Carried at Close of Period, Buildings and Improvements	8,372
Gross Amount Carried at Close of Period, Total	9,318
Accumulated Depreciation	633
Charlotte Data Center, f.k.a. Charlotte Data Center II [Member] | Charlotte, NC [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	372
Initial Cost, Buildings and Improvements	17,131
Cost Capitalized Subsequent to Acquisition	3,206
Gross Amount Carried at Close of Period, Land	372
Gross Amount Carried at Close of Period, Buildings and Improvements	20,337
Gross Amount Carried at Close of Period, Total	20,709
Accumulated Depreciation	1,387
Atlanta Data Center, f.k.a. 250 Williams Atlanta Data Center [Member] | Atlanta, GA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	116,200
Initial Cost, Land	19,159
Initial Cost, Buildings and Improvements	129,778
Cost Capitalized Subsequent to Acquisition	6,397
Gross Amount Carried at Close of Period, Land	19,159
Gross Amount Carried at Close of Period, Buildings and Improvements	136,175
Gross Amount Carried at Close of Period, Total	155,334
Accumulated Depreciation	12,264
Sunnyvale Data Center [Member] | Sunnyvale, CA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	10,013
Initial Cost, Buildings and Improvements	24,709
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	10,013
Gross Amount Carried at Close of Period, Buildings and Improvements	24,709
Gross Amount Carried at Close of Period, Total	34,722
Accumulated Depreciation	1,616
San Antonio Healthcare Facility, f.k.a. Texas Rehab - San Antonio [Member] | San Antonio, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	10,490
Initial Cost, Land	1,813
Initial Cost, Buildings and Improvements	11,706
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,813
Gross Amount Carried at Close of Period, Buildings and Improvements	11,706
Gross Amount Carried at Close of Period, Total	13,519
Accumulated Depreciation	807
Cincinnati Data Center [Member] | Cincinnati, OH [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,556
Initial Cost, Buildings and Improvements	8,966
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,556
Gross Amount Carried at Close of Period, Buildings and Improvements	8,966
Gross Amount Carried at Close of Period, Total	10,522
Accumulated Depreciation	637
Silverdale Healthcare Facility [Member] | Silverdale, WA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,530
Initial Cost, Buildings and Improvements	7,506
Cost Capitalized Subsequent to Acquisition	15
Gross Amount Carried at Close of Period, Land	1,530
Gross Amount Carried at Close of Period, Buildings and Improvements	7,521
Gross Amount Carried at Close of Period, Total	9,051
Accumulated Depreciation	545
Silverdale Healthcare Facility II [Member] | Silverdale, WA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,542
Initial Cost, Buildings and Improvements	4,981
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,542
Gross Amount Carried at Close of Period, Buildings and Improvements	4,981
Gross Amount Carried at Close of Period, Total	6,523
Accumulated Depreciation	383
King of Prussia Data Center [Member] | King of Prussia, PA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	11,961
Initial Cost, Land	1,015
Initial Cost, Buildings and Improvements	17,413
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,015
Gross Amount Carried at Close of Period, Buildings and Improvements	17,413
Gross Amount Carried at Close of Period, Total	18,428
Accumulated Depreciation	1,031
Tempe Data Center II [Member] | Tempe, AZ [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	15,803
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	15,803
Gross Amount Carried at Close of Period, Total	15,803
Accumulated Depreciation	947
Houston Data Center [Member] | Houston, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	48,607
Initial Cost, Land	10,082
Initial Cost, Buildings and Improvements	101,051
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	10,082
Gross Amount Carried at Close of Period, Buildings and Improvements	101,051
Gross Amount Carried at Close of Period, Total	111,133
Accumulated Depreciation	5,447
Saginaw Healthcare Facility [Member] | Saginaw, MI [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,251
Initial Cost, Buildings and Improvements	15,878
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,251
Gross Amount Carried at Close of Period, Buildings and Improvements	15,878
Gross Amount Carried at Close of Period, Total	17,129
Accumulated Depreciation	1,148
Elgin Data Center [Member] | Elgin, IL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	5,561
Initial Cost, Land	1,067
Initial Cost, Buildings and Improvements	7,861
Cost Capitalized Subsequent to Acquisition	(421)
Gross Amount Carried at Close of Period, Land	1,067
Gross Amount Carried at Close of Period, Buildings and Improvements	7,440
Gross Amount Carried at Close of Period, Total	8,507
Accumulated Depreciation	413
Oklahoma City Data Center [Member] | Oklahoma City, OK [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,868
Initial Cost, Buildings and Improvements	44,253
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,868
Gross Amount Carried at Close of Period, Buildings and Improvements	44,253
Gross Amount Carried at Close of Period, Total	46,121
Accumulated Depreciation	2,322
Rancho Cordova Data Center, f.k.a. Rancho Cordova Data Center I [Member] | Rancho Cordova, CA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,760
Initial Cost, Buildings and Improvements	32,109
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,760
Gross Amount Carried at Close of Period, Buildings and Improvements	32,109
Gross Amount Carried at Close of Period, Total	33,869
Accumulated Depreciation	1,464
Rancho Cordova Data Center II [Member] | Rancho Cordova, CA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,943
Initial Cost, Buildings and Improvements	10,340
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,943
Gross Amount Carried at Close of Period, Buildings and Improvements	10,340
Gross Amount Carried at Close of Period, Total	12,283
Accumulated Depreciation	481
Carrollton Healthcare Facility [Member] | Carrollton, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,995
Initial Cost, Buildings and Improvements	5,870
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,995
Gross Amount Carried at Close of Period, Buildings and Improvements	5,870
Gross Amount Carried at Close of Period, Total	7,865
Accumulated Depreciation	278
Katy Healthcare Facility, f.k.a. Oceans Katy Behavioral Health Hospital [Member] | Katy, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,443
Initial Cost, Buildings and Improvements	12,114
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,443
Gross Amount Carried at Close of Period, Buildings and Improvements	12,114
Gross Amount Carried at Close of Period, Total	13,557
Accumulated Depreciation	485
San Jose Data Center [Member] | San Jose, CA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	12,205
Initial Cost, Buildings and Improvements	34,309
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	12,205
Gross Amount Carried at Close of Period, Buildings and Improvements	34,309
Gross Amount Carried at Close of Period, Total	46,514
Accumulated Depreciation	1,359
Indianola Healthcare Facility, f.k.a. Indianola Healthcare I [Member] | Indianola, IA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	330
Initial Cost, Buildings and Improvements	5,698
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	330
Gross Amount Carried at Close of Period, Buildings and Improvements	5,698
Gross Amount Carried at Close of Period, Total	6,028
Accumulated Depreciation	201
Indianola Healthcare Facility II, f.k.a. Indianola Healthcare II [Member] | Indianola, IA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	709
Initial Cost, Buildings and Improvements	6,061
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	709
Gross Amount Carried at Close of Period, Buildings and Improvements	6,061
Gross Amount Carried at Close of Period, Total	6,770
Accumulated Depreciation	221
Canton Data Center [Member] | Canton, OH [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	345
Initial Cost, Buildings and Improvements	8,268
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	345
Gross Amount Carried at Close of Period, Buildings and Improvements	8,268
Gross Amount Carried at Close of Period, Total	8,613
Accumulated Depreciation	259
Benton Healthcare Facility, f.k.a. Benton Healthcare I (Benton) [Member] | Benton, AR [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	19,048
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	19,048
Gross Amount Carried at Close of Period, Total	19,048
Accumulated Depreciation	625
Benton Healthcare Facility II, f.k.a. Benton Healthcare III (Benton) [Member] | Benton, AR [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	1,647
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	1,647
Gross Amount Carried at Close of Period, Total	1,647
Accumulated Depreciation	60
Bryant Healthcare Facility, f.k.a. Benton Healthcare II (Bryant) [Member] | Bryant, AR [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	930
Initial Cost, Buildings and Improvements	3,539
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	930
Gross Amount Carried at Close of Period, Buildings and Improvements	3,539
Gross Amount Carried at Close of Period, Total	4,469
Accumulated Depreciation	128
Hot Springs Healthcare Facility, f.k.a. Benton Healthcare IV (Hot Springs) [Member] | Hot Springs, AR [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	384
Initial Cost, Buildings and Improvements	2,077
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	384
Gross Amount Carried at Close of Period, Buildings and Improvements	2,077
Gross Amount Carried at Close of Period, Total	2,461
Accumulated Depreciation	78
Clive Healthcare Facility [Member] | Clive, IA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	336
Initial Cost, Buildings and Improvements	22,332
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	336
Gross Amount Carried at Close of Period, Buildings and Improvements	22,332
Gross Amount Carried at Close of Period, Total	22,668
Accumulated Depreciation	789
Valdosta Healthcare Facility, f.k.a. Valdosta Healthcare I [Member] | Valdosta, GA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	659
Initial Cost, Buildings and Improvements	5,626
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	659
Gross Amount Carried at Close of Period, Buildings and Improvements	5,626
Gross Amount Carried at Close of Period, Total	6,285
Accumulated Depreciation	199
Valdosta Healthcare Facility II, f.k.a. Valdosta Healthcare II [Member] | Valdosta, GA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	471
Initial Cost, Buildings and Improvements	2,780
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	471
Gross Amount Carried at Close of Period, Buildings and Improvements	2,780
Gross Amount Carried at Close of Period, Total	3,251
Accumulated Depreciation	100
Bryant Healthcare Facility II, f.k.a. Bryant Healthcare Facility [Member] | Bryant, AR [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	647
Initial Cost, Buildings and Improvements	3,364
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	647
Gross Amount Carried at Close of Period, Buildings and Improvements	3,364
Gross Amount Carried at Close of Period, Total	4,011
Accumulated Depreciation	36
Laredo Healthcare Facility [Member] | Laredo, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	12,137
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	12,137
Gross Amount Carried at Close of Period, Total	12,137
Accumulated Depreciation	96
Laredo Healthcare Facility II [Member] | Laredo, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	23,677
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	23,677
Gross Amount Carried at Close of Period, Total	23,677
Accumulated Depreciation	187
Poplar Bluff Healthcare Facility [Member] | Poplar Bluff, MO [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	13,515
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	13,515
Gross Amount Carried at Close of Period, Total	13,515
Accumulated Depreciation	107
Tucson Healthcare Facility [Member] | Tuscan, AZ [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	5,998
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	5,998
Gross Amount Carried at Close of Period, Total	5,998
Accumulated Depreciation	48
Akron Healthcare Facility [Member] | Green, OH [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	3,503
Initial Cost, Buildings and Improvements	38,512
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	3,503
Gross Amount Carried at Close of Period, Buildings and Improvements	38,512
Gross Amount Carried at Close of Period, Total	42,015
Accumulated Depreciation	214
Akron Healthcare Facility II [Member] | Green, OH [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,085
Initial Cost, Buildings and Improvements	10,277
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,085
Gross Amount Carried at Close of Period, Buildings and Improvements	10,277
Gross Amount Carried at Close of Period, Total	11,362
Accumulated Depreciation	69
Akron Healthcare Facility III [Member] | Akron OH [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,206
Initial Cost, Buildings and Improvements	26,044
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	2,206
Gross Amount Carried at Close of Period, Buildings and Improvements	26,044
Gross Amount Carried at Close of Period, Total	28,250
Accumulated Depreciation	140
Alexandria Healthcare Facility [Member] | Alexandria, LA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	5,076
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	5,076
Gross Amount Carried at Close of Period, Total	5,076
Accumulated Depreciation	27
Appleton Healthcare Facility [Member] | Appleton WI [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	414
Initial Cost, Buildings and Improvements	1,900
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	414
Gross Amount Carried at Close of Period, Buildings and Improvements	1,900
Gross Amount Carried at Close of Period, Total	2,314
Accumulated Depreciation	14
Austin Healthcare Facility II [Member] | Austin, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	3,229
Initial Cost, Buildings and Improvements	7,534
Cost Capitalized Subsequent to Acquisition	(2,807)
Gross Amount Carried at Close of Period, Land	2,195
Gross Amount Carried at Close of Period, Buildings and Improvements	5,761
Gross Amount Carried at Close of Period, Total	7,956
Accumulated Depreciation	32
Bellevue Healthcare Facility [Member] | Green Bay, WI [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	567
Initial Cost, Buildings and Improvements	1,269
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	567
Gross Amount Carried at Close of Period, Buildings and Improvements	1,269
Gross Amount Carried at Close of Period, Total	1,836
Accumulated Depreciation	9
Bonita Springs Healthcare Facility [Member] | Bonita Springs, FL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,199
Initial Cost, Buildings and Improvements	4,373
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,199
Gross Amount Carried at Close of Period, Buildings and Improvements	4,373
Gross Amount Carried at Close of Period, Total	5,572
Accumulated Depreciation	24
Bridgeton Healthcare Facility [Member] | Bridgeton, MO [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	39,740
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	39,740
Gross Amount Carried at Close of Period, Total	39,740
Accumulated Depreciation	212
Covington Healthcare Facility [Member] | Covington, LA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,238
Initial Cost, Buildings and Improvements	16,635
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	2,238
Gross Amount Carried at Close of Period, Buildings and Improvements	16,635
Gross Amount Carried at Close of Period, Total	18,873
Accumulated Depreciation	88
Crestview Healthcare Facility [Member] | Crestview, FL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	400
Initial Cost, Buildings and Improvements	1,536
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	400
Gross Amount Carried at Close of Period, Buildings and Improvements	1,536
Gross Amount Carried at Close of Period, Total	1,936
Accumulated Depreciation	9
Dallas Healthcare Facility [Member] | Dallas, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	6,072
Initial Cost, Buildings and Improvements	27,457
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	6,072
Gross Amount Carried at Close of Period, Buildings and Improvements	27,457
Gross Amount Carried at Close of Period, Total	33,529
Accumulated Depreciation	144
Dallas Healthcare Facility II [Member] | Dallas, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	3,611
Initial Cost, Buildings and Improvements	26,907
Cost Capitalized Subsequent to Acquisition	(8,106)
Gross Amount Carried at Close of Period, Land	2,662
Gross Amount Carried at Close of Period, Buildings and Improvements	19,750
Gross Amount Carried at Close of Period, Total	22,412
Accumulated Depreciation	0
De Pere Healthcare Facility [Member] | De Pere, WI [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	615
Initial Cost, Buildings and Improvements	1,596
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	615
Gross Amount Carried at Close of Period, Buildings and Improvements	1,596
Gross Amount Carried at Close of Period, Total	2,211
Accumulated Depreciation	11
Denver Healthcare Facility [Member] | Thornton, CO [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	3,586
Initial Cost, Buildings and Improvements	32,363
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	3,586
Gross Amount Carried at Close of Period, Buildings and Improvements	32,363
Gross Amount Carried at Close of Period, Total	35,949
Accumulated Depreciation	175
El Segundo Healthcare Facility [Member] | El Segundo, CA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,659
Initial Cost, Buildings and Improvements	9,016
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	2,659
Gross Amount Carried at Close of Period, Buildings and Improvements	9,016
Gross Amount Carried at Close of Period, Total	11,675
Accumulated Depreciation	49
Fairlea Healthcare Facility [Member] | Fairlea, WV [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	139
Initial Cost, Buildings and Improvements	1,910
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	139
Gross Amount Carried at Close of Period, Buildings and Improvements	1,910
Gross Amount Carried at Close of Period, Total	2,049
Accumulated Depreciation	11
Fayetteville Healthcare Facility [Member] | Fayetteville, AR [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	485
Initial Cost, Buildings and Improvements	24,855
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	485
Gross Amount Carried at Close of Period, Buildings and Improvements	24,855
Gross Amount Carried at Close of Period, Total	25,340
Accumulated Depreciation	132
Fort Myers Healthcare Facility [Member] | Fort Myers, FL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,153
Initial Cost, Buildings and Improvements	2,387
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	2,153
Gross Amount Carried at Close of Period, Buildings and Improvements	2,387
Gross Amount Carried at Close of Period, Total	4,540
Accumulated Depreciation	16
Fort Myers Healthcare Facility II Member] | Fort Myers, FL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	3,557
Initial Cost, Buildings and Improvements	11,064
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	3,557
Gross Amount Carried at Close of Period, Buildings and Improvements	11,064
Gross Amount Carried at Close of Period, Total	14,621
Accumulated Depreciation	69
Fort Walton Beach Healthcare Facility [Member] | Fort Walton Beach, FL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	385
Initial Cost, Buildings and Improvements	3,182
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	385
Gross Amount Carried at Close of Period, Buildings and Improvements	3,182
Gross Amount Carried at Close of Period, Total	3,567
Accumulated Depreciation	18
Frankfort Healthcare Facility [Member] | Frankfort, KY [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	342
Initial Cost, Buildings and Improvements	950
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	342
Gross Amount Carried at Close of Period, Buildings and Improvements	950
Gross Amount Carried at Close of Period, Total	1,292
Accumulated Depreciation	6
Frisco Healthcare Facility [Member] | Frisco, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	22,114
Cost Capitalized Subsequent to Acquisition	4,200
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	26,314
Gross Amount Carried at Close of Period, Total	26,314
Accumulated Depreciation	125
Goshen Healthcare Facility [Member] | Goshen, IN [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	383
Initial Cost, Buildings and Improvements	5,355
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	383
Gross Amount Carried at Close of Period, Buildings and Improvements	5,355
Gross Amount Carried at Close of Period, Total	5,738
Accumulated Depreciation	31
Grapevine Healthcare Facility [Member] | Grapevine, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,726
Initial Cost, Buildings and Improvements	26,849
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,726
Gross Amount Carried at Close of Period, Buildings and Improvements	26,849
Gross Amount Carried at Close of Period, Total	28,575
Accumulated Depreciation	144
Hammond Healthcare Facility [Member] | Hammond, LA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,693
Initial Cost, Buildings and Improvements	23,750
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	2,693
Gross Amount Carried at Close of Period, Buildings and Improvements	23,750
Gross Amount Carried at Close of Period, Total	26,443
Accumulated Depreciation	131
Hammond Healthcare Facility II [Member] | Hammond, LA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	950
Initial Cost, Buildings and Improvements	12,147
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	950
Gross Amount Carried at Close of Period, Buildings and Improvements	12,147
Gross Amount Carried at Close of Period, Total	13,097
Accumulated Depreciation	66
Harlingen Healthcare Facility [Member] | Harlingen, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	10,628
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	10,628
Gross Amount Carried at Close of Period, Total	10,628
Accumulated Depreciation	61
Henderson Healthcare Facility [Member] | Henderson, NV [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	839
Initial Cost, Buildings and Improvements	2,390
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	839
Gross Amount Carried at Close of Period, Buildings and Improvements	2,390
Gross Amount Carried at Close of Period, Total	3,229
Accumulated Depreciation	14
Houston Healthcare Facility III [Member] | Houston, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	752
Initial Cost, Buildings and Improvements	5,832
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	752
Gross Amount Carried at Close of Period, Buildings and Improvements	5,832
Gross Amount Carried at Close of Period, Total	6,584
Accumulated Depreciation	31
Howard Healthcare Facility [Member] | Howard, WI [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	529
Initial Cost, Buildings and Improvements	1,818
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	529
Gross Amount Carried at Close of Period, Buildings and Improvements	1,818
Gross Amount Carried at Close of Period, Total	2,347
Accumulated Depreciation	13
Jacksonville Healthcare Facility [Member] | Jacksonville, FL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,233
Initial Cost, Buildings and Improvements	6,173
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,233
Gross Amount Carried at Close of Period, Buildings and Improvements	6,173
Gross Amount Carried at Close of Period, Total	7,406
Accumulated Depreciation	35
Lafayette Healthcare Facility [Member] | Lafayette, LA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	4,819
Initial Cost, Buildings and Improvements	35,424
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	4,819
Gross Amount Carried at Close of Period, Buildings and Improvements	35,424
Gross Amount Carried at Close of Period, Total	40,243
Accumulated Depreciation	191
Lakewood Ranch Healthcare Facility [Member] | Lakewood Ranch, FL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	636
Initial Cost, Buildings and Improvements	1,784
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	636
Gross Amount Carried at Close of Period, Buildings and Improvements	1,784
Gross Amount Carried at Close of Period, Total	2,420
Accumulated Depreciation	13
Las Vegas Healthcare Facility II [Member] | Las Vegas, NV [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	651
Initial Cost, Buildings and Improvements	5,323
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	651
Gross Amount Carried at Close of Period, Buildings and Improvements	5,323
Gross Amount Carried at Close of Period, Total	5,974
Accumulated Depreciation	18
Lehigh Acres Healthcare Facility [Member] | Lehigh Acres, FL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	441
Initial Cost, Buildings and Improvements	2,956
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	441
Gross Amount Carried at Close of Period, Buildings and Improvements	2,956
Gross Amount Carried at Close of Period, Total	3,397
Accumulated Depreciation	17
Lubbock Healthcare Facility [Member] | Lubbock, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	5,210
Initial Cost, Buildings and Improvements	39,939
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	5,210
Gross Amount Carried at Close of Period, Buildings and Improvements	39,939
Gross Amount Carried at Close of Period, Total	45,149
Accumulated Depreciation	212
Manitowoc Healthcare Facility [Member] | Manitowoc, WI [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	257
Initial Cost, Buildings and Improvements	1,733
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	257
Gross Amount Carried at Close of Period, Buildings and Improvements	1,733
Gross Amount Carried at Close of Period, Total	1,990
Accumulated Depreciation	12
Manitowoc Healthcare Facility II [Member] | Manitowoc, WI [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	250
Initial Cost, Buildings and Improvements	11,231
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	250
Gross Amount Carried at Close of Period, Buildings and Improvements	11,231
Gross Amount Carried at Close of Period, Total	11,481
Accumulated Depreciation	66
Marinette Healthcare Facility [Member] | Marinette, WI [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	208
Initial Cost, Buildings and Improvements	1,002
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	208
Gross Amount Carried at Close of Period, Buildings and Improvements	1,002
Gross Amount Carried at Close of Period, Total	1,210
Accumulated Depreciation	7
New Bedford Healthcare Facility [Member] | New Bedford, MA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,464
Initial Cost, Buildings and Improvements	26,297
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	2,464
Gross Amount Carried at Close of Period, Buildings and Improvements	26,297
Gross Amount Carried at Close of Period, Total	28,761
Accumulated Depreciation	143
New Braunfels Healthcare Facility [Member] | New Braunfels, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,568
Initial Cost, Buildings and Improvements	11,386
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	2,568
Gross Amount Carried at Close of Period, Buildings and Improvements	11,386
Gross Amount Carried at Close of Period, Total	13,954
Accumulated Depreciation	61
North Smithfield Healthcare Facility [Member] | North Smithfield, RI [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,309
Initial Cost, Buildings and Improvements	14,024
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,309
Gross Amount Carried at Close of Period, Buildings and Improvements	14,024
Gross Amount Carried at Close of Period, Total	15,333
Accumulated Depreciation	80
Oklahoma Healthcare Facility IX [Member] | Oklahoma City, OK [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,316
Initial Cost, Buildings and Improvements	9,822
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,316
Gross Amount Carried at Close of Period, Buildings and Improvements	9,822
Gross Amount Carried at Close of Period, Total	11,138
Accumulated Depreciation	60
Oshkosh Healthcare Facility [Member] | Oshkosh Wisconsin [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	414
Initial Cost, Buildings and Improvements	2,043
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	414
Gross Amount Carried at Close of Period, Buildings and Improvements	2,043
Gross Amount Carried at Close of Period, Total	2,457
Accumulated Depreciation	14
Palm Desert Healthcare Facility [Member] | Palm Desert, California [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	582
Initial Cost, Buildings and Improvements	5,927
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	582
Gross Amount Carried at Close of Period, Buildings and Improvements	5,927
Gross Amount Carried at Close of Period, Total	6,509
Accumulated Depreciation	36
Rancho Mirage Healthcare Facility II [Member] | Rancho Mirage, CA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,286
Initial Cost, Buildings and Improvements	5,481
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	2,286
Gross Amount Carried at Close of Period, Buildings and Improvements	5,481
Gross Amount Carried at Close of Period, Total	7,767
Accumulated Depreciation	32
San Antonio Healthcare Facility II [Member] | San Antonio, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	5,935
Initial Cost, Buildings and Improvements	23,411
Cost Capitalized Subsequent to Acquisition	221
Gross Amount Carried at Close of Period, Land	5,935
Gross Amount Carried at Close of Period, Buildings and Improvements	23,632
Gross Amount Carried at Close of Period, Total	29,567
Accumulated Depreciation	128
San Antonio Healthcare Facility III [Member] | San Antonio, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,824
Initial Cost, Buildings and Improvements	22,809
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,824
Gross Amount Carried at Close of Period, Buildings and Improvements	22,809
Gross Amount Carried at Close of Period, Total	24,633
Accumulated Depreciation	120
San Antonio Healthcare Facility IV [Member] | San Antonio, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	31,694
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	31,694
Gross Amount Carried at Close of Period, Total	31,694
Accumulated Depreciation	167
San Antonio Healthcare Facility V [Member] | San Antonio, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	3,273
Initial Cost, Buildings and Improvements	19,697
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	3,273
Gross Amount Carried at Close of Period, Buildings and Improvements	19,697
Gross Amount Carried at Close of Period, Total	22,970
Accumulated Depreciation	110
Santa Rosa Beach Healthcare Facility [Member] | Santa Rosa Beach, FL [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	741
Initial Cost, Buildings and Improvements	3,049
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	741
Gross Amount Carried at Close of Period, Buildings and Improvements	3,049
Gross Amount Carried at Close of Period, Total	3,790
Accumulated Depreciation	16
Savannah Healthcare Facility [Member] | Savannah, GA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	2,300
Initial Cost, Buildings and Improvements	20,186
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	2,300
Gross Amount Carried at Close of Period, Buildings and Improvements	20,186
Gross Amount Carried at Close of Period, Total	22,486
Accumulated Depreciation	107
St. Louis Healthcare Facility [Member] | Creve Coeur, MO [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,164
Initial Cost, Buildings and Improvements	8,052
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	1,164
Gross Amount Carried at Close of Period, Buildings and Improvements	8,052
Gross Amount Carried at Close of Period, Total	9,216
Accumulated Depreciation	45
Sturgeon Bay Healthcare Facility [Member] | Sturgeon Bay, WI [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	248
Initial Cost, Buildings and Improvements	700
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	248
Gross Amount Carried at Close of Period, Buildings and Improvements	700
Gross Amount Carried at Close of Period, Total	948
Accumulated Depreciation	5
Victoria Healthcare Facility [Member] | Victoria, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	328
Initial Cost, Buildings and Improvements	12,908
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	328
Gross Amount Carried at Close of Period, Buildings and Improvements	12,908
Gross Amount Carried at Close of Period, Total	13,236
Accumulated Depreciation	70
Victoria Healthcare Facility II [Member] | Victoria, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	446
Initial Cost, Buildings and Improvements	12,986
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	446
Gross Amount Carried at Close of Period, Buildings and Improvements	12,986
Gross Amount Carried at Close of Period, Total	13,432
Accumulated Depreciation	70
Webster Healthcare Facility II [Member] | Webster, TX [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	7,371
Initial Cost, Buildings and Improvements	243,983
Cost Capitalized Subsequent to Acquisition	2,505
Gross Amount Carried at Close of Period, Land	7,371
Gross Amount Carried at Close of Period, Buildings and Improvements	246,488
Gross Amount Carried at Close of Period, Total	253,859
Accumulated Depreciation	1,274
Wilkes-Barre Healthcare Facility [Member] | Mountain Top, PA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	821
Initial Cost, Buildings and Improvements	4,139
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	821
Gross Amount Carried at Close of Period, Buildings and Improvements	4,139
Gross Amount Carried at Close of Period, Total	4,960
Accumulated Depreciation	26
Yucca Valley Healthcare Facility [Member] | Yucca Valley, CA [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	901
Initial Cost, Buildings and Improvements	4,788
Cost Capitalized Subsequent to Acquisition	0
Gross Amount Carried at Close of Period, Land	901
Gross Amount Carried at Close of Period, Buildings and Improvements	4,788
Gross Amount Carried at Close of Period, Total	5,689
Accumulated Depreciation	31
Tucson Healthcare Facility II [Member] | Tucson, AZ [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	0
Initial Cost, Buildings and Improvements	0
Cost Capitalized Subsequent to Acquisition	1,764
Gross Amount Carried at Close of Period, Land	0
Gross Amount Carried at Close of Period, Buildings and Improvements	1,764
Gross Amount Carried at Close of Period, Total	1,764
Accumulated Depreciation	0
Tucson Healthcare Facility III [Member] | Tucson, AZ [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial Cost, Land	1,763
Initial Cost, Buildings and Improvements	0
Cost Capitalized Subsequent to Acquisition	1,152
Gross Amount Carried at Close of Period, Land	1,763
Gross Amount Carried at Close of Period, Buildings and Improvements	1,152
Gross Amount Carried at Close of Period, Total	2,915
Accumulated Depreciation	$ 0

SCHEDULE III - REAL ESTATE AS_3

SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION (SCHEDULE OF REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION - NARRATIVE) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)property	Dec. 31, 2018USD ($)
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Number of properties collateralized under line of credit facility | property	128
Credit facility, principal amount outstanding	$ 908,000	$ 355,000
Aggregated cost for federal income tax purposes	$ 3,138,568
Minimum [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Life used for depreciation	15 years
Maximum [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Life used for depreciation	40 years

SCHEDULE III - REAL ESTATE AS_4

SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION (SCHEDULE OF REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION - ROLLFORWARD) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate [Roll Forward]
Balance at beginning of year	$ 1,758,326	$ 1,551,194	$ 915,521
Acquisitions	1,151,827	195,328	601,546
Improvements	15,084	11,804	34,127
Impairment	(25,501)	0	0
Dispositions	(2,807)	0	0
Other adjustments	(163)	0	0
Balance at end of year	2,896,766	1,758,326	1,551,194
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation [Roll Forward]
Balance at beginning of year	(84,594)	(45,789)	(18,521)
Depreciation	(48,215)	(38,805)	(27,268)
Impairment	4,501	0	0
Dispositions	4	0	0
Balance at end of year	$ (128,304)	$ (84,594)	$ (45,789)

Uncategorized Items - cik000156

Label	Element	Value
Parent [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 0
Noncontrolling Interest [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 0